






















Holistic complex systems modelling approaches for cell signalling 





submitted in partial fulfilment 
of the requirements for the Degree of 














Abstract of a thesis submitted in partial fulfilment of the 
requirements for the Degree of Doctor of Philosophy in Computer Science. 
Abstract 
Holistic complex systems modelling approaches for cell signalling networks - 




Cell cycle is a precisely regulated process in which cells of living organisms go through a sophisticated 
growth and division cycle that eventually leads to production of two daughter cells (Morgan, 2007; 
Satyanarayana & Kaldis, 2009). The progression of cell cycle is monitored through different 
checkpoints to guarantee the genome integrity (Kastan & Bartek, 2004; Novák et al., 2001; Nyberg et 
al., 2002; Walworth, 2000). Understanding the underlying mechanism and behaviour of these 
checkpoints is one of the most important topics in biology. In this study, Ordinary Differential 
Equation (ODE) and Petri Net (PN) modelling techniques and numerical analyses have been used to 
gain deeper insights into (i) the efficiency of checkpoints in detecting damaged/healthy cells, (ii) 
identifying the most significant parts of the system on G1-S and G2-M transitions, (iii) and the 
behaviour of the whole mammalian cell cycle control system (not just a part of it) from a systems 
perspective where all the crucial cell cycle sub-systems interact with each other to control cell cycle 
progression.  
This research begins with identifying the current gaps in the field of mammalian cell cycle modelling. 
The findings led us to developing a comprehensive mathematical model with all the missing essential 
components to integrate the important cell cycle sub-systems (Growth Factor, G1-S checkpoint, G2-
M checkpoint and DNA damage signalling sub-systems) and their constituent modules (i.e., modules 
of G2-M sub-system are: Cdk1_Related, Tyrosine Phosphatase, Tyrosine Kinase, APC-Related and 
Plk1-Related modules). This arrangement maintains the functionality of the cell cycle control system 
while giving a better understanding of the underlying interactions by lessening the complexity of the 
system as a whole. The proposed comprehensive mathematical model was evaluated and further 
analysed in order to investigate the behaviour of mammalian cell cycle system and DNA damage 
response as well as to verify the role of the newly added components in cell cycle. 
The next part of this research is devoted to system behaviour analysis using parameters of the 
comprehensive mathematical model presented in the first section of the thesis. Therefore, we 
 iii 
developed an analytical model (named SOMCCA) based on Self-Organizing Map (SOM) and 
Correlation Coefficient Analysis (CCA) to perform Global Sensitivity Analysis (GSA) on model 
parameters. Through this analysis, the most significant parameters, modules and sub-systems on G1-
S and G2-M transitions were identified. The results of the SOMCCA model revealed that two sub-
systems (the Growth Factor signalling and G1-S checkpoint) and seven parameters in the modules 
within them are significant on G1-S and G2-M transitions. 
The third part of this research investigates the efficacy of cell cycle checkpoints in correctly detecting 
damaged and healthy cells under DNA damage condition as there is biological evidence that G2-M 
checkpoint is relatively more efficient in detecting damaged/healthy cells in comparison to G1-S 
checkpoint. To do this analysis, we developed a model called Checkpoint Efficiency Evaluation (CEE) 
model based on statistical Type II error and Probability Density Function (PDF) of Peak Times (PTs) of 
G1-S and G2-M indicators (CycE_Cdk2 and CycB_Cdk1, respectively). The CEE model was applied to 
the comprehensive mathematical model presented in the first part of the thesis and the results were 
in good agreement with biological findings.  
Having developed a comprehensive mathematical model in the first part of this thesis, the main 
focus of the last part of the thesis is to perform a model abstraction in order to develop an abstract 
minimised model where the main characteristics of the model (such as dynamics of cell cycle core 
components, G1-S and G2-M transitions and response to DNA damage) remain qualitatively the 
same. First step towards model abstraction was to determine the key components that should be 
present in the abstract model. This was done based on the most significant parameters of the 
comprehensive model identified in the second part of the thesis. The next step was to determine the 
most suitable modelling approach. The presence of different time scales (from quick activations to 
slow synthesis processes) as well as presentation at different levels (from sub-systems down to 
modules and proteins) led us to choose Petri Net (PN) modelling for model abstraction because PN 
can be developed as a hybrid model and it is also an intuitive graphical approach that has the ability 
to present complex systems at different levels of abstraction. Therefore, we developed a hybrid PN-
based model called Multi-Level Hybrid Petri Net (MLHPN). The MLHPN model has just four equations 
while the comprehensive model has 61 equations. In order to scrutinize the efficiency of G1-S and 
G2-M checkpoints in correctly detecting damaged and healthy cells, the CEE model was applied to 
the MLHPN model, and similar to the analysis results for the comprehensive model, the results for 
the MLHPN model showed that G2-M is more efficient than G1-S. 
In conclusion, this study showed the value of computational modelling (Ordinary Differential 
Equations (ODE) and Petri Net (PN)-based models) and Artificial Neural Networks/statistical methods 
(Self Organising Maps and Correlation Coefficient Analysis (SOMCCA) and Checkpoint Efficiency 
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Evaluation (CEE) models) in comprehending complex signalling networks and obtaining deeper 
insights into the underlying mechanisms of the mammalian cell cycle control system from a systems 
point of view integrating all the essential cell cycle sub-systems including G1-S and G2-M 
checkpoints, the Growth Factor signalling and the DNA damage signalling pathway. Furthermore, the 
thesis showed the importance of newly added components and modules along with the Artificial 
Neural Networks and statistics based numerical investigation to identify the most significant parts of 
the system on system response. The demonstration of the value of the comprehensive mathematical 
model and the MLHPN model in investigating the efficiency of G1-S and G2-M checkpoints and 
verifying the greater efficiency of G2-M checkpoint in correctly detecting damaged/healthy cells is an 
important contribution of this research. Finally, this research demonstrated the value of model 
abstraction from a comprehensive model with 61 equations down to a hybrid PN-based model with 
just four equations while the system characteristics remained the same. 
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List of Publications 
 
Publications from this thesis: 
 
• Abroudi, A., Samarasinghe, S., & Kulasiri, D. (2017). A comprehensive complex systems 
approach to the study and analysis of mammalian cell cycle control system in the presence of 
DNA damage stress. Journal of Theoretical Biology (JTB), 429, 204-228. 
• Abroudi, A., Samarasinghe, S., & Kulasiri, D. (2015). A Review of Computational Models of 
Mammalian Cell Cycle. Paper presented at the meeting of the 21st International Congress on 
Modelling and Simulation (MODSIM), Australia. 
• Abroudi, A., Samarasinghe, S. (2015). System Modelling of Mammalian Cell Cycle Regulation 
Using Multi-Level Hybrid Petri Nets. Paper presented at the meeting of the 21st International 
Congress on Modelling and Simulation (MODSIM), Australia. 
Abstract presentations from this thesis: 
 
• Abroudi, A. (2014). System Modelling in Biology – Mammalian Cell Cycle. Abstract presented 
at the Lincoln University Postgraduate Conference,  Lincoln, New Zealand. 
• Abroudi, A. (2015). Multi-Level Modelling of Cell Cycle System - A Petri Net Approach. 
Abstract presented at the Lincoln University Postgraduate Conference, Lincoln, New Zealand. 
Submitted to Journal of Theoretical Biology (JTB) - 2019: 
 
• Abroudi, A., Samarasinghe, S., & Kulasiri, D. Towards Abstraction of Computational Modelling 




I would like to express my sincere gratitude to my supervisors Prof. Sandhya Samarasinghe and Prof. 
Don Kulasiri for the continuous support of my Ph.D, for thier patience, motivation, and immense 
knowledge. Their guidance helped me during all the time of research and writing of this thesis. I 
could not have imagined having a better supervisors and mentors for my research. 
I greatly appreciate Lincoln University for granting me the Lincoln University Doctoral Scholarship 
which gave me the opportunity to undertake this research and I have always been proud of holding 
this prestigious scholarship. I also greatly thank Lincoln university for supporting me to attend 
conferences and meet so many interesting people. I take this opportunity to thank the administrative 
staff of the Faculty of Environment, Society and Design: Douglas Broughton, Tracey Shields, and 
Michelle Collings for their friendly and professional support. My gratitude goes out to the Library, 
Teaching and Learning of Lincoln University for holding helpful academic workshops.  
Last but not least, I would like to thank my parents for their great support, although they were 
thousands miles away, they listened to me and my challenges everyday. I also want to greatly thank 
my lovely wife, Zohreh, for supporting me. Without her encouragement, I would have never been 












Table of Contents 
Abstract ............................................................................................................................................. ii 
List of Publications............................................................................................................................. v 
Acknowledgements .......................................................................................................................... vi 
Table of Contents ............................................................................................................................ vii 
List of Tables ...................................................................................................................................... x 
List of Figures.................................................................................................................................... xi 
Chapter 1 Introduction ...................................................................................................................... 1 
 Overview .................................................................................................................................. 1 
 Research Motivation ................................................................................................................ 2 
 Research Objectives ................................................................................................................. 3 
Chapter 2 Literature Review ............................................................................................................ 11 
 Overview ................................................................................................................................ 11 
 Mammalian Cell Cycle Regulation ........................................................................................... 12 
2.2.1 Cell Cycle Events ........................................................................................................ 13 
2.2.2 Key Cell Cycle Regulators ........................................................................................... 14 
2.2.3 Cell Cycle Progression ................................................................................................ 18 
2.2.4 DNA Damage Checkpoints .......................................................................................... 21 
 Computational Models of Mammalian Cell Cycle .................................................................... 25 
 Summary ................................................................................................................................ 36 
Chapter 3 A Comprehensive Complex Systems Approach to the Study of Mammalian Cell Cycle 
Control System in the Presence of DNA Damage Stress................................................................... 37 
 Overview ................................................................................................................................ 37 
 Current Gaps in Mammalian Cell Cycle Models ....................................................................... 37 
 A Comprehensive Mathematical Model of Mammalian Cell Cycle........................................... 39 
3.3.1 Growth Factor Signalling Sub-System ......................................................................... 40 
3.3.2 DNA Damage Signalling Sub-System ........................................................................... 41 
3.3.3 G1-S Checkpoint Signalling Sub-System ...................................................................... 43 
3.3.4 G2-M Checkpoint Signalling Sub-System .................................................................... 50 
 Results and Discussion............................................................................................................ 57 
 Summary ................................................................................................................................ 62 
Chapter 4 Investigation of the Effect of Sub-Systems, Modules, and Parameters on Cell Cycle 
Control System Response ................................................................................................................ 66 
 Overview ................................................................................................................................ 66 
 GSA Formulation through SOMCCA Model ............................................................................. 67 
 Most influential Parameters/Sub-Systems/Modules ............................................................... 70 
 Summary ................................................................................................................................ 76 
Chapter 5 Efficiency of Cell Cycle Checkpoints in Detecting Damaged Cells..................................... 78 
 Overview ................................................................................................................................ 78 
 viii 
 Checkpoint Efficiency Evaluation Model ................................................................................. 79 
 Checkpoint Efficiency Based on the Number of Damaged Cells Passing Checkpoints as 
Healthy Cells .......................................................................................................................... 81 
 Checkpoint Efficiency Based on the Number of Healthy Cells Getting Sacrificed as Damaged 
Cells ....................................................................................................................................... 82 
 Summary ................................................................................................................................ 83 
Chapter 6 Towards Abstraction of Computational Modelling of Mammalian Cell Cycle: A Petri 
Net Approach .................................................................................................................................. 85 
 Overview ................................................................................................................................ 85 
 Identification of the Most Significant Components ................................................................. 86 
 Abstract Cell Cycle Model Development: A Petri Net Approach .............................................. 88 
6.3.1 Key Elements of the MLHPN Model ............................................................................ 89 
6.3.2 High-level of Abstraction ............................................................................................ 90 
6.3.3 Stage-level of Abstraction (Temporal Progression) ..................................................... 92 
6.3.4 Low-level of Abstraction ............................................................................................ 94 
 Kinetics of the Abstract Model.............................................................................................. 104 
 MLHPN Simulation Results ................................................................................................... 106 
 Checkpoint Efficiency Evaluation on the MLHPN Model ........................................................ 108 
6.6.1 Checkpoint Efficiency Based on the Number of Damaged Cells Passing Checkpoints 
as Healthy Cells ........................................................................................................ 109 
6.6.2 Checkpoint Efficiency Based on the Number of Healthy Cells Getting Sacrificed as 
Damaged Cells ......................................................................................................... 110 
 Summary .............................................................................................................................. 111 
Chapter 7 Conclusions ................................................................................................................... 113 
 Research Overview ............................................................................................................... 113 
 Research Highlights .............................................................................................................. 116 
 Recommendations for Future Research ................................................................................ 116 
 Conclusions .......................................................................................................................... 117 
Appendix A Equations of the Comprehensive Mathematical Model ............................................. 119 
 Growth Factor Signalling Sub-system .................................................................................... 119 
 DNA Damage Signalling Sub-system...................................................................................... 119 
 G1-S Checkpoint Signalling Sub-system................................................................................. 120 
 G2-M Checkpoint Signalling Sub-system ............................................................................... 123 
Appendix B Initial Values of Concentration of Chemical Species of the Comprehensive 
Mathematical Model ..................................................................................................................... 126 
Appendix C Parameters of the Comprehensive Mathematical Model ........................................... 129 
Appendix D Simulation of the Comprehensive Mathematical Model Over More Than One Cycle 137 
Appendix E Results of GSA on Iwamoto et al. Model..................................................................... 138 
Appendix F Kinetic Parameters of the MLHPN Model ................................................................... 140 
 ix 
Appendix G Initial Values of Places of the MLHPN Model ............................................................. 142 
Appendix H Transitions of the MLHPN Model ............................................................................... 145 
References ..................................................................................................................................... 149 
 x 
List of Tables 
Table 2.1 The most important Cyclin-Dependent Kinase Inhibitors in mammalian cells. ............... 17 
Table 2.2 Tyrosine kinases and phosphatases .............................................................................. 18 
Table 2.3 Updating rule for CycB activation.................................................................................. 26 
Table 2.4 Summary of Mammalian and Generic Cell Cycle Models ............................................... 31 
Table 4.1 List of effective parameters as well as sub-systems and modules for G1-S & G2-M 
transitions with and without DNA damage (italicised modules in columns 3 and 5, 
respectively, indicate the additional modules for DDS compared to No DDS condition 
for G1-S and G2-M shown in columns 2 and 4; and underlined modules in columns 4 
and 5 are additional modules for G2-M compared to G1-S shown in columns 2 and 3). 
The value of the correlation coefficient of parameters with respect to PTs of G1-S and 
G2-M indicators are shown in brackets in the last row next to the corresponding 
parameter. Parameters with correlation coefficient value greater than 0.05 are 
considered as significant parameters. ........................................................................... 75 
Table 5.1 Efficiency of checkpoints based on the number of damaged cells that pass each of the 
G1-S and G2-M checkpoints as normal cells under DNA damage and different 
perturbation levels (the total number of damaged cells is 2000). [For example, for 
±5% perturbation, the number of damaged cells passing G1-S as healthy is shown in 
the second column (i.e., 543 out of 2000); the number of these damaged cells that 
are not caught at G2-M is in the fourth column (i.e., 78 out of 543); therefore, the 
efficiency of G1-S and G2-M are 𝟐𝟎𝟎𝟎 − 𝟓𝟒𝟑𝟐𝟎𝟎𝟎 = 𝟕𝟐.𝟖𝟓% and 𝟓𝟒𝟑 −
𝟕𝟖𝟓𝟒𝟑 = 𝟖𝟓.𝟔𝟑%, respectively. The combined checkpoint efficiency is  𝟐𝟎𝟎𝟎−
𝟕𝟖𝟐𝟎𝟎𝟎 = 𝟗𝟔.𝟏%]. .................................................................................................... 82 
Table 5.2 Efficiency of checkpoint based on the number of healthy cells that get sacrificed as 
damaged cells at G1-S and G2-M checkpoints for different perturbation levels (the 
total number of healthy cells is 2000). [For example, for ± 5% perturbation, the 
number of healthy cells incorrectly identified and arrested at G1-S is shown in the 
second column (i.e., 17 out of 2000 are sacrificed); the number of incorrectly 
arrested cells at G2-M is shown in the 4th column (i.e., 2000-17=1983 healthy cells go 
to G2-M checkpoint and just 10 cells (10 out of 1983) get incorrectly arrested as 
damaged). Therefore, the efficiency of G1-S and G2-M is 𝟐𝟎𝟎𝟎 − 𝟏𝟕𝟐𝟎𝟎𝟎 =
𝟗𝟗.𝟏𝟓% and 𝟏𝟗𝟖𝟑− 𝟏𝟎𝟏𝟗𝟖𝟑 = 𝟗𝟗.𝟒𝟗%, respectively. The combined checkpoint 
efficiency in releasing healthy cells is  𝟐𝟎𝟎𝟎 − (𝟏𝟎 + 𝟏𝟕)𝟐𝟎𝟎𝟎 = 𝟗𝟖.𝟔𝟓%]. ............. 83 
Table 6.1 The most significant components of mammalian cell cycle based on component type 
and corresponding sub-system. .................................................................................... 86 
Table 6.2 Elements used in the proposed model. ......................................................................... 89 
Table 6.3 Efficiency and the number of damaged cells that pass each of the G1-S and G2-M 
checkpoints as normal cells under DNA damage and different perturbation levels (the 
total number of damaged cells is 2000) for the MLHPN model.................................... 109 
Table 6.4 Checkpoint efficiency and the number of healthy cells that get sacrificed as damaged 
cells at G1-S and G2-M checkpoints for different perturbation levels (the total 




List of Figures 
Figure 2.1 A schematic of Cell Cycle and its corresponding phases/events and sub-phases. Cell 
cycle comprises four main phases (G1, S, G2, and M): during G1 a cell grows following 
the presence of Growth Factor, then in S its DNA is replicated, and following further 
growth in G2 the mother cell divides into two daughter cells during M. These phases 
are controlled by four different Cyclins (Cyclin D, Cyclin E, Cyclin A, and Cyclin B) in 
complex with corresponding Cdks. There are also two important DNA damage 
checkpoints (G1-S and G2-M) to guarantee genome integrity. ...................................... 12 
Figure 2.2 Three main regulatory mechanisms of Cdk activity: Synthesis and Degradation of 
Cyclins (Bottom), Activation and Inactivation of Cyc_Cdk complexes through Tyrosine 
Phosphatases and Kinases (top right), and Inhibition of Cyc_Cdks through CKIs (top 
left). ............................................................................................................................. 15 
Figure 2.3 Growth Factor signalling pathway (Morgan, 2007). ....................................................... 19 
Figure 2.4 A holistic picture of DNA damage response. ................................................................. 21 
Figure 2.5 G1-S checkpoint with rapid and delayed DNA damage response pathways. Red round-
ended arrows indicate negative effects (i.e., inhibition, inactivation, etc.); green 
arrows denote positive effects (i.e., activation, synthesis, etc.); blue arrows 
correspond to biochemical reactions (i.e., binding of two proteins, etc.) and thick 
black arrows show the results of formation of a particular complex (i.e., formation of 
active CycE_Cdk2 leads to G1-S progression, etc.). ........................................................ 23 
Figure 2.6 Cell cycle arrest at G2-M checkpoint. Red round-ended arrows indicate negative 
effects (i.e., inhibition, inactivation, etc.); green arrows denote positive effects (i.e., 
activation, synthesis, etc.); blue arrows correspond to biochemical reactions (i.e., 
binding of two proteins, etc.) and thick black arrows show the results of formation of 
a particular complex (i.e., formation of active CycB_Cdk1 leads to G2-M progression, 
etc.). ............................................................................................................................. 24 
Figure 2.7 An example of a discrete Boolean graph for CycB (Cyclin B) regulation. Green arrows 
and red round-ended arrows indicate activation and inhibition, respectively. ............... 26 
Figure 2.8 A demonstration of E2F-dependent production of Cyclin E through a Hybrid PN. E2F is 
presented discretely (using discrete Places and Transitions) while production and 
degradation of cyclin E are modelled continuously using continuous places and 
transitions (the degrader of cyclin is not shown here). Places iE2F and aE2F 
correspond to inactive and active E2Fs, respectively. Transitions T1, T2, T3, T4 denote 
activation, inactivation, synthesis, and degradation processes, respectively. 
Parameters k1 and k2 are synthesis and degradation rate constants, respectively. ....... 30 
Figure 3.1 Growth Factor Signalling Sub-System. Growth factor triggers the MAPK cascade that 
eventually activates transcription factor c-Myc which stimulates the synthesis of 
Cyclin D, the first cyclin in the cell cycle system. In this study, we use a 
minimal/compact version of Growth Factor signalling pathway shown as Minimal 
Growth Factor Sub-System at the bottom left corner in this figure. Green solid arrows 
denote biochemical reactions (i.e., synthesis of a protein or activation of an inactive 
element) while purple dashed arrows correspond to regulatory effects (i.e., 
enzymatic effect, transcriptional regulation through transcription factor). ................... 41 
Figure 3.2 Chk-Related (rapid) DNA Damage Module. Active Cdc25 Tyrosine phosphatase is 
important in activation of Cyc_Cdks and cell cycle progression. DNA damage results in 
activation of Chk2 which in turn deactivates Cdc25. Therefore, through a number of 
relatively fast interactions (activation/inactivation), the DNA damage rapidly arrests 
the cell cycle. Green solid arrows denote biochemical reactions (i.e., synthesis of a 
protein or activation of an inactive element) while purple dashed arrows correspond 
to regulatory effects (i.e., enzymatic effect, transcriptional regulation through 
transcription factor, etc.). ............................................................................................. 42 
 xii 
Figure 3.3 p53-Related DNA Damage Module. This module represents the delayed DNA damage 
signalling that centres on transcription factor p53, which stimulates the synthesis of 
p21, 14-3-3σ and Gadd45α. These products contribute to cell cycle arrest in different 
ways. Red solid round-ended arrows indicate inhibition; green solid arrows denote 
biochemical reactions (i.e., synthesis or degradation of a protein, etc.) and purple 
dashed arrows correspond to transcriptional regulation. .............................................. 43 
Figure 3.4 G1-S Checkpoint Signalling Sub-System in the context of the whole system and its 
four modules: Cdk4-Related, E2F-pRb, Cdk2-Related, Tyrosine Phosphatase modules. 
Black arrows indicate interactions between modules while blue arrows indicate 
interactions between G1-S checkpoint and other sub-systems. .................................... 44 
Figure 3.5 Cdk4-Related Module. The key elements of this module are Cyclin D, Cdk4, and p27. 
The effects of some other elements on production, degradation, and combination of 
these proteins have also been presented in this module. Transcription factor c-Myc 
triggers the synthesis of Cyclin D which in complex with Cdk4 forms the most crucial 
controller (CycD_Cdk4) of mammalian cell cycle during early to mid G1 phase. 
Elements in the rectangular boxes are the proteins in this module; whereas, the 
other elements belong to other modules (their dynamics are presented elsewhere in 
the corresponding modules). Green solid arrows denote the biochemical reactions 
(i.e., synthesis, degradation, association, dissociation, etc.) while purple dashed 
arrows correspond to regulatory effects (i.e., enzymatic effect, transcriptional 
regulation through transcription factor, etc.). Double-ended arrows represent 
reversible reactions. Elements in blue rectangular boxes are the proteins of this 
module whereas the other elements belong to other modules. .................................... 45 
Figure 3.6 E2F-pRb Module. The key factor in this module is transcription factor E2F. When 
active, this transcription factor stimulates the production of a number of crucial cell 
cycle proteins, such as Cyclin E, Cyclin A, Tyrosine phosphatase Cdc25A, another 
transcription factor called B-Myb and itself. E2F is initially inactivated by a tumour 
suppressor protein called pRb. The detail of the process which results in activation of 
E2F is well covered in this module. Green solid arrows denote biochemical reactions 
(i.e., synthesis, degradation, association, dissociation, phosphorylation, etc.) while 
purple dashed arrows correspond to regulatory effects (i.e., enzymatic effect, 
transcriptional regulation through transcription factor, etc.). Elements in blue 
rectangular boxes are the proteins of this module whereas the other elements 
belong to other modules. ............................................................................................. 46 
Figure 3.7 Cdk2-Related Module. The key players of this module are Cyclin E and Cyclin A whose 
synthesis and degradation depends on a number of transcription factors (E2F, B-Myb 
and NFY) and ubiquitin ligases (SCF, APC_Cdh1, and apc_Cdc20), respectively. 
Furthermore, the activity of CycE_Cdk2 and CycA_Cdk2 are affected by CKIs (p21 & 
p27) and Tyrosine phosphatase Cdc25A. Green solid arrows denote the biochemical 
reactions (i.e., synthesis, degradation, association, dissociation, etc.) while purple 
dashed arrows correspond to regulatory effects (i.e., enzymatic effect, transcriptional 
regulation through transcription factor, etc.). Double-ended arrows represent 
reversible reactions. Elements in blue rectangular boxes are the proteins of this 
module whereas the other elements belong to other modules. .................................... 48 
Figure 3.8 Tyrosine Phosphatase Module. The main player of this module is Tyrosine 
phosphatase Cdc25A. Its synthesis and degradation are mediated through E2F and 
Chk2, respectively. Cdc25A has an important role in activating CycE_Cdk2 and 
CycA_Cdk2. The positive feedback loop between these Cyc_Cdks and Cdc25A triggers 
activation of more Cdc25A. Green solid arrows denote biochemical reactions (i.e., 
synthesis, degradation, association, dissociation, etc.) while purple dashed arrows 
correspond to regulatory effects (i.e., enzymatic effect, transcriptional regulation 
through transcription factor, etc.). Elements in blue rectangular boxes are the 
proteins of this module whereas the other elements belong to other modules. ........... 50 
 xiii 
Figure 3.9 G2-M Signalling Sub-System including its five modules: Cdk1-Related, APC-Related, 
Tyrosine Phosphatase, Tyrosine Kinase, and Plk1-Related modules. Black arrows 
indicate interactions between modules while blue arrows show interactions between 
G2-M checkpoint and other sub-systems. ..................................................................... 51 
Figure 3.10 Tyrosine Kinase Module. Tyrosine Kinase Wee1 plays the main role in this module 
where active Wee1 mediates inactivation of CycB_Cdk1 inside the nucleus. Wee1 
becomes inactivated by Plk1 and then degraded by active ubiquitin ligase SCF. Green 
solid arrows denote the biochemical reactions (i.e., degradation, changing in the 
state of a protein by phosphorylation or dephosphorylation, etc.) while purple 
dashed arrows correspond to regulatory effects (i.e., enzymatic effect, etc.). 
Elements in blue rectangular boxes are the proteins of this module whereas the 
other elements belong to other modules. ..................................................................... 52 
Figure 3.11 Tyrosine Phosphatase Module. This module covers the process of activation of 
Tyrosine phosphatase Cdc25C and its phosphorylated version Cdc25CP_S216. This 
phosphatase helps activation of CycB_Cdk1 which is the main controller of 
mammalian cell cycle during M phase. The effect of other regulatory proteins on 
different versions of this phosphatase is shown in this figure and explained in the 
text. Green solid arrows denote biochemical reactions (i.e., degradation, changing in 
the state of a protein by phosphorylation or dephosphorylation, etc.) while purple 
dashed arrows correspond to regulatory effects (i.e., enzymatic effect, etc.). 
Elements in blue rectangular boxes are the proteins of this module whereas the 
other elements belong to other modules. ..................................................................... 53 
Figure 3.12 Plk1-Related Module. Plk1 is one of the key cell cycle elements prior to, and during, 
M phase where it activates Cdc25CP_S216 and mediates translocation of CycB_Cdk1 
from cytoplasm to nucleus. It also helps activation and inactivation of APC_Cdc20 and 
Wee1, respectively. The effects of aPlk1 on elements from other modules are shown 
with outgoing dashed arrows from aPlk1. Green solid arrows denote biochemical 
reactions (i.e., degradation, changing in the state of a protein by phosphorylation or 
dephosphorylation, etc.) while purple dashed arrows correspond to regulatory 
effects (i.e., enzymatic effect, etc.). Elements in blue rectangular boxes are the 
proteins of this module whereas the other elements belong to other modules. ........... 54 
Figure 3.13 Cdk1-Related Module. CycB_Cdk1 is the main controller of cell cycle system during M 
phase. This module comprises Cyclin B, Cdk1, their complexes in cytoplasm and 
nucleus and the impact of other proteins on them. The detailed description of all the 
shown interactions is presented in the text. Green solid arrows denote biochemical 
reactions (i.e., degradation, changing in the state of a protein by phosphorylation or 
dephosphorylation, etc.) while purple dashed arrows correspond to regulatory 
effects (i.e., enzymatic effect, etc.). Double-ended arrows represent reversible 
reactions. Elements in blue rectangular boxes are the proteins of this module 
whereas the other elements belong to other modules.................................................. 55 
Figure 3.14 APC-Related Module. This module presents the process of activation/inactivation of 
ubiquitin ligases APC_Cdc20 and APC_Cdh1. These ligases are crucial ubiquitinators 
and their impact on CycB_Cdk1 is particularly important during M phase. Green solid 
arrows denote biochemical reactions (i.e., degradation, changing in the state of a 
protein by phosphorylation or dephosphorylation, etc.) while purple dashed arrows 
correspond to regulatory effects (i.e., enzymatic effect, etc.). Elements in blue 
rectangular boxes are the proteins of this module whereas the other elements 
belong to other modules. ............................................................................................. 57 
Figure 3.15 Temporal dynamics of the key players of mammalian cell cycle control system 
including newly added elements (c-Myc, PP1, SCF, and Plk1), indicators of G1-S and 
G2-M checkpoints (CycE_Cdk2, aCycB_Cdk1_Nuc) and some other significant proteins 
(p27, E2F, CycD_Cdk4, CycA_Cdk2, APC_Cdc20, APC_Cdh1). Cyc_Cdks are at the 
centre of this control system and the other elements regulate their concentration. 
 xiv 
G1-S and G2-M transitions under no DNA damage are denoted on the horizontal axis. 
The peak time (PT) of active CycE_Cdk2 and CycB_Cdk1_Nuc correspond to G1-S and 
G2-M transition, respectively [x-axis indicates time (simulation time units as well as 
hours); y-axis indicates protein concentration (mg/ml)]. ............................................... 59 
Figure 3.16 Impact of newly added Cyclin E degrader SCF on Cyclin E dynamics (solid line – with 
SCF and dashed line – without SCF). Figure shows that in the presence of SCF, Cyclin E 
peaks slightly sooner and degrades quicker than without SCF. Peak time (PT) of 
aCycE_Cdk2 indicates G1-S transition (with SCF: PT =1095, without SCF: PT= 1133; PT 
difference is 38) [x-axis indicates time (simulation time units as well as hours); y-axis 
indicates protein concentration (mg/ml)]. .................................................................... 60 
Figure 3.17 Impact of newly added Plk1 on Cyclin B dynamics (solid line – with Plk1; and dashed 
line – without Plk1).  Figure shows that Plk1 alters the concentration and Peak time 
(PT) of CycB_Cdk1_Cyt and CycB_Cdk1_Nuc complexes. PT of CycB_Cdk1_Nuc 
indicates G2-M transition (PT with Plk1 is 3208 and without Plk1 is 3238; PT 
difference is 30) [x-axis indicates time (simulation time units as well as hours); y-axis 
indicates protein concentration (mg/ml)]. .................................................................... 61 
Figure 3.18 Temporal dynamics of important elements in the rapid and delayed DNA damage 
response in cell cycle arrest. Chk2 is the key player in rapid DNA damage signalling 
(explained in Section 3.3.2) which becomes activated after the presence of DNA 
damage and inhibits the progression of cell cycle. This is followed by the delayed 
response centred on transcription factor p53. Since transcription is slower than 
activation (of Chk2), this module is called delayed DNA damage response. These 
results show the integrated response of the rapid and delayed pathways as proposed 
in this study. Transcription factor p53 induced the synthesis of Cyclin-dependent 
Kinase Inhibitor p21 and the newly added Gadd45α showing latter’s close 
correspondence to p53 and the joint activity of the delayed module (the significance 
of these elements is described in Section 3.3.2) [x-axis indicates time (simulation time 
units as well as hours); y-axis indicates protein concentration (mg/ml)]. ....................... 62 
Figure 4.1 A flowchart of the SOMCCA model. This model comprises two main phases, SOM and 
CCA. During the SOM phase, the SOM network is constructed and then trained using 
cell samples. The parameters are first qualitatively assessed through SOM input 
planes and then the input weight matrix (W) is extracted. The W matrix is used as 
input to CCA phase in order to calculate the Covariance (Cov) matrix. Using the Cov 
matrix, Pearson Correlation Coefficient (PCC) can be calculated and used to assess 
the parameters quantitatively. Finally, by sorting the effective parameters, we 
identify the most effective parameters from a global perspective................................. 67 
Figure 4.2 A schematic diagram of SOM. It includes a set of input variables, 𝒚𝟏,𝒚𝟐,… , 𝒚𝒎, 
(parameters and PT) and a set of neurons arranged in a 2D Feature Map.  Each 
neuron is represented by a weight vector linking it to input vectors. Input vectors are 
presented to the SOM and the output (activation level) of each neuron is the 
weighted sum of the input vector. The neuron with the highest activation is declared 
the winner and its weight vector is adjusted along with that of the neurons in its 
neighbourhood.  This learning process continues until there is no or minimal weight 
adjustment. .................................................................................................................. 68 
Figure 4.3 SOM planes showing the spread of the most significant parameters sorted through 
SOMCCA (in order of significance - parameters with correlation coefficient value 
greater than 0.05 are considered as significant) with respect to PT of G1-S indicator 
(the last figure). It shows the relationship of variables/parameters to the output PT 
and relationship of parameters to each other. Darker colours indicate lower values of 
a parameter and lighter ones indicate higher values. By comparing the colour pattern 
in the output plane with those in the input plane it is easy to see which parameter 
have similar patterns to the output (positive relationship = positive correlation) and 
which ones have opposite colour pattern (negative correlation) and which ones have 
 xv 
weak or no correlation to the output. This is considered as qualitative evaluation.  
Also, comparing the parameter planes to each other, it can be determined which 
variables are positively, negatively, weakly, or not correlated. Parameters	𝒌𝟔𝟒	(rate 
of dephosphorylation of pRbPPP to pRb through PP1),	𝒌𝟒𝟗 (synthesis rate of 
p27),	𝒌𝟓𝟐 (association rate of p27 and aCycE_Cdk2),	𝒌𝟖𝟑 (degradation rate of 
iCycE_Cdk2 to Cdk2) and	𝒌𝟏𝟎𝟎 (degradation rate of iCdc25A) have positive 
correlation with PT of G1-S indicator, while others (	𝒌𝟒𝟎 (synthesis rate of Cyclin D 
through transcription factor c-Myc),	𝒌𝟔𝟎 (dissociation rate of E2F_pRbPP complex 
through aCycE_Cdk2),	𝒌𝟓𝟎 (dissociation rate of p27_aCycE_Cdk2 complex),	𝒌𝟗𝟖 
(synthesis rate of iCdc25A through E2F),	𝒌𝟖𝟖 (activation rate of iCycE_Cdk2 through 
aCdc25A),	𝒌𝟏𝟎𝟏	(activation rate of iCdc25A through aCycE_Cdk2 and 
aCycA_Cdk2),	𝒌𝟒𝟖 (association rate of p27 and CycD_Cdk4),	𝒌𝟕𝟎 (synthesis rate of 
Cyclin E through transcription factor E2F) and	𝒌𝟐 (activation rate of ic-Myc through 
Growth Factor)) have negative correlation. .................................................................. 71 
Figure 4.4 Influential parameters, sub-systems and modules on G1-S transition under No DDS. 
Growth Factor sub-system and all the modules of G1-S checkpoint have impact on 
G1-S transition. The significant parameters are shown on the corresponding arrows. ... 72 
Figure 4.5 The most Influential parameters, sub-systems and modules in G2-M transition under 
No DDS. The parameters are shown on the corresponding arrows. The newly found 
significant parameters (in comparison to those found significant for G1-S) are bolded. 74 
Figure 5.1 Diagram of the Checkpoint Efficiency Evaluation (CEE) Model. The CEE model 
evaluates the performance of checkpoints in correctly identifying cells. Using the 
significant parameters identified through SOMCCA model, the CEE generates a cell 
population (by perturbing the significant parameters within a particular range) for 
both normal (healthy) and damage conditions and then calculates PTs of G1-S and 
G2-M checkpoint indicators for all the cells in the population. Then it draws the 
probability Density Function (PDF) of PTs for normal and damaged conditions for 
each checkpoint and labels the damaged cells passing each checkpoint as healthy 
cells (to calculate the efficiency of checkpoints in correctly identifying/arresting the 
damaged cells) or alternatively labels the healthy cells arrested as damaged at 
checkpoints (to calculate the efficiency of checkpoints in correctly letting the healthy 
cells pass the checkpoints) based on Type II error. Finally, it calculates the efficiency 
of checkpoints in correctly arresting the damaged cells using the number of identified 
damaged cells (those damaged cells correctly classified as damaged by the 
checkpoint) and the total number of damaged cells. To calculate the efficiency of 
checkpoints in correctly letting the healthy cells pass checkpoints, the number of 
identified healthy cells (those healthy cells correctly classified as healthy by the 
checkpoint) and the total number of healthy cells are used. ......................................... 80 
Figure 5.2 A hypothetical example of PDF of PT of Normal and Damaged cells for G1-S (left 
figure) and G2-M (right figure) checkpoints showing how Type II Error is used to 
estimate the checkpoint efficiency. The figure shows a hypothetical case of a number 
of damaged cells (red dots) that pass each checkpoint as normal cells (the vertical 
line shows the significance level, 10%). In this example, G1-S checkpoint could not 
identify five damaged cells while G2-M checkpoint identified all but 1 of those 
damaged cells that escape G1-S. In this hypothetical case, G2-M checkpoint performs 
better than G1-S in detecting damaged cells. The concept of healthy cells arrested at 
each checkpoint as damaged cells can be shown with a similar example but in the 
opposite direction. ....................................................................................................... 81 
Figure 6.1 A schematic of the most significant components of mammalian cell cycle categorized 
under different sub-systems, and corresponding effects on ordered sequence of cell 
cycle transitions............................................................................................................ 88 
Figure 6.2 High-level view of the MLHPN model. For all Cyc_Cdks, the active form is considered. . 91 
 xvi 
Figure 6.3 Stage-level view of the MLHPN model. It is assumed that at the beginning, the system 
is in G0 or Early_G1 state. The black squares demonstrate discrete transitions while 
the circles represent discrete/continuous places. For example, the cell cycle state 
switches from Late_G1 phase (modelled by a discrete place) to S phase (also 
modelled as a discrete place) through discrete transition G1_S when the level of 
continuous place CycE_Cdk2 is more than a threshold (8.5 simulation time units). The 
grey elements (places/transitions) are logical elements which may appear 
somewhere else in the model (it may be at the same level or at another level of 
abstraction). The weights for the arcs whose weight value is not equal to one are 
shown in the figure. For instance, the time it takes for the cell cycle to perform DNA 
replication (which happens during S phase) is assumed to be seven hours shown 
under S_G2 discrete transition in the figure. ................................................................. 93 
Figure 6.4 Growth Factor Sub-System (inside dashed green rectangle) which includes GF as a 
discrete place and G0_G1_Activation macro transition. The connections between this 
sub-system and other cell cycle sub-systems have already been demonstrated in 
Figure 6.2. .................................................................................................................... 94 
Figure 6.5 Elements of G0_G1_Activation macro transition as the main part of Growth Factor 
signalling sub-system. Active and inactive forms of transcription factor c-Myc are 
presented as aG0_G1_TF and iG0_G1_TF, respectively. At the beginning (initial state), 
Growth Factor (GF) is present and G0_G1_TF is inactive. Following the presence of 
GF, G0_G1_TF becomes active through discrete transition t1_1 and aG0_G1_TF, in 
turn, triggers the synthesis of CycD_Cdk4 through continuous transition T1. The 
absence of GF results in inactivation of G0_G1_TF through discrete transition t1_2. .... 95 
Figure 6.6 G1-S Sub-System (inside dashed brown enclosure) which includes G1_S_Activation 
macro transition, five macro places (UBQ_D, UBQ_E, UBQ_A, p27 and Cdc25A), three 
continuous places (for CycD_Cdk4, CycE_Cdk2 and CycA_Cdk2) and three continues 
transitions associated with degradation of Cyc_Cdks. The connections between this 
sub-system and other cell cycle sub-systems have already been demonstrated in 
Figure 6.2. .................................................................................................................... 96 
Figure 6.7 Elements of UBQ_D macro place which is a part of G1-S sub-system. This macro place 
is mainly associated with degradation of Cyclin D (CycD_Cdk4) through different 
ubiquitin ligases. ........................................................................................................... 96 
Figure 6.8 Elements of G1_S_Activation macro transition as a part of G1-S sub-system. Active 
and inactive G1_S_TF are demonstrated as aG1_S_TF and iG1_S_TF, respectively. The 
weight values for the arcs whose weight is other than one are shown in the figure. ..... 97 
Figure 6.9 Elements of p27 macro place as a part of G1-S sub-system. Active and inactive p27 
are shown as ap27 and ip27, respectively. .................................................................... 98 
Figure 6.10 Elements of Cdc25A macro place as a part of G1-S sub-system. Active and inactive 
Cdc25A are presented as aCdc25A and iCdc25A, respectively. The weights for the arcs 
whose weight value is other than one are shown in the figure. ..................................... 99 
Figure 6.11 Elements of UBQ_E macro place as a part of G1-S sub-system. Active and inactive SCF 
are demonstrated as aSCF and iSCF, respectively. ......................................................... 99 
Figure 6.12 Elements of UBQ_A macro place as a part of G1-S sub-system. Active and inactive 
APC_Cdc20A are shown as aAPC_Cdc20A and iAPC_Cdc20A, respectively. The same 
prefixes are used for APC_Cdh1. The weights for the arcs whose weight value is other 
than one are shown in the figure. ............................................................................... 100 
Figure 6.13 G2-M Sub-System (inside dashed purple enclosure) which includes G2_M_Activation 
macro transition, two macro places (UBQ_B and Cdc25C), one continuous place (for 
CycB_Cdk1) and one continues transition associated with degradation of CycB_Cdk1. 
The connections between this sub-system and other cell cycle sub-systems have 
already been demonstrated in Figure 6.2.................................................................... 101 
Figure 6.14 Elements of G2_M_Activation macro transition as a part of G2-M sub-system. Active 
and inactive G2_M_TF are demonstrated as aG2_M_TF and iG2_M_TF, respectively. 
 xvii 
The weights for the arcs whose weight value is other than one are shown in the 
figure. ......................................................................................................................... 101 
Figure 6.15 Elements of Cdc25C macro place as a part of G2-M sub-system. Active and inactive 
Cdc25C are demonstrated as aCdc25C and iCdc25C, respectively. .............................. 102 
Figure 6.16 Elements of UBQ_B macro place as a part of G2-M sub-system. Active and inactive 
APC_Cdc20B are demonstrated as aAPC_Cdc20B and iAPC_Cdc20B, respectively. The 
same prefixes are used for APC_Cdh1. ........................................................................ 103 
Figure 6.17 DNA Damage Sub-System (inside dashed blue rectangle) which includes 
DNA_Damage macro place. The connections between this sub-system and other cell 
cycle sub-systems has already been demonstrated in Figure 6.2. ................................ 103 
Figure 6.18 Elements of DNA_Damage macro place which presents the DNA damage sub-system 
in the MLHPN model. ................................................................................................. 104 
Figure 6.19 Temporal dynamics of Cyc_Cdks as key controllers of mammalian cell cycle system 
under no DNA damage for (A) the MLHPN model and (B) the comprehensive 
mathematical model. The vertical dashed pink lines show the G1-S and G2-M 
transitions in both top and bottom figures [x-axis indicates time (both simulation 





An important process in the growth of any biological organism is its ability to proliferate, a tightly 
controlled process called the cell cycle in which a cell divides into two daughter cells (Morgan, 2007; 
Satyanarayana & Kaldis, 2009). Although the dependent sequence of cell cycle events has been 
identified for decades, the underlying regulatory basis was not completely clear until the 
introduction of checkpoint concept by Hartwell and Weinert (1989). They demonstrated that there 
are some checkpoints which arrest the cell cycle progression in the case of an uncompleted event or 
DNA damage. This arrest can provide enough time for a repairing process so that fidelity of genome 
is maintained (Kastan & Bartek, 2004; Novák et al., 2001; Nyberg et al., 2002; Walworth, 2000). Upon 
discovery of underlying elements of the cell cycle control system, and thanks to fast technical 
improvements, a lot of knowledge about involved biochemical interactions has been produced for all 
kinds of species. Therefore, it is obvious now that the complex behaviour of cell cycle and its 
response to different types of internal and external signals are due to chemical interactions between 
a large variety of proteins (Berridge, 2014; Morgan, 2007; Novák et al., 2001; Nurse, 2000; Tyers, 
2004; Tyson et al., 2001; Tyson et al., 2003; Vermeulen et al., 2003). 
The complex system of cell cycle can be presented through computational models which have the 
ability to reproduce the system dynamics and they generally belong to a rather new framework 
called Systems Biology. Based on this framework, an entity is considered as a part of a system which 
has interaction with other elements in the system rather than being an individual unit. In fact, 
systems biology is an inter-disciplinary area that concentrates on system-level understanding of 
complex biological systems (Alon, 2006; Kitano, 2002a; Klipp et al., 2008; Noble, 2008). The initial 
attempts to model the cell cycle using mathematical methods date back to more than fifty years ago 
(Koch & Schaechter, 1962; Shields, 1977; Smith & Martin, 1973). Due to the availability of more 
detailed data from the last decade of the twentieth century, there has been an explosion in the field 
of computational modelling of cell cycle (Goldbeter, 1991; Norel & Agur, 1991; Nurse, 1990; Thron, 
1991; Tyson, 1991). Over the past years, systems biology has led to creation of more comprehensive 
models (Aderem, 2005; Csikász-Nagy, 2009; Ideker et al., 2001; Kitano, 2002a, 2002b; Klipp et al., 
2016; Palsson & Palsson, 2015). In this chapter, we briefly present the current gaps in mammalian 
cell cycle modelling which lead us to motivations for our study. We also provide our research 
objectives together with some challenging questions that can be answered through this study. 
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 Research Motivation 
In this study, our focus is on mammalian cell cycle because there is a lack of proper modelling for this 
most complicated cell cycle system in the current literature. Having reviewed literature in the field of 
mammalian cell cycle modelling, we have recognized some gaps in the field. Most models have 
utilized the mathematical formulation for representing the dynamical behaviour of the cell cycle with 
different number of equations, ranging from a few to tens of equations. Small-scale models suffer 
the problem of comprehensiveness and they cannot be considered as a complete representation of 
the whole cell cycle system. For instance, some of them just consider the effect of cyclins. On the 
other hand, more complicated models, which have tens of different equations, lack a deep 
understanding of biological processes in cell cycle. Investigators mostly investigate the dynamics of 
some biomarkers in their large-scale models but rarely study the interconnected and purposeful 
cause and effect mechanisms in cell cycle, especially from systems point of view. Therefore, there is a 
need to characterise all the major and supporting components as well as their inter-relationships in 
order to draw a clear picture of underlying mechanism, particularly for a well-organized system like 
mammalian cell cycle.  
In current models, G1-S and G2-M checkpoint signalling pathways have not been properly 
incorporated from systems perspective and also there are some missing elements whose existence 
can shed more light on the function of key players of cell cycle control system. Therefore, there is a 
need for proper incorporation of these checkpoints together with missing elements. Another gap is 
related to investigation of DNA damage and its impact on cell cycle system. There exist many articles 
dedicated to modelling DNA damage but they do not give a complete picture of the two different 
DNA damage pathways, namely rapid and delayed pathways. Thus, it is important to cover the two 
different DNA damage pathways in order to understand the reason why there should exist rapid and 
delayed pathways. It will definitely help us grasp biological meaning of these pathways and their 
essential effects on cell cycle progression. There is also a gap in incorporating Growth Factor 
signalling pathway into mammalian cell cycle models as Growth Factor has been modelled through a 
constant on-off signal in current models.  
Therefore, in our study, the important sub-systems of mammalian cell cycle, which are Growth 
Factor signalling, G1-S and G2-M checkpoints, and DNA damage pathways, will be included to 
achieve a better understanding of behaviour of this complex system. We divide the system into its 
constituent sub-systems and further divide the sub-systems into their constituent modules, which 
interact with each other to fulfil the function of the corresponding sub-system. As a case in point, G1-
S checkpoint signalling sub-system has the following modules: (1) Cdk4-Related module (receives the 
signal from Growth Factor sub-system to initiate the cell cycle); (2) E2F-pRb module (receives the 
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signal from Cdk4-Related module and induces the production of some critical cell cycle proteins 
through transcription factor, E2F); (3) Cdk2-Related module (talks to other internal and external 
modules and sub-systems to prepare the cell for entering into S phase); and (4) Tyrosine Phosphatase 
module (stimulates the activation of Cyc_Cdk2 complexes which are crucial for G1-S transition). 
Our intention is to create an inherently easy to understand yet comprehensive model which can help 
readers (modellers, biologists, etc.) grasp concepts of mammalian cell cycle control system. In this 
study, we aim to apply and advance methods for developing and implementing a comprehensive 
systemic mathematical model with sub-systems and modules as well as an abstract Petri Net (PN)-
based model for the whole cell cycle at different levels of abstraction. These systemic approaches 
incorporating all known aspects of cell cycle allow us to (i) study, through dynamic simulation of an 
ODE model, comprehensive details of cell cycle dynamics under normal and DNA damage conditions 
revealing the role and value of the added new modules and elements (presented in Chapter 3), (ii) 
assess, through a Global Sensitivity Analysis (GSA), the most influential sub-systems, modules and 
parameters on system response, such as G1-S and G2-M transitions (presented in Chapter 4), (iii) 
probe deeply into the relationship between DNA damage and cell cycle progression and test the 
biological evidence that G1-S checkpoint is relatively inefficient in arresting damaged cells compared 
to G2-M (presented in Chapter 5), and (iv) perform a model abstraction through developing an 
intuitive multi-level PN-based model for cell cycle based on the comprehensive mathematical model 
presented in Chapter 3 to gain deeper insights into how the abstract model can coordinate such an 
intricate system of interactions in a robust and timely manner (presented in Chapter 6). Thus, this 
study shows the efficacy of the proposed systems approaches to gain a better understanding of 
different aspects of mammalian cell cycle system separately and as an integrated system that will 
also be useful in investigating targeted therapy in future cancer treatments. 
 Research Objectives 
The first objective of this research is to mathematically present the whole mammalian cell cycle 
control system together with its constituent sub-systems. Therefore, we need to determine the 
sub-systems and the underlying mechanism for their elegant cooperation. We further identify the 
constituent functional modules of each sub-system. 
To achieve the first objective, we update an existing mathematical model of mammalian cell cycle 
(Iwamoto et al., 2011)  and therefore develop a new ODE model with the most recent knowledge of 
mammalian cell cycle (Abroudi et al., 2017). In our comprehensive model, some important elements 
missing in existing models have been added. Furthermore, key inter-connecting sub-systems are 
identified where each sub-system is demonstrated separately with its corresponding wiring diagram. 
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In order to better understand the function of sub-systems, each sub-system is decomposed into its 
constituent modules. Hence, based on this objective, the following critical questions can be asked: 
1. What are the newly added elements in our model and what is the rationale for adding each of 
them? 
Past models have considered Growth Factor to be a binary signal - on or off (Iwamoto et al., 2011; 
Iwamoto et al., 2008). The reality is that following the presence of Growth Factor, a transcription 
factor (c-Myc) through a particular signalling cascade (MAPK signalling) is responsible for triggering 
cell cycle machinery. It stimulates the synthesis of Cyclin D, one of the most critical controllers in 
early-mid G1 phase of mammalian cell cycle (Adhikary & Eilers, 2005; Alberts et al., 2014; de Alboran 
et al., 2001; Morgan, 2007; Schmidt, 1999). We believe that addition of c-Myc has value in the model 
because of its biological significance to the cell cycle system. Further, as an extension to the cell cycle 
model, it gives a more complete description of the cell cycle. In our model, the relationship 
(continuous dynamic) between c-Myc and Cyclin D is realistically represented. Also, with c-Myc in the 
system, we now have the transcription factors of all cyclins of cell cycle in one model. Furthermore, 
our numerical analysis shows that c-Myc is the most significant element in the whole system from a 
systems perspective and adding it is beneficial. Therefore, we add transcription factor c-Myc in our 
model (see Chapter 3 for details). 
Polo-like kinase-1 (Plk1) is another newly added element which is one of the most important proteins 
in mitotic entry. In Iwamoto model, there were two versions of CycB_Cdk1: nucleus and cytoplasmic 
versions; but there was no explanation for the translocation of the cytoplasmic into nucleus, which 
marks the mitotic entry (Iwamoto et al., 2011). Our model provides this explanation through Plk1. 
Plk1 has multiple functions including activation of Cdc25C phosphatase and APC_Cdc20 (degrader of 
Cyclin A & Cyclin B), inactivation of Wee1 kinase, and translocation of CycB_Cdk1 from cytoplasm to 
nucleus (Golan et al., 2002; Lindqvist et al., 2009; Van De Weerdt & Medema, 2006; van Vugt & 
Medema, 2005; Zitouni et al., 2014). Plk1 modifies the peak time (PT) and concentration of the two 
versions of CycB_Cdk1 (i.e., PT of CycB_Cdk1_Nuc with Plk1 is 3208 and without Plk1 is 3238; PT 
difference is 30 simulation time units). Importantly, the model now incorporates correctly a process 
that explains an important cell cycle stage transition- mitotic entry. The full details can be found in 
Chapter 3. 
Protein Phosphatase 1 (PP1) is another newly added protein. It should be noted that Iwamoto model 
is not cyclic because PP1 is missing in that model. It has been biologically proven that at the end of 
cell cycle (mid-late M phase), Retinoblastoma protein (pRb) becomes dephosphorylated by a crucial 
phosphatase called Protein Phosphatase 1 (PP1) (Berndt, 2002; Ludlow et al., 1993; Nelson et al., 
1997; Trinkle-Mulcahy et al., 2003). Through our numerical analysis, we found out that the 
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parameter associated with dephosphorylation of pRb by PP1 is one of the most significant 
parameters in the system which shows the importance of this addition. By adding this element to 
correct the situation, we have made the model cyclic (Chapter 3).   
SCF is another newly added element that is a ubiquitin ligase whose function is to degrade a number 
of core components in the cell cycle control system. The reason for adding SCF to our model is that 
there is biological evidence that Cyclin E, which is the key player of cell cycle during G1 phase, is 
degraded by SCF (Ang & Harper, 2004; Cardozo & Pagano, 2004; Nakayama & Nakayama, 2005). In 
Iwamoto model (Iwamoto et al., 2011), the process of Cyclin E degradation is not complete and we 
believe that adding SCF to the model makes it more accurate. Specifically, in Iwamoto model, 
biologically relevant Cyclin E degradation details are not incorporated as in our model and therefore, 
CycE_Cdk2 degradation happens over a longer time. With SCF, CycE_Cdk2 peaks slightly sooner and 
degrades quicker. Peak time of aCycE_Cdk2 (which indicates G1-S transition) with SCF is 1095 and 
without SCF is 1133 (peak time difference is 38). Therefore, we can assume that Cyclin E degrades 
more realistically in our model (see Chapter 3 for details).     
The DNA damage part in Iwamoto model has p53 as a transcription factor that induces synthesis of a 
number of proteins. One of them was 14-3-3σ that affects (inactivates) B-type Cyclin_Cdk complex 
(the main controller of cell cycle during M phase) to arrest cell cycle in the case of DNA damage. 
However, that does not represent the complete picture of impact of p53 on CycB_Cdk1. To make 
that picture more complete, we found another product of p53, Gadd45α, that also inactivates 
CycB_Cdk1 (Jin et al., 2002; Zhan, 2005). Furthermore, biological evidence shows that the way that 
14-3-3σ and Gadd45α act upon CycB_Cdk1 inactivation is different. The first factor (14-3-3σ)  inhibits 
Cdc25C (which is the CycB_Cdk1 activator), while the second (Gadd45α) physically interacts with 
Cdk1 in order to stimulate CyclinB_Cdk1 unbinding (Jin et al., 2002; Zhan, 2005). Therefore, Gadd45α 
is added to the model to present a more complete picture of G2-M checkpoint. Gadd45α is produced 
throughout the period of activity of p53 (see Chapter 3 for details). 
Newly added elements provide an opportunity for biologists to set up new hypothesis to experiment 
in their lab for targeted cancer therapies. For example, PP1 can be used for cancer therapy as its 
knocking out can halt the cell proliferation by stopping the system from cycling. 
2. Why is it important to have sub-systems in our model and what are the model sub-systems 
and corresponding modules? 
The model with sub-systems enables us to seamlessly and realistically study the function of sub-
systems as well as the influence of sub-systems on each other where the Growth Factor sub-system 
senses the Growth Factor signals and triggers the activation of subsequent sub-systems. This 
 6 
presentation also retains the functionality of the system and provides a clearer interpretation of the 
processes within it while reducing the complexity in comprehending these processes. 
The Growth Factor signalling is a sub-system that has not been properly incorporated into 
mammalian cell cycle modelling yet and existing models have assumed just a constant signal as 
Growth Factor. We present it as a continuous signal and now the relationship between c-Myc and 
Cyclin D is realistically represented. The function of Growth Factor signal is to activate c-Myc that in 
essence initiates the cell cycle by triggering the synthesis of Cyclin D. Therefore, this sub-system is 
added to our model to give a better understanding of the interplay between Growth Factor signalling 
and cell cycle initiation. G1-S and G2-M checkpoints play an important role in controlling cell cycle 
progression, particularly in the presence of DNA damage, and their response mechanisms and 
corresponding inter-relationships should be properly investigated to understand DNA damage 
response in cell cycle more comprehensively. G1-S checkpoint sub-system is abstracted into four 
interconnected modules (Cdk4-Related, E2F-pRb, Cdk2-Related and Tyrosine phosphatase where the 
latter is a novel addition to this sub-system and E2F-pRb module is expanded and modified to make 
the model cyclic); G2-M is abstracted into five modules (Cdk1-Related, Tyrosine phosphatase, 
Tyrosine kinase, Plk1-Related and APC-Related where the latter four are novel additions and 
contained new components). To provide a complete picture of DNA damage signalling and its impact 
on cell cycle progression, we incorporate both rapid and delayed pathways into one sub-system. 
Therefore, DNA damage sub-system is abstracted into two modules including Chk-Related (rapid) and 
newly added elements in p53-Related (delayed) modules. The details of the abovementioned four 
sub-systems and the corresponding mathematical equations are given in Chapter 3. 
3. Are the results of our comprehensive model consistent with biological findings? 
The simulation results are in good agreement with biological findings about the dynamics of the 
newly added elements as well as the key players of the cell cycle system (Chapter 3). The results 
associated with this study objective have been published in Journal of Theoretical Biology (JTB) with 
the title of “A comprehensive complex systems approach to the study and analysis of mammalian cell 
cycle control system in the presence of DNA damage stress” (Abroudi et al., 2017). 
The second objective corresponds to identifying the parts (sub-systems, modules, and parameters) 
of the mammalian cell cycle system which have the most significant effect on system response 
with and without DNA damage. The system response is either G1-S or G2-M transition. 
Regarding the second objective, the following questions can be asked: 
4. What are the biological indicators associated with G1-S and G2-M transitions? 
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Peak times (PTs) of aCycE_Cdk2 and aCycB_Cdk1 are considered as indicators of G1-S and G2-M, 
respectively. 
5. How is it possible to investigate and characterise the most influential parts of the system 
from systems point of view? 
Using the comprehensive mathematical model developed in Chapter 3, we propose an analytical 
approach through Global Sensitivity Analysis (GSA), which focuses on global impact of parameters. A 
model based on Artificial Neural Networks (ANNs) and statistical analysis called Self-Organizing Map 
with Correlation Coefficient Analysis (SOMCCA) is developed to perform GSA which shows that 
Growth Factor and G1-S checkpoint sub-systems and seven parameters in the modules within them 
are significant towards both G1-S and G2-M transitions (see details in Chapter 4).  
The third objective is about exploring the relationship between DNA damage and cell cycle 
progression since there is biological evidence that G1-S checkpoint is relatively inefficient in 
arresting damaged cells compared to G2-M. 
According to the third objective, the following questions can be asked: 
6. Is it possible to define and formulate the efficiency of checkpoints using our comprehensive 
mathematical model to recapitulate the corresponding biological findings? 
To study the relative efficiency of DNA damage checkpoints, a Checkpoint Efficiency Evaluation (CEE) 
model is developed based on perturbation studies and statistical Type II error using the 
comprehensive model presented in Chapter 3. This is based on the number of damaged cells passing 
checkpoints as normal cells. For this analysis, Probability Density Functions (PDFs) of PT for normal 
and damaged cells for both G1-S and G2-M checkpoints are developed. From these two tests, we first 
assess the number of damaged cells that escape the two checkpoints. Then, the damaged cells that 
escape G2-M checkpoint are compared with those passing G1-S to determine the proportion of the 
latter that also escapes G2-M. G2-M checkpoint is capable of identifying and arresting a greater 
percentage of damaged cells than G1-S. For example, under ±5% perturbation, 543 out of 2000 
damaged cells pass G1-S checkpoint as healthy cells and then only 78 out of these 543 damaged cells 
are not caught at G2-M checkpoint. Therefore, the efficiency of G1-S is 8999:;<=
8999
= 72.8%, while the 
efficiency of G2-M is ;<=:AB
;<=
= 85.6% (the efficiency of G2-M is higher than that of G1-S). The rate at 
which damage cells pass the combined checkpoint system as healthy cells is 3.9% (78/2000) (False 
Negative rate) making the whole system efficiency 8999:AB
8999
= 96.1%. The full details of the CEE 
model are presented in Chapter 5. 
 8 
7. Although it is more important for damaged cells to be stopped, it is not beneficial for the cell 
to sacrifice many healthy cells. Therefore, what is the statistic for healthy cells to become 
arrested? 
We also conduct the checkpoint efficiency analysis for incorrectly sacrificing healthy cells. Results 
show that both checkpoints are highly efficient and near perfect in recognising healthy cells (99.15% 
for G1-S and 99.49% for G2-M). As the perturbation level increases, both checkpoints drop in 
efficiency but G2-M not only remains more efficient but also is more robust against sacrificing 
healthy cells. Results are shown in Chapter 5. 
8. What is the benefit of having a model that can represent the efficiency of checkpoints? 
Biological findings have shown that cancer cells relay more on G2-M checkpoint in order to repair 
their excess DNA damage and avoid Apoptosis as their G1-S checkpoint is usually deficient which 
causes accumulation of mutations (Bucher & Britten, 2008; Chen et al., 2012). Therefore, having a 
model that can represent the behaviour of checkpoints is beneficial for targeted cancer therapies. 
New hypotheses can be formulated by scientists to test in their lab, such as knocking out G2-M 
proteins in order to push cancer cells into unscheduled M-phase which leads to Apoptosis through 
mitotic catastrophe.    
The forth objective of this research involves how Petri Nets (PNs) modelling approach can be 
applied towards model abstraction. 
This objective leads us to a number of challenging questions: 
9. Why PN-based modelling is selected as a suitable approach for model abstraction? 
Mammalian cell cycle is a sophisticated system comprising specified phases which occur in a 
purposeful and timely way. There exist a huge number of chemical reactions that make accurate 
modelling of this system a challenging issue. In Chapters 3, we propose a comprehensive 
mathematical model of mammalian cell cycle control system and published a journal article (as 
mentioned before) based on that (Abroudi et al., 2017) and now, it is of interest to develop an 
abstract/minimised model of mammalian cell cycle in a way that the main system characteristics 
(such as dynamics of key players) and system response (such as G1-S and G2-M transitions as well as 
response to DNA damage) are qualitatively similar. Petri Nets are well suited to represent biological 
systems, especially complex systems like mammalian cell cycle, which comprises different timescales. 
In PN modelling, biological entities, such as genes and proteins, can be presented as Places; different 
kinds of interactions can be denoted by Transitions. This one to one mapping of molecules-reactions 
to places-transitions permits a powerful intuitive structure for such a computational modelling 
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approach (Gilbert & Heiner, 2006; Hardy & Robillard, 2004; Herajy et al., 2013; Koch et al., 2010; 
Matsuno et al., 2003). Furthermore, it provides an appropriate platform for combining continuous 
and discrete processes at different levels of abstraction. Therefore, Multi-Level Hybrid Petri Net 
(MLHPN), a graphical Petri Net-based modelling method, is proposed to model the mammalian cell 
cycle regulation system. It involves incorporation of Cyc_Cdks (as the most essential controllers of 
mammalian cell cycle) and regulators of Cyc_Cdks at different levels of abstraction to develop a 
minimal yet comprehensive model. For example, CycB_Cdk1 is the key player of G2-M transition, 
which controls the progression of cell cycle through Mitosis (presented at high-level of abstraction); 
there are some regulatory elements which regulate CycB_Cdk1 complex in either positive or negative 
way (presented at low-level of abstraction). Cdc25C is one of the positive regulators and APC_Cdc20 
is a negative one (Bollen & Beullens, 2002; Boutros et al., 2007; Goulev & Charvin, 2011; Mateo et al., 
2009; Perry & Kornbluth, 2007). This way, with the MLHPN model, we minimise the comprehensive 
mathematical model with 61 ODEs and 148 parameters down to just four equations and 31 
parameters. The study related to this part is given in Chapter 6.  
10. How do we select the components of the abstract model? 
In order to perform model abstraction, we identify the core components of the comprehensive 
mathematical model presented in Chapter 3 with the highest significance on system response (G1-S 
and G2-M transitions). The most effective parameters are identified using the “Self-Organizing Map 
with Correlation Coefficient Analysis” (SOMCCA) model. Full details are presented in Chapter 6. 
11. Is it possible to evaluate the efficiency of checkpoints using the abstract MLHPN model and if 
so, are the results consistent with the results from the comprehensive model? 
We conduct the Checkpoint Efficiency Evaluation (CEE) analysis on the MLHPN model and the results 
confirm that G2-M checkpoint performs better than G1-S in detecting damaged cells under DNA 
damage. Furthermore, the trend of efficiencies for G1-S and G2-M checkpoints (and combined 
checkpoint efficiency) is the same for both models on either detecting damaged cells passing 
checkpoints as healthy or healthy cells getting arrested as damaged cells. However, the MLHPN is 
more sensitive to system perturbation which is expected because of the smaller number of elements 
and parameters in this model. 
12. How close the PN abstract model results are to those of the comprehensive model? 
The trends of Cyc_Cdks are qualitatively similar between the two models. In order to compare the 
results of the two models, we convert the results of the comprehensive model to the scale of the 
MLHPN model (or vice versa) as each cell cycle of the MLHPN model is 20.57 simulation time units 
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while the corresponding value for the comprehensive model is approximately 3700 simulation time 
units (they can easily be converted to each other as well as to hours as shown in the corresponding 
simulation figures). The results show that G1-S and G2-M transitions in the MLHPN model (6.0756 
and 17.2901 for G1-S and G2-M transitions, respectively) happen almost at the same time points as 
those of the comprehensive mathematical model (6.0876 and 17.8347 for G1-S and G2-M transitions, 
respectively – converted to the simulation time unit of the MLHPN). Furthermore, the simulation 
results show that following the DNA damage, the G1-S transition time shifts from 6.0756 (no 
damage) to 6.2232 (damage condition). Moreover, the corresponding shift for the G2-M transition is 
from 17.2901 (no damage) to 17.9438 (damage condition). Thus, the G1-S and G2-M arrest durations 
are 26.5 and 117.5, respectively (converted to the simulation time unit of the comprehensive model), 
which are close to the corresponding arrest durations for the comprehensive model (30 and 122, 
respectively). Therefore, similar to the comprehensive model, the MLHPN model can qualitatively 
present the cell cycle arrest under a DNA damage condition. In conclusion, the proposed abstract 
model provides an intuitive approach to represent the complex system of mammalian cell cycle from 
different levels of abstraction where the sub-systems and their constituent elements (different 







This chapter provides a literature review on mammalian cell cycle and an overview of the chapter is 
provided in the first section (Section 2.1). Then, the literature review is presented from two different 
aspects. The first is the biological point of view where a comprehensive background of mammalian 
cell cycle control system is presented (Section 2.2). The second aspect is related to the computational 
modelling of mammalian cell cycle (Section 2.3). A summary of the chapter is presented in Section 
2.4. 
 Overview 
The cell cycle refers to a number of phases that happen in a proliferating cell which eventually leads 
to production of two daughter cells (Morgan, 2007; Satyanarayana & Kaldis, 2009). This happens 
within a dynamic environment, where a cell responds to various internal and external signals through 
a well-ordered sequence of events called cell cycle. Any defect in the function of cell cycle control 
system may lead to a variety of diseases, such as cancer (Hartwell & Kastan, 1994; Park & Lee, 2003; 
Stein & Pardee, 2004). In eukaryotic cells, cell cycles have more or less similar sequence of events 
(Novák et al., 2001; Novak et al., 2007). First, cell grows to an appropriate size to be eligible for DNA 
duplication. Then, it goes through a process of division (Ferrell et al., 2011). There are some DNA 
damage checkpoints in order to monitor the progression of cell cycle in the case of any DNA damage 
(Kastan & Bartek, 2004; Novák et al., 2001; Nyberg et al., 2002; Walworth, 2000). 
This complex system can be represented by computational models which have the ability to 
reproduce the dynamics of the corresponding system. Most computational models have studied the 
behaviour of yeast cell cycle system and there have been fewer models on mammalian cell cycle, 
which is the most complicated amongst different species. Therefore, our focus in this chapter is 
mainly on reviewing mammalian cell cycle regulation system, its response to DNA damage, and 
corresponding computational modelling approaches. This can be useful for understanding and 
gaining deeper insights into cell cycle control system as well as potential ways to treatment of cell 
cycle related diseases, like cancer. Furthermore, integrating all the available information, this chapter 
attempts to provide the most complete yet succinct functional overview of mammalian cell cycle 
from a holistic perspective. 
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 Mammalian Cell Cycle Regulation 
Generally, there are two different types of cell: Prokaryotic and Eukaryotic. A prokaryotic cell (such as 
bacteria) doesn’t have a nucleus while the latter has a nucleus (Nelson et al., 2008; Stein & Pardee, 
2004). A cell can duplicate itself by the process of growth and division which eventually leads to 
production of two cells (daughter cells) with identical genetic information (Morgan, 2007). 
Mammalian cells are in the category of eukaryotic cells which have four phases in each cell cycle. 
Typically, these phases refer to DNA duplication (S) and DNA segregation (M) separated by two gaps 
(G1 & G2 phases). There is a cell cycle control mechanism whose function is to ensure the correct 
ordering and timing of the cell cycle events and its malfunction may result in many diseases, such as 
cancer (Hartwell & Kastan, 1994; Park & Lee, 2003; Stein & Pardee, 2004). A schematic of cell cycle 
phases together with checkpoints is shown in Figure 2.1 and described in the following sections.  
Figure 2.1 A schematic of Cell Cycle and its corresponding phases/events and sub-phases. Cell 
cycle comprises four main phases (G1, S, G2, and M): during G1 a cell grows following 
the presence of Growth Factor, then in S its DNA is replicated, and following further 
growth in G2 the mother cell divides into two daughter cells during M. These phases 
are controlled by four different Cyclins (Cyclin D, Cyclin E, Cyclin A, and Cyclin B) in 
complex with corresponding Cdks. There are also two important DNA damage 
checkpoints (G1-S and G2-M) to guarantee genome integrity. 
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2.2.1 Cell Cycle Events 
The first cell cycle phase is G1 in which a cell grows and becomes ready for DNA replication in S 
phase. G1 is the most studied phase due to the existence of the Restriction Point (R) in this phase. 
The R is considered as a point of no return because it is here that a cell is committed to either keep 
continuing cell cycle or exit from it (Berridge, 2014). Cells may go into a stationary state called G0 
(during early G1) if the environmental conditions are not favourable or the cell growth is not enough, 
but the cell exits from G0 following the presence of Growth Factors (Figure 2.1). If the cell commits to 
cell cycle and passes beyond R, it proceeds to S phase, where DNA is replicated. In S phase, DNA 
strands become separated and each strand helps the production of a new DNA strand by functioning 
as a template (Nelson et al., 2008). At the end of DNA synthesis process, two identical DNA 
molecules, which have one strand from the original DNA and a new one from the replication process, 
are produced. The replicated chromosomes are called sister chromatids (Morgan, 2007; Seeley et al., 
2007). 
In the second gap phase (G2), the DNA replication accuracy, environmental condition, and the 
volume of the cell are checked. Typically, the gap phases characterise crucial regulatory events 
associated with transition in which some extracellular or intracellular signals control the cell cycle 
progression to the next phase. Part of this transition process is preparation for cell division, which 
happens in M phase. A cell cycle can also be divided into two distinct stages: Interphase and M 
phase. Interphase includes the G1, S, and G2 phases in which a cell prepares to divide. Generally, the 
time duration of the interphase is more than ninety percent of a typical cell cycle time (Morgan, 
2007). 
M phase (cell division) is composed of two main parts: Mitosis and Cytokinesis (Cyt). At the beginning 
of Mitosis, the cell has a set of condensed pairs of chromosomes (sister chromatids) which are first 
segregated and then distributed into separate regions of the cell. Mitosis usually has five main sub-
phases: Prophase (Pro), ProMetaphase (ProM), Metaphase (Meta), Anaphase (Ana), Telophase (Telo) 
as demonstrated in Figure 2.1. 
During Prophase, Chromatin condensation, centrosome separation, and nuclear envelope 
breakdown (NEB) are initiated. Next, the spindle assembly is carried out in ProMetaphase right 
before the chromosome alignment on the spindle plate that happens during Metaphase. Completion 
of spindle alignment is a signal to start the next sub-phase, Anaphase. All chromosomes are 
separated and moved toward the opposite spindle poles during Anaphase. Eventually, in Telophase, 
the chromosomes become decondensed and two nuclei appear. Division into two distinct daughter 
cells is carried out in Cytokinesis phase. At the end of M phase, each of the new daughter cells has 
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one of the newly created nuclei and its function is similar to that of the parent cell (Berridge, 2014; 
Cooper, 2000; Morgan, 2007).   
2.2.2 Key Cell Cycle Regulators 
Cyclin-Dependent Kinases (Cdks) are the core components of the cell cycle control system and 
regulate the coordination and timing of the cell cycle events. Mammalian cells have at least ten 
different kinds of Cdks. Cdk 1, 2, 4, and 6 are the kinases that appear in the mammalian cell cycle 
(Malumbres & Barbacid, 2005). There is another Cdk (Cdk7) which phosphorylates and activates 
other Cdks and it is usually known as Cdk-Activating Kinase (CAK) (Harper & Elledge, 1998). It is 
important to note that the Cdk4 and Cdk6 (also known as starter kinases) have the crucial duty in 
ensuring a cell’s entering cell cycle following the presence of Growth Factor signals. On the other 
hand, Cdk1 and Cdk2 control the M phase and S phase of the mammalian cell cycle, respectively. 
During cell cycle, the levels of Cdks oscillate and these oscillations lead to phase transitions. 
Activation of the Cdks during cell cycle is mainly due to the binding of cyclins. Four different kinds of 
cyclins (see Figure 2.1) have crucial effects on mammalian cell cycle system (Cyclin D, Cyclin E, Cyclin 
A, Cyclin B). These cyclins, which bind to and activate Cdks, stimulate particular cell cycle events. For 
example, CycE_Cdk2 complex leads to the phosphorylation of some proteins that begin the DNA 
Replication in S phase. As shown below, there are three regulatory mechanisms that control Cdk 
activities (Berridge, 2014; Morgan, 1997; Ruddon, 2007; Satyanarayana & Kaldis, 2009). These three 
processes are also shown in Figure 2.2. 
Ø Cyclins synthesis and degradation (activates and deactivates Cdks) (bottom part of Figure 
2.2) 
Ø Presence of Cdk inhibitors, CKIs (inhibits Cdks) (top left-hand side of Figure 2.2) 
Ø Addition/removal of inhibitory phosphate groups by Tyrosine kinases/phosphatases 
(inhibition/activation of Cdks) (top right-hand side of Figure 2.2) 
It is important to note that levels of different Cdks are always high during cell cycle and therefore 
their gene expressions have little effect on Cdk activities. The levels of cyclins and CKIs are low and 
high, respectively, during stationary state (G0), but following the presence of Growth Factor, cyclin 
levels increase and lead to the formation of more Cyc_Cdk complexes. The required elements for 
each process are clearly illustrated in Figure 2.2. As shown in this figure, cyclins and CKIs affect Cdks 
through binding processes while the corresponding impact of Tyrosine kinases and phosphatases on 
Cdks is through dephosphorylation and phosphorylation processes, respectively. As the above-
mentioned regulators (CKIs and Tyrosine kinases and phosphatases) can regulate Cyc_Cdk activity, 
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active Cyc_Cdk can also regulate those regulators via phosphorylation reactions. This process 
comprises regulation of transcription factors of CKIs and cyclins as well as phosphorylation of 
ubiquitin ligases, CKIs, and Tyrosine kinases/phosphatases through feedback processes (not shown 
here).  
Figure 2.2 Three main regulatory mechanisms of Cdk activity: Synthesis and Degradation of 
Cyclins (Bottom), Activation and Inactivation of Cyc_Cdk complexes through Tyrosine 
Phosphatases and Kinases (top right), and Inhibition of Cyc_Cdks through CKIs (top 
left). 
 
These three Cdk regulatory processes are described in detail in the following sections.  
Cyclins 
Cyclins act as triggers or switches (activating Cdks) in cell cycle (Figure 2.2, bottom part). The cyclin 
protein concentrations keep changing during cell cycle due to their regulated expression and 
degradation. The gene expression depends on transcription factor which binds to the promoter of a 
gene to induce the expression of that particular gene (Chen & Rajewsky, 2007; Latchman, 1997; 
Levine & Tjian, 2003). For instance, E2F is a transcription factor that induces the production of Cyclin 
A and Cyclin E (Trimarchi & Lees, 2002) (bottom right part of Figure 2.2).  
The degradation of cyclins is mainly carried out by the process of ubiquitination (tagging for 
destruction) via ubiquitin ligases, such as “Skp_Cullin_F-box containing complex” (SCF) and 
“Anaphase-Promoting Complex” (APC) which become activated after binding to two different sub-































units, Cdc20 and Cdh1. Following ubiquitination, protease complexes named Proteasomes recognize 
tagged cyclins and destroy them (Cardozo & Pagano, 2004; Nakayama & Nakayama, 2006; 
Vodermaier, 2004) (Figure 2.2, bottom left part).  
The first cyclin which has a major influence on start of a new cell cycle in mammalian cells is Cyclin D. 
The D-type cyclin which is also called G1 Cyclin has the key role in synchronization of cell growth and 
cell cycle initiation. The level of Cyclin D starts to increase after sensing the Growth Factor signals by 
the cell’s receptors. The level of Cyclin D can be a biomarker for Restriction point (R) transition in G1 
phase. Cyclin E (G1-S Cyclin) is another cyclin whose major function is to help transition from G1 to S 
that eventually leads to the initiation of DNA synthesis process. Cyclin E does this job in two ways: 
first, it triggers the destruction of a Cdk Inhibitor, p27. The main function of p27 is to maintain the 
cell in stationary state by binding to and inhibiting Cyc_Cdk complexes. In fact, following the 
presence of Growth Factors, first, Cyclin D and subsequently, Cyclin E are produced. Afterwards, 
some of CycE_Cdk complexes, which are not suppressed by p27, induce release of p27 from inactive 
CycE_Cdks and thereby, stimulate their activation. The second function of Cyclin E is to inactivate 
APC_Cdh1. This ubiquitin ligase degrades some proteins, such as Cdc25A, Cyclin A, and Cyclin B. 
CycE_Cdk2 complex causes phosphorylation of APC_Cdh1 and therefore, dissociation of Cdh1 sub-
unit from APC leading to inactivation of APC_Cdh1 (Murray, 2004). It is important to note that Cyclin 
E is degraded by another ubiquitin ligase (SCF) at the end of G1 phase (Cardozo & Pagano, 2004). 
Cyclin A (S Cyclin) has a key function in the process of DNA replication. Its level starts to increase at 
the end of G1 phase with a gradually increasing trend from early S phase to early M phase, where it 
triggers the activation of the next cyclin (Cyclin B) in the cell cycle. Cyclin A is destroyed by 
APC_Cdc20 through the ubiquitination process which occurs after nuclear envelope breakdown in 
early M phase (Prometaphase). Cyclin B (M Cyclin) concentration begins to increase from the end of 
S phase and it helps the spindle assembly and chromosomes alignment at Metaphase. During 
Anaphase, the concentration level of Cyclin B falls due to the ubiquitination process that is started by 
APC_Cdc20 and finished by APC_Cdh1 (Morgan, 2007; Vodermaier, 2004). It is this destruction 
mechanism that leads to the M phase exit at the end of cell cycle.  
Cyclin-Dependent Kinase Inhibitors (CKIs) 
When a cell is not in cell cycle, its Cdks must be regulated to keep them in check. One of the most 
important categories of Cdk regulators is the family of Cdk inhibitors or CKIs, which bind to and 
supress the activity of Cyc_Cdk complexes (see Figure 2.2, top left part). Some important CKIs are 
p21 and p27, which have different functions toward different Cyc_Cdk complexes (Besson et al., 
2008; Malumbres & Barbacid, 2005).  
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Passing through G1-S and entering a new cell cycle require the rise of CycE_Cdk2 levels which is kept 
suppressed by p27. Therefore, p27 should be destroyed by the end of G1 phase. This removal of p27 
from CycE_Cdk2 is carried out via two mechanisms: first one is related to CycD_Cdk4 complexes. 
Since p27 is required for the activation of CycD_Cdk4 complex, after sensing the Growth Factor 
during G1 phase, more complexes of CycD_Cdk4s bind to p27 leaving less free p27 proteins for 
binding and suppressing CycE_Cdk2s. Secondly, in the mid to late G1, Growth Factors and mitogens 
cause the phosphorylation of p27 on Ser10 and Thr157 residues and their destruction. This process 
leads to the activation of a small number of CycE_Cdk2 complexes in late G1. These active 
complexes, in turn, trigger the destruction of remaining p27 inhibitors via phosphorylation on 
Thr187. This results in full activation of CycE_Cdk2 complexes at the G1-S transition. In either case, 
the phosphorylation of p27 leads to SCF-dependent ubiquitination and degradation of p27 (Hao et 
al., 2005; Kamura et al., 2004; Morgan, 2007; Sherr & Roberts, 1999). CKI p21 has also a crucial 
function in mammalian cell cycle in that it leads to cell cycle arrest in the presence of DNA damage. 
The corresponding impact of p21 on G1-S transition is that it binds to CycE_Cdk2 and CycA_Cdk2 and 
inactivates them. Likewise, it binds to and inactivates CycB_Cdk1 therefore supresses the G2_M 
transition. On the other hand, p21 activates CycD_Cdk4 by mediating assembly of this complex in 
cytoplasm (Cazzalini et al., 2010; Karimian et al., 2016; Yoon et al., 2012). Table 2.1 shows the most 
important mammalian Cdk Inhibitors and the corresponding functions. 
Table 2.1 The most important Cyclin-Dependent Kinase Inhibitors in mammalian cells. 
CKI Name Function 
p21, p27 Suppresses CycE_Cdk2, CycA_Cdk2, and CycB_Cdk1.  Activates CycD_Cdk4,6 
 
Tyrosine Kinases and Tyrosine Phosphatases 
The phosphorylation of Thr14 and Tyr15 residues in mammalian Cdks inhibits the activity of Cyc_Cdk 
complexes. In particular, the phosphorylation state of these sites is important in Cdk1 at the initiation 
of M phase. The phosphorylation of Cdks is regulated by Tyrosine kinases and phosphatases. The 
most important Tyrosine kinase and phosphatase in the mammalian cell cycle are Wee1 and Cdc25 
family, respectively (Boutros et al., 2006; Morgan, 2007; Perry & Kornbluth, 2007). There is also 
another kinase (Myt1) which phosphorylates both Tyr15 and Thr14 residues in vertebrates. The 
family of Cdc25 includes three different Cdc25 proteins whose functions, together with those of 
Wee1 and Myt1, are summarized in Table 2.2. Phosphorylation of Cdk1 on the aforementioned 
residues, which leads to CycB_Cdk1 inactivation, can be neutralized by dephosphorylation via Cdc25 
phosphatases (Figure 2.2, top right part). These interactions trigger a process that leads to the 
activation of Cdk1 and the onset of M phase. 
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Table 2.2 Tyrosine kinases and phosphatases  
Tyrosine Kinases (phosphorylate Cdks) 
Name Function Corresponding Cdks 
Wee1 Tyr 15 Phosphorylation Cdk1 & Cdk2 
Myt1 Tyr 15 and Thr14 Phosphorylation Cdk1 & Cdk2 
Tyrosine Phosphatases (dephosphorylate Cdks) 
Name Function Point Corresponding Cdks 
Cdc25A Important at transition from G1 to S Cdk2 
Cdc25B Important at transition from G2 to M Cdk1 
Cdc25C Important at transition from G2 to M Cdk1 
 
In the following section, the important effect of Cyc_Cdk complexes on cell cycle progression and 
DNA damage checkpoints will be described.  
2.2.3 Cell Cycle Progression  
The progression of the cell cycle is tightly controlled by a set of interactions characterized by 
synthesis/degradation and activation/inactivation of some regulators. Furthermore, there are some 
checkpoints whose function is to check the fidelity of the genome and to arrest the cell cycle 
progression in the presence of unfavourable conditions such as DNA damage (Nyberg et al., 2002; 
Zhou & Elledge, 2000). The existence of Growth Factor signal (or mitogen) can either make a cell in 
G0 state enter G1 phase (initiate cell cycle) or allow a newly synthesized cell to go directly from M to 
G1 phase. Likewise, if the Growth Factor signal is removed, it lets the cell return to the stationary 
state G0, provided that this removal happens before the Restriction point (R). The Restriction point, 
which is in the late G1 phase, is the point from which the cell cycle progression will be independent 
of Growth Factors. A cell which passes the Restriction point is committed to finishing the current 
cycle. After the Restriction point, different types of cyclins, which have a key role in the cell cycle 
signalling system, operate at particular points in order to control cell cycle progression.  
It has been proven that Growth Factor signals induce the synthesis of Cyclin D via a Ras-mediated 
pathway (Alberts et al., 2014; Morgan, 2007). The Growth Factor signalling is shown in Figure 2.3. 
The activated Growth Factor receptors cause binding of the guanine-nucleotide exchange factor Sos 
to GDP-bound Ras via interaction with an SH2-containing protein named Grb2. This binding 
stimulates the activation of Ras by turning it in the form of GTP-bound Ras. Thereafter, a cascade of 
protein kinase activation is initiated which finally leads to the phosphorylation and activation of MAP 
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Kinase (MAPK). This kinase is translocated to the nucleus and eventually causes the synthesis of 
Cyclin D through a number of gene regulation processes. The corresponding gene regulations start 
with the transcription of immediate early genes. Serum-Response Factor (SRF) is one of the gene 
regulatory proteins which stimulates the transcription of immediate early genes. The proteins that 
are the products of the aforementioned process (such as c-Fos and c-Myc) induce the expression of a 
second series of genes called delayed response genes (Adhikary & Eilers, 2005; Alberts et al., 2014; 
Morgan, 2007). Cyclin D is a product of these genes.  
 
Figure 2.3 Growth Factor signalling pathway (Morgan, 2007). 
 
Image removed for copyright compliance 
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The story begins when a cell receives the Growth Factor signals which eventually lead to production 
of Cyclin D through activation of a transcription factor called c-Myc. Once produced, Cyclin D binds to 
Cdk4,6 to form CycD_Cdk4,6 complex, which triggers activation of transcription factor E2F. This 
Transcription factor, in turn, induces the expression of two key cyclins (Cyclin A and Cyclin E) as well 
as Cdc25A, B-Myb and E2F itself. There are two important inhibitory regulators (p27 and APC_Cdh1) 
during the G1 phase that inhibit Cyclin E and Cyclin A. The function of these regulators is to make 
sure that no new cell cycle starts unless the environmental conditions favour the proliferation 
process. B-Myb is another transcription factor (which is produced and activated by E2F and 
CycA_Cdk2, respectively) that triggers the production of Cyclin A (Fung & Poon, 2005; Joaquin & 
Watson, 2003; Zhu et al., 2004). However, Transcription factor NFY, which also becomes activated by 
CycA_Cdk2, stimulates the production of both Cyclin A and Cyclin B (Chae et al., 2004; Chae & Shin, 
2011; Fung & Poon, 2005; Yun et al., 2003). Cdc25A is a phosphatase that induces activation of 
CycE_Cdk2 and active CycE_Cdk2 promotes degradation of p27 and APC_Cdh1. This results in higher 
expression of proteins needed for DNA synthesis, such as Cyclin A. In mammalian cells, Cyclin E 
typically increases transiently at late G1 phase. But, Cyclin A starts to rise from the beginning of S 
phase and is degraded during prometaphase, after nuclear envelope breakdown (Berridge, 2014; 
Morgan, 2007).  
Cyclin B is synthesised through transcription factor NFY and then binds to Cdk1 to create CycB_Cdk1 
complex. The activity of this complex is low during G2 phase due to inhibitory phosphorylation by 
Tyrosine kinase, Wee1. Dephosphorylation of CycB_Cdk1 by Tyrosine phosphatases (Cdc25 proteins) 
triggers the activation of this complex. It is important to note that CycA_Cdk2 complex stimulates 
activation of Cdc25 phosphatases. In late Prometaphase, free APC is phosphorylated and activated by 
CycB_Cdk1 complex and binds to APC20. But this type of active APC_Cdc20 (partially active form) just 
functions toward Cyclin A (by ubiquitination and degradation of Cyclin A) till the end of Metaphase. 
Upon the deactivation of spindle assembly checkpoint during Metaphase, APC_Cdc20 attains its full 
activity and trigger the destruction Cyclin B. Cyclin B is degraded during Anaphase and this leads to 
dephosphorylation of Cdh1 which results in formation of APC_Cdh1. Active APC_Cdh1, in turn, 
stimulates the degradation of Cdc20 and drives the final steps of M phase that leads to ending a cell 
cycle (Morgan, 2007).  
There are two main checkpoints in cell cycle (G1-S and G2-M) which control the progression through 
cell cycle stages (Hartwell & Weinert, 1989). Various proteins and complexes, such as cyclins, CKIs, 
Tyrosine kinases and phosphatases, ubiquitin ligases, etc. are the players which regulate the cell 
cycle events at G1-S and G2-M checkpoints. These checkpoints are related to DNA damage checking. 
Mutation in one or more of these regulators can cause diseases like different types of cancer (Kastan 
& Bartek, 2004). It should be noted that there is another checkpoint called Mitotic Spindle or Spindle 
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Assembly Checkpoint (SAC), which takes place during M phase. This checkpoint monitors the 
assembly of all sister chromatids’ kinetochores to microtubules on the mitotic plate to make sure 
that all of them are correctly connected and it happens at Metaphase to Anaphase transition.    
The cell cycle can be considered as an engine with some brakes and accelerators which monitor the 
cell cycle system to ensure the correct order of events. Furthermore, this robust surveillance 
mechanism can block an event if any problem occurs. Therefore, entering into the next phase is 
delayed until the problem is resolved or the previous phase is finished. As mentioned before, the 
components of the cell cycle control system exert their regulatory effects on progression of cycle in 
different stages. The appropriate conditions (like sufficient cell size or enough nutrients) can 
accelerate the cell cycle engine while the inhibitory signals (such as DNA damage or unreplicated 
DNA) lead to a brake in cell cycle progression (Novák et al., 2001; Nyberg et al., 2002). Therefore, the 
DNA damage checkpoints and their core elements are explained in the following section as a lot of 
existing computational models of mammalian cell cycle have investigated these checkpoints.  
2.2.4 DNA Damage Checkpoints 
There are some sensing mechanisms which detect DNA damage and send negative signals to cell 
cycle control system that can lead to cell cycle arrest at particular places. After sensing DNA damage 
by special sensor proteins, the damage signal is transduced by a cascade of protein kinases that 
eventually phosphorylate and activate some effector proteins. Some of these effector proteins 
stimulate the expression of some enzymes that repair the DNA damage. Some other effectors are 
responsible for cell cycle arrest. Usually, cell cycle can be resumed after the repair process is done if 
the damage is not severe (Fry et al., 2005; Morgan, 2007; Nyberg et al., 2002; Rouse & Jackson, 
2002). In the case of severe damage, cell goes through Apoptosis or programmed cell death (Elmore, 
2007). Figure 2.4 shows a holistic picture of DNA damage response. 















Two protein kinases (ATM & ATR) are at the centre of DNA damage signalling pathway. ATM is 
related to Double-Strand Breaks (DSBs) and ATR is responsible for other kinds of DNA damage, like 
stalled replication fork and Single-Strand Breaks (SSB) (Nyberg et al., 2002). There are two types of 
DNA damage responses: rapid response and delayed (or maintenance) response. Rapid response 
pathway, which is transcription-independent, gets activated within a few minutes. It acts through the 
activation of two effector kinases called Chk1 and Chk2 which inhibit some cell cycle regulators, such 
as Cdc25 phosphatases. These kinases trigger a signalling pathway which leads to quick blocking of 
cell cycle as well as production of some DNA repair enzymes (Figure 2.4) (Bartek & Lukas, 2001; 
Morgan, 2007; Sancar et al., 2004).  
The delayed signalling pathway, which is transcription-dependent and is based on a protein called 
p53 (ATR and ATM activate p53), is activated following the activation of rapid pathway and leads to 
prolonged cell cycle arrest (Figure 2.4). Transcription factor p53 stimulates higher production of 
various target proteins related to DNA repair and temporary and permanent cell cycle arrest. 
Activation of p53 results in expression of a CKI protein called p21 which inactivates some key 
components of cell cycle progression, such as CycE_Cdk2, CycA_Cdk2, and CycB_Cdk1. It (p53) is also 
responsible for programmed cell death or Apoptosis if the damage is irreparable (Abraham, 2001; 
Bartek & Lukas, 2003; Liu et al., 2006; Zhou & Elledge, 2000).  
G1-S Checkpoint 
The first checkpoint in the eukaryotic cell cycle is called G1-S checkpoint and it occurs after the 
Restriction point. This checkpoint can block the cell cycle system from entering into S phase in the 
presence of different DNA damages. In fact, DNA damage can trigger some signalling pathways which 
lead to cell cycle arrest that stops the onset of DNA duplication process. The purpose of this arrest is 
to provide enough time for the cell cycle control system to assess the damage and either repair the 
DNA damage before allowing the cell to enter S phase or eliminate/kill the cell (apoptosis) if damage 
is irreparable.  
It is important to note that the Restriction point and G1-S checkpoint are two distinct points in the 
cell cycle. For instance, in the presence of favourable environmental conditions, a cell with or 
without DNA damage can pass through Restriction point but not G1-S checkpoint (Bartek & Lukas, 
2001; Pardee, 2002). Following DNA damage, either ATR or ATM is auto-phosphorylated and 
activated and therefore it can phosphorylate some target proteins such as Chk1/Chk2 and p53 as 
shown in Figure 2.4. As mentioned before, the phosphorylation of these proteins triggers two 
different signalling pathways; one for initiating and another for maintaining the G1-S blockage 
(Bartek & Lukas, 2001). G1-S checkpoint details with these two response pathways are shown in 
Figure 2.5. Regardless of DNA damage type, activated Chk1/Chk2 causes phosphorylation and 
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inactivation of Cdc25A phosphatase (Figure 2.5). As a result, there are no active phosphatases to 
remove the inhibitory phosphate group from Cyc_Cdks and therefore cell cycle is halted at G1-S 
checkpoint (Bartek et al., 2001; Molinari et al., 2000).  
Figure 2.5 G1-S checkpoint with rapid and delayed DNA damage response pathways. Red round-
ended arrows indicate negative effects (i.e., inhibition, inactivation, etc.); green 
arrows denote positive effects (i.e., activation, synthesis, etc.); blue arrows 
correspond to biochemical reactions (i.e., binding of two proteins, etc.) and thick black 
arrows show the results of formation of a particular complex (i.e., formation of active 
CycE_Cdk2 leads to G1-S progression, etc.). 
 
The rapid response which is mediated by Chk1/Chk2 is followed by the delayed response. The latter 
comes into the picture after the rapid response (Bartek & Lukas, 2001). In the delayed stage, Ser15 
and Ser20 residues of p53 are phosphorylated by ATR/ATM and Chk1/Chk2, respectively (Banin et al., 
1998; Chehab et al., 1999; Kastan & Lim, 2000; Ryan et al., 2001). There is an important ubiquitin 
ligase named Mdm2 which has an inhibitory effect on p53 under no DNA damage condition. Mdm2 
causes instability and nuclear export of p53 but Mdm2 is inactivated by ATR-/ATM-mediated 
phosphorylation at Ser395 following the presence of DNA damage signal (Meek, 2004; Nyberg et al., 
2002; Zhang & Xiong, 2001).  
Activated p53 acts as a transcription factor for inducing the synthesis of p21 which is a Cyclin-
Dependent Kinase inhibitor that inhibits the activity of CycE_Cdk2 complexes needed for G1-S 
transition. The whole point in inhibiting CycE_Cdk2 is to stop preparing the conditions for G1-S 
transition, such as preparation of Cyclin A. As discussed before, there is a protein called 
Retinoblastoma protein (pRb) which inhibits the activity of transcription factor E2F by binding to it. 
The phosphorylation of pRb (via active Cyc_Cdk2 complexes) leads to the release of E2F which 
stimulates the expression of G1-S cyclins. Therefore, inactive Cyc_Cdk2 complexes, which become 
inactive by the DNA damage response, suppress the production of proteins (such as E2F) which are 
required for preparing Cyclin E and Cyclin A for G1-S transition.  
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When DNA damage happens, G2 cells (cells that are in G2 phase) are prevented from entry into M 
phase. This checkpoint controls the transition from G2 to M phase by regulating CycB_Cdk1 complex 
as shown in Figure 2.6. Following the DNA damage in G2 phase, either ATR→Chk1→Cdc25 or 
ATM→Chk2→Cdc25 pathway is stimulated to block the cell cycle progression (rapid response) 
(Brown & Baltimore, 2003; Xu et al., 2002; Zhao & Piwnica-Worms, 2001). As demonstrated in Figure 
2.6, Chk1/Chk2 (shown as Chk1,2 in the figure) inhibits the activity of Cdc25 phosphatases (by 
phosphorylating their different sites).  
The delayed response, which is mediated by ATM/ATR→p53 pathway, induces the expression of 
some genes that encode inhibitor regulators such as p21, 14-3-3σ, and Gadd45α. The first one (p21) 
is a CKI which binds to and inhibits the activity of CycB_Cdk1 complex. The second one (14-3-3σ) is a 
phosphoserine binding protein that following phosphorylation of Cdc25 proteins by Chk1/Chk2 binds 
to these phosphatases to further suppress their activity  (Chan et al., 2000). Another crucial protein 
synthesised after DNA damage is “Growth Arrest and DNA Damage-Inducible” (Gadd) protein, 
Gadd45α. Although both Cdc25-Related pathway and Gadd45α inactivate CycB_Cdk1 complex, the 
way they do this inactivation is different. The former uses dephosphorylation of Cdk1, but the latter 
(Gadd45α) establishes a physical interaction with Cdk1 and triggers an unbinding reaction between 
Cyclin B and Cdk1. This way, Gadd45α stimulates cell cycle arrest at G2-M transition (Jin et al., 2002; 
Zhan, 2005).  
Figure 2.6 Cell cycle arrest at G2-M checkpoint. Red round-ended arrows indicate negative 
effects (i.e., inhibition, inactivation, etc.); green arrows denote positive effects (i.e., 
activation, synthesis, etc.); blue arrows correspond to biochemical reactions (i.e., 
binding of two proteins, etc.) and thick black arrows show the results of formation of a 
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Following the increase in cell cycle-Related experimental data in the last two decades, a variety of 
computational models aimed at understanding the behaviour of this complex system have been 
developed (Csikász-Nagy, 2009). Majority of these models have focused on yeast cell cycle. 
Mammalian cell cycle has been less investigated and modelled in comparison to that of other 
eukaryotes due to its higher complexity. Furthermore, most mammalian cell cycle models have been 
concentrated just on a part of cell cycle, such as G1-S checkpoint. In the next section, we describe 
modelling approaches to mammalian cell cycle and also provide a list of computational models in 
each category. 
 Computational Models of Mammalian Cell Cycle 
There are five main approaches for modelling biological systems: Discrete, Continuous Deterministic, 
Stochastic, Hybrid, and Petri Net-based. A summary of all mammalian cell cycle models including the 
corresponding reference and modelling type is presented at the end of this section in Table 2.4.  
The first category is the group of discrete/logical models that qualitatively describe the system 
behaviour, and mostly correspond to Boolean networks. They provide a high degree of abstraction as 
well as a fundamental understanding of dynamical behaviour of system under different conditions. 
Such models are not only flexible but also easy to fit into cell cycle system. These models introduce 
the states of species in the form of active/inactive (present/absent) and construct causal 
relationships between them. These models do not have the problem of parameter estimation that 
ODE models have and they in particular are useful for large scale networks. A main disadvantage of 
Boolean modelling is that it cannot describe intermediate states such as slow or small state changes 
and it can easily generate spurious results (Albert & Wang, 2009). Most Boolean models of cell cycle 
were developed for yeast and not many for mammalian cell cycle. In one of the most referenced 
Boolean models of mammalian cell cycle, Fauré et al. (2006) constructed a discrete version of an ODE 
model in synchronous as well as asynchronous updating schemes. They assessed the corresponding 
merits and limitations of these two schemes in determining the regulatory network behaviour. A 
logical simulation software named “GINsim” was also developed by this group. However, this model 
does not take the important effect of some cell cycle regulatory proteins such as Cdc25, Wee1, etc. 
into consideration.  
For construction of a discrete model, three main steps should be followed: (1) constructing network 
graph; (2) determining logical nodes; (3) defining rules. Logical operators, such as AND, OR, and NOT, 
are used to define the rules that update the state of the nodes. An example of a discrete graph for a 
small part of mammalian cell cycle, which shows the regulation of Cyclin B controlled by two 
ubiquitin ligases (APC_Cdc20 & APC_Cdh1), is illustrated in Figure 2.7 (Morgan, 2007). The logical rule 
for updating the activity of Cyclin B is illustrated in Table 2.3. According to Figure 2.7 and Table 2.3, 
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CycB node becomes active (state = 1) if both APC_Cdc20 AND APC_Cdh1 are absent or inactive. 
These ubiquitin ligases may have some effects on other elements of cell cycle, but just the effect on 
CycB has been highlighted here to illustrate the Boolean concept.  
 
Figure 2.7 An example of a discrete Boolean graph for CycB (Cyclin B) regulation. Green arrows 
and red round-ended arrows indicate activation and inhibition, respectively. 
 
Table 2.3 Updating rule for CycB activation 
Updating rule for CycB Rationale 
CycB:	𝑁𝑂𝑇(𝐴𝑃𝐶_𝐶𝑑𝑐20)	𝐴𝑁𝐷	𝑁𝑂𝑇(𝐴𝑃𝐶_𝐶𝑑ℎ1) To become active, CycB needs absence of two 
ubiquitin ligases, APC_Cdc20 AND APC_Cdh1 
(Morgan, 2007).  
 
	
As discrete models are only able to present system variables discretely, continuous models have 
become more popular in the field of cell cycle modelling. The main approach here has been 
mathematical models based on Ordinary Differential Equations (ODEs) that deterministically track 
the exact concentration of species via continuous representation of system dynamics using a set of 
ODEs (Fuβ et al., 2005). The rate of chemical reaction 𝑚 in a dynamic system is expressed as a 
function (𝑔V) of species 𝑦X, 𝑦8,…, and 𝑦Y that effect 𝑚	and can be presented as 𝑟V:  
𝑟V = 𝑔V(𝑦X, 𝑦8, … , 𝑦Y)                                                                                          (2-1) 
Different kinetic laws are used to mathematically formulate 𝑟V. Mass Action law and Michaelis-
Menten are two common kinetic laws used in mathematical models (Sauro, 2012). Mass Action 
Kinetic is utilized for elementary reactions with single transition step (Eq. (2-2)) and describes the 
rate of reaction as in Eq. (2-3); therefore, change in concentration of reactants and product can be 
calculated by Eq. (2-4) 
𝑑𝐷 + 𝑒𝐸
Y




𝑟 = 𝑘 × [𝐷]c × [𝐸]d                                                    (2-3) 
	c[e]
cf
= −𝑑 × 𝑟,			 c[g]
cf
= −𝑒 × 𝑟, c[h]
cf
= 𝑝 × 𝑟							                                                          (2-4)   
where 𝐷 and 𝐸 are reactants and 𝑃 is product; 𝑑, 𝑒, and 𝑝 are stoichiometric coefficients; and 𝑘 is 
rate constant (Sauro, 2012). On the other hand, Michaelis-Menten law is used when the reaction is 
enzymatic. The typical reaction of this type can be shown as follows:  
𝑆 + 𝐸 ⇌ 	𝐸𝑆
Yk→ 	𝑃 + 𝐸						 	 			                                                  (2-5)	
where S, E, ES, and P are substrate, enzyme, enzyme-substrate compound, and product, respectively. 
𝑘l, 𝑘m, and 𝑘n  are rate constants. There are two assumptions to write the Michaelis-Menten kinetic: 
ES concentration is almost constant; and the total concentration of enzyme (bounded and 
unbounded) (Etotal) is constant. Therefore, Michaelis-Menten equation formulates the rate of 






                               (2-6) 
where 𝑟Vlo = 𝑘n × [𝐸ftflu] is the maximum reaction rate and 𝐾w =
YxsYk
Yy
 is Michaelis-Menten 
constant. The detailed description of other kinetic laws (such as Hill Function) can be found in (Sauro, 
2012). Due to data availability, the last decade of the 20th century has seen a much growth in 
computational modelling of cell cycle. The first mathematical model of cell cycle was “Modelling the 
cell division cycle: cdc2 and cyclin interactions” (Tyson, 1991). Comprising six species, this model 
could qualitatively represent cell division. Tyson characterized “M phase Promoting Factor” (MPF) as 
the most crucial regulatory element in the cell cycle (MPF corresponds to CycB_Cdk1) which can be 
regulated by synthesis and degradation of cyclins, dephosphorylated by phosphatase Cdc25, and 
phosphorylated by kinase Wee1. Also, Novak and Tyson (Novak & Tyson, 1993) showed that 
“Hysteresis” exists in the MPF–Cyclin relationship which was confirmed experimentally ten years 
later (Sha et al., 2003), demonstrating the value of computational modelling in biological discovery. 
In 2004, Novak and Tyson developed a mathematical model for the Restriction point control (Novak 
& Tyson, 2004) where they investigated the mutations in some key elements of mammalian cell 
cycle, like Cyclin E and Retinoblastoma protein (pRb). They also considered the important effect of 
Growth Factor on passage through the Restriction point by exploring the interactions between 
Growth Factors and cell cycle core components, such as Cyclin_Cdks, and made a good comparison 
between mammalian and yeast cell cycle dynamics. But their model lacked a strategy to investigate 




In 1999, Aguda and Tang published a detailed mathematical model to investigate the kinetic origin of 
the Restriction point in mammalian cell cycle (Aguda & Tang, 1999). In the same year, Aguda 
explored the effect of DNA damage on G2-M checkpoint  (Aguda, 1999a). Iwamoto et al. who partly 
utilized Aguda’s models, developed more complex models of mammalian cell cycle checkpoints and 
investigated the effect of DNA damage (following UV-irradiation) on G1-S transition in mammalian 
cell cycle  (Iwamoto et al., 2008). This study inspired Ling et al. to investigate the robustness of G1-S 
checkpoint in depth. Using Type II Error, they introduced a novel approach to quantify the 
percentage of damaged cells passing G1-S checkpoint under different system perturbations (Ling et 
al., 2010).  
In 2011, Iwamoto et al. added G2-M checkpoint to their previous model in order to make it more 
comprehensive and meaningful as it then covered almost the whole cell cycle (Iwamoto et al., 2011). 
This model was insightful in that it could determine cell fate based on DNA damage strength. One of 
the most complete models of mammalian cell cycle was constructed by Gauthier and Pohl (2011). It 
included both molecular and cellular systems from nucleotides and amino acids to proteins (33 cell 
cycle proteins) and consisted 387 equations and around 1100 rates represented in elementary mass 
action kinetics. The authors presented a table to describe the corresponding location, ubiquitinator, 
inducer, activator, inactivator and function of each cell cycle protein. This model presented some 
predictions on both molecular and system levels including the effect of cell growth (Gauthier & Pohl, 
2011). The drawback of deterministic models such as ODE is that model complexity increases with 
the number of chemical reactions. Furthermore, it is hard to estimate kinetic parameters with the 
limited available data and it becomes even harder for large scale systems.  
The third category of models is based on the fact that the functionality of cell cycle regulatory 
network is often influenced by noise. Unlike deterministic models, stochastic models consider the 
random variations in concentration of biological species. They are suitable for cases where 
concentration levels of species are lower than what are applicable for deterministic ones (of the 
order of many hundreds or above). Thus, as concentrations become lower, the variability of 
concentration becomes higher and therefore the random element in chemical interactions becomes 
significant (Donnet & Robert, 2012). In a model, stochasticity can be presented by Gillespie 
Stochastic Simulation Algorithm (GSSA) (Kar et al., 2009) or Stochastic Langevin Equations (SLA) 
(Steuer, 2004). The mathematical details of these algorithms can be found in the three 
aforementioned references. As stochastic models take the number of molecules into account 
(instead of concentrations), they suffer from the problem of computational complexity.  
The next category of models is hybrid type. They integrate strengths of other methods, such as 
discrete models for rapid changes, continuous models for slow changes, deterministic and stochastic 
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models for predictable and unpredictable behaviours, respectively (Kiehl et al., 2004). Majority of 
hybrid models have aimed to overcome the limitations of ODE-based models. Some of these 
constraints are: (1) problem of passing from the number of molecules to concentration levels; (2) 
difficulty in combining discrete state transitions and continuous dynamics which is particularly 
needed throughout cell cycle; (3) limited available experimental data for reaction rates, parameters, 
and real protein concentrations. In recent years, hybrid modelling has become popular and a few cell 
cycle models, but not many for mammals, have been proposed and proved to be successful due to 
incorporation of the best features of individual models as well as the capability to represent different 
timescales. Singhania et al. (2011) developed a simplified hybrid model emphasizing the vital effect 
of cyclins on mammalian cell cycle regulation. The authors combined discrete (Boolean), 
deterministic (ODEs), and stochastic approaches, just three different cyclins (Cyclin E, A, and B) and 
continuous tracking of cell mass. Here, cyclins were considered as continuous variables but 
regulators of cyclins as discrete variables which followed Boolean logic with some time delays. 
However, this model is not completely autonomous and the Boolean part could not update itself 
based on the current system state. Noel et al. (2013) developed a hybrid model for mammalian cell 
cycle by combining discrete and continuous methods. They transformed an ODE model developed by 
Csikász-Nagy et al. (2006) into a piecewise smooth hybrid model with simplified reaction rates using 
an approximate hybridization scheme.  
Petri Nets (PNs) are the last category of models which have emerged as a strong graphical method 
for modelling biological systems. Following its introduction in the 60’s by Carl Adam Petri, PN has 
been expanded with many extensions, such as Discrete, Continuous, Time-Delayed, Stochastic and 
Hybrid, which make it possible to incorporate different modular elements into a single model (Baldan 
et al., 2010; Chaouiya, 2007; Koch et al., 2010; Murata, 1989; Peleg et al., 2005; Pinney et al., 2003; 
Silva, 2013). Furthermore, it provides a graphical representation of the corresponding network, so 
that the whole framework can be easily understood by readers (especially those with less 
mathematical background). All PN models, more or less, share some common features: first, entities 
and interactions are defined by groups of Places and Transitions, respectively. Second, a number of 
Tokens which is also called Marking can be assigned to each place to describe the PN state at any 
given time. Third, a transition can be fired if all the corresponding pre-places have enough tokens to 
overcome some thresholds. These thresholds are represented by the corresponding values (weights) 
of the edges which connect the transitions (places) to the places (transitions). As a result of firing, 
some tokens are subtracted from pre places of the corresponding transition and added to its post 
places, leading to a change in the state of the PN (Koch et al., 2010; Peleg et al., 2005).  
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Over the recent years, PN-based modelling started to be implemented for modelling biological 
networks and cell cycle, but unfortunately there are not many Petri Net models for mammalian cell 
cycle at the moment (Fujita et al., 2004; Gilbert & Heiner, 2006; Grunwald et al., 2008; Hardy & 
Robillard, 2004; Herajy & Heiner, 2012; Herajy et al., 2013; Matsui et al., 2004; Matsuno et al., 2003; 
Mura & Csikász-Nagy, 2008; Windhager & Zimmer, 2008). More models of this type are expected to 
be developed in near future and the reason is that PNs are intuitive (due to their graphical 
representation) and they also have different extensions that can be combined to attain better 
results. Figure 2.8 shows an E2F-dependent production of Cyclin E through a hybrid PN, which 
includes both discrete and continuous parts. The box on the right side of Figure 2.8 illustrates some 
comments. In this model, transcription factor E2F is modelled as a discrete variable that can be 
switched on or off according to some conditions (i.e., inactive EF2 becomes activated through 
discrete transition T1) and after activation, it leads to initiation of Cyclin E synthesis continuously 
(continuous transition T3 represents the synthesis of Cyclin E).  
Figure 2.8 A demonstration of E2F-dependent production of Cyclin E through a Hybrid PN. E2F is 
presented discretely (using discrete Places and Transitions) while production and 
degradation of cyclin E are modelled continuously using continuous places and 
transitions (the degrader of cyclin is not shown here). Places iE2F and aE2F correspond 
to inactive and active E2Fs, respectively. Transitions T1, T2, T3, T4 denote activation, 
inactivation, synthesis, and degradation processes, respectively. Parameters k1 and k2 
are synthesis and degradation rate constants, respectively. 
 
Among all the research groups worked on PNs, two groups stand out: a Japanese group (Matsuno, 
Nagazaki, and colleagues) and Heiner’s groups in Germany. Matsuno’s group has developed a petri 
net tool for biological networks named “Genomic Object Net” in early 2000s. Later, they updated it 
into a more powerful graphical tool called “Cell-Illustrator” which helps modellers to create and 
simulate different types of biological systems in a very effective and user-friendly interface (Nagasaki, 



























tool to model cell cycle in Fission Yeast and Xenopus (Fujita et al., 2004; Matsui et al., 2004). Heiner 
and colleagues worked on Petri net modelling (not just on biological systems) from early 90’s. They 
have also constructed a petri net tool called “Snoopy” in order to design and simulate hierarchical 
graphs. This tool had also the ability to convert different extensions, such as Qualitative, Continuous, 
Stochastic, Hybrid, etc. to each other (Heiner et al., 2010; Heiner et al., 2012; Heiner et al., 2008; 
Rohr et al., 2010). In one interesting Petri Net extension called “Coloured Petri Nets”, it is possible to 
present each place with tokens in different colours. This capability is especially important in 
biological networks in which an entity may have different states, such as active and inactive (which 
can be represented with different colours) and this option is embedded in Snoopy as well (Lee et al., 
2006; Liu & Heiner, 2010, 2013; Liu et al., 2014). Heiner’s group have also developed a model of 
Eukaryotic cell cycle using Snoopy (Herajy et al., 2013).  
Table 2.4 demonstrates mammalian as well as generic cell cycle models published in literature. The 
title of the article, the type of modelling, and the corresponding reference are presented in this 
summary table. 
Table 2.4 Summary of Mammalian and Generic Cell Cycle Models 
Article Title Type of Model Reference 
Modeling the cell division cycle: cdc2 and cyclin 
interactions 
Continuous 
Deterministic (Tyson, 1991) 
A minimal cascade model for the mitotic oscillator 
involving cyclin and cdc2 kinase 
Continuous 
Deterministic (Goldbeter, 1991) 
A model for the adjustment of the mitotic clock by cyclin 
and MPF levels 
Continuous 
Deterministic (Norel & Agur, 1991) 
Mathematical analysis of a model of the mitotic clock Continuous Deterministic (Thron, 1991) 
A mathematical model for the G1/S transition of the 
mammalian cell cycle 
Continuous 
Deterministic 
(Hatzimanikatis et al., 
1995) 
A model of the G1 phase of the cell cycle incorporating 
cyclin E/cdk2 complex and retinoblastoma protein 
Continuous 
Deterministic 
(Obeyesekere et al., 
1995) 
A mathematical model of the regulation of the G1 phase 
of Rb+/+ and Rb-/- mouse embryonic fibroblasts and an 
osteosarcoma cell line 
Continuous 
Deterministic 
(Obeyesekere et al., 
1997) 
Bistable biochemical switching and the control of the 
events of the cell cycle 
Continuous 
Deterministic (Thron, 1997) 
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Functional capabilities of molecular network components 
controlling the mammalian G1/S cell cycle phase 
transition 
Continuous 
Deterministic (Kohn, 1998) 
A theory for controlling cell cycle dynamics using a 
reversibly binding inhibitor 
Continuous 
Deterministic (Gardner et al., 1998) 
Model scenarios for evolution of the eukaryotic cell cycle Continuous Deterministic (Novak et al., 1998) 
A mathematical description of regulation of the G1-S 
transition of the mammalian cell cycle 
Continuous 
Deterministic 
(Hatzimanikatis et al., 
1999) 
A model of cell cycle behavior dominated by kinetics of a 
pathway stimulated by growth factors 
Continuous 
Deterministic 
(Obeyesekere et al., 
1999) 
The kinetic origins of the restriction point in the 
mammalian cell cycle 
Continuous 
Deterministic (Aguda & Tang, 1999) 
A quantitative analysis of the kinetics of the G2 DNA 
damage checkpoint system 
Continuous 
Deterministic (Aguda, 1999b) 
Shape-dependent control of cell growth, differentiation, 
and apoptosis: switching between attractors in cell 
regulatory networks  
Discrete (Huang & Ingber, 2000) 
A model for a network of phosphorylation-
dephosphorylation cycles displaying the dynamics of 
dominoes and clocks 
Continuous 
Deterministic 
(Gonze & Goldbeter, 
2001) 
Regulation of the eukaryotic cell cycle: molecular 
antagonism, hysteresis, and irreversible transitions 
Continuous 
Deterministic (Tyson & Novak, 2001) 
Variability in the timing of G1/S transition Stochastic (Chiorino & Lupi, 2002) 




(Qu, Weiss, et al., 
2003) 
Simulation of the dynamics of gene networks regulating 
the cell cycle in mammalian cells 
Continuous 
Deterministic (Deineko et al., 2003) 
A mathematical model for analysis of the cell cycle in cell 
lines derived from human tumors 
Continuous 
Deterministic (Basse et al., 2003) 
Theoretical and experimental evidence for hysteresis in 
cell proliferation 
Continuous 
Deterministic (Bai et al., 2003) 
Dynamics of the cell cycle: checkpoints, sizers, and timers Continuous Deterministic 
(Qu, MacLellan, et al., 
2003) 
A model for restriction point control of the mammalian 
cell cycle 
Continuous 
Deterministic (Novak & Tyson, 2004) 
A mathematical model of the effects of hypoxia on the 
cell-cycle of normal and cancer cells. 
Continuous 
Deterministic (Alarcon et al., 2004) 
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Model predictions of MDM2 mediated cell regulation Continuous Deterministic 
(Obeyesekere et al., 
2004) 
Coordination of cell growth and cell division: a 
mathematical modeling study 
Continuous 
Deterministic (Qu et al., 2004) 
Bifurcation analysis of the regulatory modules of the 
mammalian G1/S transition 
Continuous 
Deterministic (Swat et al., 2004) 
Multisite phosphorylation and network dynamics of 
cyclin-dependent kinase signaling in the eukaryotic cell 
cycle 
Continuous 
Deterministic (Yang et al., 2004) 
Dynamical analysis of a generic Boolean model for the 
control of the mammalian cell cycle Discrete (Fauré et al., 2006) 
Using a mammalian cell cycle simulation to interpret 




(Chassagnole et al., 
2006) 




(Csikász-Nagy et al., 
2006) 
Linking cell division to cell growth in a spatiotemporal 
model of the cell cycle 
Continuous 
Deterministic (Yang et al., 2006) 
Periodic forcing of a mathematical model of the 
eukaryotic cell cycle 
Continuous 
Deterministic 
(Battogtokh & Tyson, 
2006) 
Computational analysis of mammalian cell division gated 
by a circadian clock: quantized cell cycles and cell size 
control 
Stochastic (Zámborszky et al., 2007) 




(Pfeuty & Kaneko, 
2007) 
Mathematical modelling of G2/M phase in the cell cycle 
involving the p53/Mdm2 oscillation system 
Continuous 
Deterministic (Tashima et al., 2007) 
A systems biology dynamical model of mammalian G1 
cell cycle progression 
Continuous 
Deterministic 
(Haberichter et al., 
2007) 
Cell cycle control in eukaryotes: A biospi model Stochastic (Lecca & Priami, 2007) 
Underlying principles of cell fate determination during G1 
phase of the mammalian cell cycle 
Continuous 
Deterministic (Pfeuty et al., 2008) 
Prediction of Key Factor Controlling G1/S Phase in the 
Mammalian Cell Cycle Using System Analysis 
Continuous 
Deterministic (Tashima et al., 2008) 
Mathematical modelling and sensitivity analysis of G1/S 
phase in the cell cycle including the DNA-damage signal 
transduction pathway 
Continuous 
Deterministic (Iwamoto et al., 2008) 
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A bistable Rb-E2F switch underlies the restriction point Continuous Deterministic (Yao et al., 2008) 
Temporal self-organization of the cyclin/Cdk network 
driving the mammalian cell cycle 
Continuous 
Deterministic 
(Gérard & Goldbeter, 
2009) 
Sophisticated framework between cell cycle arrest and 
apoptosis induction based on p53 dynamics 
Continuous 
Deterministic (Hamada et al., 2009) 
Modeling ERBB receptor-regulated G1/S transition to find 
novel targets for de novo trastuzumab resistance Discrete (Sahin et al., 2009) 
Mitotic exit in mammalian cells Stochastic (Kapuy et al., 2009) 
Towards a systems biology approach to mammalian cell 
cycle: modeling the entrance into S phase of quiescent 
fibroblasts after serum stimulation 
Continuous 
Deterministic (Alfieri et al., 2009) 
Robustness of G1/S checkpoint pathways in cell cycle 
regulation based on probability of DNA-damaged cells 
passing as healthy cells 
Continuous 
Deterministic (Ling et al., 2010) 
Restriction point control of the mammalian cell cycle via 
the cyclin E/Cdk2:p27 complex 
Continuous 
Deterministic (Conradie et al., 2010) 
A skeleton model for the network of cyclin-dependent 




(Gérard & Goldbeter, 
2010) 
Modeling the cell cycle: From deterministic models to 
hybrid systems Hybrid (Alfieri et al., 2011) 
Regulation of mammalian cell cycle progression in the 
regenerating liver 
Continuous 
Deterministic (Chauhan et al., 2011) 
Mathematical modeling of cell cycle regulation in 
response to DNA damage: exploring mechanisms of cell-
fate determination 
Continuous 
Deterministic (Iwamoto et al., 2011) 
System-level feedbacks make the anaphase switch 
irreversible 
Continuous 
Deterministic (He et al., 2011) 




(Gauthier & Pohl, 
2011) 
A hybrid model of mammalian cell cycle regulation Hybrid (Singhania et al., 2011) 
An automaton model for the cell cycle Stochastic (Altinok et al., 2011) 
Effect of positive feedback loops on the robustness of 
oscillations in the network of cyclin-dependent kinases 
driving the mammalian cell cycle. 
Continuous 
Deterministic (Gérard et al., 2012) 
Strategic cell-cycle regulatory Continuous (Pfeuty, 2012) 
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features that provide mammalian cells with 
tunable G1 length and reversible G1 arrest 
Deterministic 
From quiescence to proliferation: 
Cdk oscillations drive the mammalian cell cycle 
Continuous 
Deterministic 
(Gérard & Goldbeter, 
2012) 
Robustness and Backbone Motif of a Cancer Network 
Regulated by miR-17-92 Cluster during the G1/S 
Transition 
Discrete (Yang et al., 2013) 
Hybrid Petri Nets for Modelling the Eukaryotic Cell Cycle Petri Net (Herajy et al., 2013) 
A mathematical analysis of DNA damage induced G2 
phase transition 
Continuous 
Deterministic (Zhang et al., 2013) 
A Data-Driven, Mathematical Model of Mammalian Cell 
Cycle Regulation 
Continuous 
Deterministic (Weis et al., 2014) 
Mathematical modeling of p53 pulses in G2 phase with 
DNA damage 
Continuous 
Deterministic (Zhang et al., 2014a) 
A mathematical study of the robustness of G2/M 
regulatory network in response to DNA damage with 
parameters sensitivity 
Continuous 
Deterministic (Zhang et al., 2014b) 
Modelling the onset of senescence at the G1/S 
cell cycle checkpoint Discrete (Mombach et al., 2014) 
The balance between cell cycle arrest and cell 




(Gérard & Goldbeter, 
2014) 
Cyclin and DNA Distributed Cell Cycle Model 
for GS-NS0 Cells 
Continuous 
Deterministic (Münzer et al., 2015) 




(Gérard & Goldbeter, 
2015) 
An application of invertibility of Boolean control networks 
to the control of the mammalian cell cycle Discrete (Zhang et al., 2017) 
Modelling of the cancer cell cycle as a tool for rational 
drug development: A systems pharmacology approach to 
cyclotherapy 
Continuous 
Deterministic (Jackson et al., 2017) 
Modelling T cell proliferation: Dynamics heterogeneity 






Logical modelling and analysis of cellular regulatory 
networks with GINsim 3.0 Discrete (Naldi et al., 2018) 
Mathematical modelling of reversible transition between 
quiescence and proliferation 
Continuous 
Deterministic 
(Pandey & Vinod, 
2018) 
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A comprehensive model for the proliferation–quiescence 
decision in response to endogenous DNA damage in 
human cells 
Continuous 
Deterministic (Heldt et al., 2018) 
 
 Summary 
Mammalian cell cycle is the least studied cell cycle system, experimentally or through modelling. The 
goal in this chapter was to review both biological regulatory system and computational modelling 
paradigms of mammalian cell cycle in order to understand its underlying mechanism and see how 
these methods have facilitated that understanding. We explained the mechanism of mammalian cell 
cycle regulation system by highlighting the important effect of Cyclin_Cdks as main controllers as 
well as their regulators. The role of checkpoints as the guardians of genome was also highlighted. 
Then, different modelling approaches (Discrete, Continuous-Deterministic, Stochastic, Hybrid and 
Petri Net-Based) that have been used in cell cycle modelling (fewer for mammalian) were presented 
with their pros and cons in terms of complexity and knowledge presentation. At the end of the 
chapter, a summary list of all computational models of mammalian cell cycle was presented where 
most of the models were Continuous-Deterministic type. There are many open questions that 
computational models can potentially answer through a variety of analyses that can be done on 
them. Increased understanding of different aspects of mammalian cell cycle systems and their 








A Comprehensive Complex Systems Approach to the Study of 
Mammalian Cell Cycle Control System in the Presence of DNA 
Damage Stress 
In this chapter, we develop a comprehensive complex systems approach to the study of mammalian 
cell cycle control system in the presence of DNA damage. The proposed comprehensive 
mathematical model comprises 61 state variables and 148 kinetic parameters that together with the 
detailed description of sub-systems and their corresponding modules and interactions are explained 
in-depth in this chapter. This chapter comprises five sections. An overview of the chapter is provided 
in Section 3.1. The second section (Section 3.2) is about the current gaps in mammalian cell cycle 
modelling. Section 3.3 is devoted to four cell cycle sub-systems and their corresponding modules 
together with mathematical formulations. Results and discussion are given in Section 3.4. Finally, a 
summary of this chapter is provided in the last section (Section 3.5).  
 Overview 
Not many models of mammalian cell cycle system exist due to its complexity. Some models are too 
complex and hard to understand, while some others are too simple and not comprehensive enough. 
Moreover, some essential aspects, such as the response of G1-S and G2-M checkpoints to DNA 
damage as well as the Growth Factor signalling, have not been investigated from a systems point of 
view in current mammalian cell cycle models. To address these issues, we bring a holistic perspective 
to cell cycle by mathematically modelling it as a complex system consisting of important sub-systems 
that interact with each other. This retains the functionality of the system and provides a clearer 
interpretation to the processes within it while reducing the complexity in comprehending these 
processes. To achieve this, we first update a published ODE mathematical model of cell cycle with 
current knowledge by adding the important missing components. Then the part of the mathematical 
model relevant to each sub-system is shown separately in conjunction with a diagram of the sub-
system as part of this representation. The model sub-systems are Growth Factor, DNA damage, G1-S, 
and G2-M checkpoint signalling pathways. To further simplify the model and better explore the 
function of sub-systems, they are further divided into modules.  
 Current Gaps in Mammalian Cell Cycle Models 
The state of current cell cycle models reveals a number of areas for improvement. G1-S and G2-M 
checkpoints play an important role in controlling cell cycle progression, particularly in the presence 
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of DNA damage, and their response mechanisms and corresponding inter-relationships should be 
properly investigated to understand DNA damage response in cell cycle more comprehensively. In 
the current literature, there is a lack of proper incorporation of G1-S and G2-M checkpoint sub-
systems into a single mammalian cell cycle model, especially with DNA damage sub-system, where 
each sub-system comprises interconnected modules to give a better systems understanding of the 
whole cell cycle. The rationale for incorporation of  G1-S and G2-M checkpoints are that during cell 
cycle both are crucial in checking if the conditions allow a proliferating cell to continue (Beishline & 
Azizkhan-Clifford, 2014). In fact, if there is any malfunction in either of these checkpoints, a damaged 
cell may be considered as normal and allowed to proliferate that can cause tumours and cancer. 
Furthermore, DNA response has two parts- rapid (Chk-Related module) and delayed (p53 module) 
responses - and these parts need to be seamlessly integrated into a cell cycle model to aid our 
understanding of this important aspect of cell cycle and the crucial originator of uncontrolled cell 
proliferation. Additionally, it could be advantageous to incorporate some recently found new 
elements that show p53 pathway with greater clarity.        
The Growth Factor signaling is another sub-system that has not been properly incorporated into 
mammalian cell cycle modelling yet and past models have assumed just a constant growth signal as 
cell cycle trigger (Iwamoto et al., 2011; Iwamoto et al., 2008). Growth Factor signaling is a crucial 
pathway that interacts with cell cycle system through a particular signaling cascade called MAPK and 
a transcription factor called c-Myc to initiate cell cycle machinery. It is this pathway that stimulates 
the production of D-type Cyclin which is the most critical controller in early-mid G1 phase of 
mammalian cell cycle (Adhikary & Eilers, 2005; Alberts et al., 2014; de Alboran et al., 2001; Morgan, 
2007; Schmidt, 1999). Therefore, incorporation of Growth Factor signaling and especially c-Myc has 
value due to the biological significance of c-Myc to the cell cycle system. Also, as an extension to 
models, it gives a more complete description of cell cycle. Further, it allows the relationship 
(continuous dynamic) between c-Myc and Cyclin D to be realistically represented. Additionally, with 
c-Myc in the system, transcription factor of all Cyclins of cell cycle are represented in one model. 
There are also a number of other pathways that can be incorporated to improve cell cycle models to 
allow greater and insightful understanding of cell cycle and meaningful investigation into cell cycle 
related diseases: Two Tyrosine phosphatase modules that are crucial for activating cell cycle 
controllers (Cyc_Cdk complexes) and also crucial in rapid and delay cell cycle arrest at both G1-S and 
G2-M checkpoints as cell cycle arrest involves inactivation of Cyc_Cdk complexes; Tyrosine Kinase 
module that plays the crucial role through Wee1 of inactivating nuclear version of CycB_Cdk1 to 
arrest transition to M phase;  Plk1-Related module that plays a crucial role in both activating Tyrosine 
phosphatases and inactivating Tyrosine kinase in normal progression of cell cycle; and APC-Related 
module that includes two important steps in Cyclin B degradation.    
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The complexity of cell cycle system where many pathways interact calls for a clearer and simpler 
approach that still incorporates all the important facets so that future expansion and growth of 
models is manageable. Therefore, in this chapter, we incorporate all the above essential pathways 
into a comprehensive ODE mathematical model using a systems modelling paradigm. Specifically, 
mammalian cell cycle system is divided into four different functional sub-systems (Growth Factor, 
G1-S checkpoint, G2-M checkpoint, and DNA damage sub-systems) that cooperate with each other to 
effectively control accurate cell cycle progression. Moreover, each sub-system is divided into its 
constituent modules which link together to form the corresponding functional sub-system. 
Therefore, we add important new modules of: Chk-Related rapid cell cycle arrest, p53 modules 
expanded to seamlessly integrate with the rapid arrest module, Tyrosine phosphatase modules that 
activate Cyc_Cdk complexes and play a crucial role in rapid and delay arrest at both G1-S and G2-M, 
Tyrosine Kinase module that is important for inactivating nuclear transport of CycB_Cdk1 through 
Wee1 to resist M phase entry, Plk1-Related module that is crucial in activating Tyrosine 
phosphatases and inactivating Tyrosine kinase, and APC-Related module to show steps in Cyclin B 
degradation. This comprehensive system model is built, tested and further analysed to study cell 
cycle and DNA damage response as well as to verify the role of the newly added modules and 
elements in cell cycle. 
 A Comprehensive Mathematical Model of Mammalian Cell Cycle 
We describe here a mathematical model comprising the four sub-systems, Growth Factor, G1-S 
checkpoint, G2-M checkpoint, and DNA damage signalling (each of which is divided into its 
constituent modules), developed to study the whole mammalian cell cycle control system, especially 
in the presence of DNA Damage Signal (DDS). Briefly, Growth Factor signals activate cell cycle 
proliferation. This sub-system, in turn, stimulates the activation of G1-S checkpoint sub-system by 
production of proteins that are crucial for cell cycle initiation. The G1-S checkpoint sub-system 
induces DNA replication (through interaction with DNA damage sub-system to ensure that DNA is 
intact), and then, sets the stage for the downstream activation of G2-M checkpoint sub-system. The 
G2-M checkpoint sub-system collaborates with DNA damage sub-system to check the existence of 
DNA damage and in the case of no damage, it allows transition to cell division phase. The proposed 
model is an extension of Iwamoto et al. (2011) ODE model with the above mentioned additions. The 
proposed model comprises 61 state variables and 148 kinetic parameters. A detailed description of 
sub-systems and their corresponding modules and interactions are explained in-depth in the 
following sub-sections. In this chapter, for the sake of brevity and clarity, ODE equations for only the 
newly added variables and modules are presented and all equations are presented in Appendix A. 
Some parameters are adopted from Iwamoto et al. (2011) model and others are estimated. The 
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initial concentration of proteins and value of kinetic parameters (with corresponding definitions) are 
given in Appendices B (in Table B. 1) and C (in Table C. 1), respectively. 
3.3.1 Growth Factor Signalling Sub-System 
Generally, a cell cycle begins when a cell receives Growth Factor signals. Upon receiving the signals, 
synthesis of Cyclin D (or G1 Cyclin) is initiated at G0-G1 transition (early G1) (Pardee, 1989). Growth 
Factor signals lead to an increase in cell size to a certain threshold without which cell cycle is not 
initiated. It has been proven that Growth Factor signals induce the synthesis of Cyclin D through a 
Ras-mediated pathway (Alberts et al., 2014; Morgan, 2007). The Growth Factor signalling sub-system 
(complete and simplified version) is shown in Figure 3.1. The activated Growth Factor receptors 
stimulate the activation of Ras by turning it into a form of GTP-bound Ras. Thereafter, a cascade of 
protein kinase activations is initiated which finally leads to phosphorylation and activation of MAP 
Kinase (MAPK). This kinase is translocated to the nucleus and it activates a transcription factor called 
c-Myc that eventually promotes the synthesis of Cyclin D (Adhikary & Eilers, 2005; Alberts et al., 
2014; de Alboran et al., 2001; Morgan, 2007; Schmidt, 1999). Most of the previous models have 
represented Growth Factor as being present or absent and in this study for the first time (to the best 
of our knowledge) a Growth Factor model is incorporated into the mammalian cell cycle model. We 
use the minimal version of this sub-system shown at the bottom of Figure 3.1 to simplify the model 
while incorporating the most crucial aspect of Cyclin D synthesis.   
According to our minimal version of the system, it is assumed that Growth Factor (GF) is available 
from early G1, and c-Myc is the most important link between GF and cell cycle machinery to trigger 
cell cycle initiation (by inducing Cyclin D synthesis): following the presence of GF, c-Myc becomes 
activated and subsequently stimulates the synthesis of Cyclin D.  The corresponding dynamics of this 
sub-system are presented below where the bold letters refer to new elements/parameters.  
c[𝒊𝒄𝑴𝒚𝒄]
cf
= 𝒌𝟏 ∙ [𝒂𝒄𝑴𝒚𝒄] − 𝒌𝟐 ∙ 𝐺𝐹 ∙ [𝒊𝒄𝑴𝒚𝒄]                                                  (3-1)	 
c[𝒂𝒄𝑴𝒚𝒄]
cf
= 𝒌𝟐 ∙ 𝑮𝑭 ∙ [𝒊𝒄𝑴𝒚𝒄] − 𝒌𝟏 ∙ [𝒂𝒄𝑴𝒚𝒄]		 	 	 																 															(3-2)	
Within brackets is shown the concentration of respective proteins. We assumed c-Myc to be 
switched between active [acMyc] and inactive [icMyc] forms (Eq. (3-1) and Eq. (3-2)) in order to 




Figure 3.1 Growth Factor Signalling Sub-System. Growth factor triggers the MAPK cascade that 
eventually activates transcription factor c-Myc which stimulates the synthesis of Cyclin 
D, the first cyclin in the cell cycle system. In this study, we use a minimal/compact 
version of Growth Factor signalling pathway shown as Minimal Growth Factor Sub-
System at the bottom left corner in this figure. Green solid arrows denote biochemical 
reactions (i.e., synthesis of a protein or activation of an inactive element) while purple 
dashed arrows correspond to regulatory effects (i.e., enzymatic effect, transcriptional 
regulation through transcription factor). 
 
3.3.2 DNA Damage Signalling Sub-System  
During cell cycle, DNA damage is sensed by particular sensor proteins whose role is to ensure that 
the response is proportional to damage by appropriately activating some downstream elements. 
These elements trigger a variety of responses, such as damage repair, cell cycle arrest, or Apoptosis 
(if the damage is irreparable) (Fry et al., 2005; Nyberg et al., 2002). For Double-Strand Breaks (DSBs), 
Ataxia telangiectasia mutated (ATM) is the sensor protein (Shiloh & Ziv, 2013). Ataxia telangiectasia 
and Rad3-related protein (ATR) is responsible for sensing other types of breaks, such as Single-Strand 
Breaks (SSBs) (Smith et al., 2010). There are two important DNA damage signalling pathways, Chk-
Related (rapid) and p53-Related (delayed), which become activated following DNA damage sensing.  
Chk-Related Module 
Upon DNA damage, Chk-Related (rapid) module becomes activated within a few minutes to arrest 
cell cycle progression. It is a transcription-independent process involving post-translational 
modifications, such as phosphorylation, that happens much faster than transcription. Upon sensing 
DSB (in this study, we focus on DSB), ATM becomes activated and then it phosphorylates Chk2 
kinase. Eventually, Chk2 regulates the activity of Cyc_Cdks, the main controllers of cell cycle 
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progression (specially, in transition between cell cycle phases), by inhibiting the activity of Cdc25 
phosphatases. These phosphatases remove the inhibitory phosphate from Cyc_Cdks, so they are 
necessary for activation of these complexes (Beishline & Azizkhan-Clifford, 2014; Morgan, 2007; 
Sancar et al., 2004). The diagram of Chk-Related module in the presence of DSB is shown in Figure 
3.2. The proper definition of it as a rapid DNA damage module and its presentation within a sub-
system is new in our model. 
 Figure 3.2 Chk-Related (rapid) DNA Damage Module. Active Cdc25 Tyrosine phosphatase is 
important in activation of Cyc_Cdks and cell cycle progression. DNA damage results in 
activation of Chk2 which in turn deactivates Cdc25. Therefore, through a number of 
relatively fast interactions (activation/inactivation), the DNA damage rapidly arrests 
the cell cycle. Green solid arrows denote biochemical reactions (i.e., synthesis of a 
protein or activation of an inactive element) while purple dashed arrows correspond 
to regulatory effects (i.e., enzymatic effect, transcriptional regulation through 
transcription factor, etc.). 
 
p53-Related Module 
A schematic of p53-Related (delayed) DNA damage module is illustrated in Figure 3.3. This module is 
transcription-dependent. In fact, the sensor protein ATM, which becomes activated following DSBs, 
phosphorylates and activates an important transcription factor p53. There is an important ubiquitin 
ligase (Mdm2) which inhibits p53 under no DNA damage condition. Mdm2 causes instability and 
nuclear export of p53, but Mdm2 becomes inactivated by ATM-mediated phosphorylation at Ser395 
following the presence of DNA damage signal there by releasing p53. Thus, the negative feedback 
loop between p53 and Mdm2 is an essential part of this module (Bar-Or et al., 2000; Geva-Zatorsky 
et al., 2006; Kohn & Pommier, 2005; Meek, 2004; Nyberg et al., 2002; Zhang & Xiong, 2001). A 
putative (Imaginary) Factor (IF) is added to the model to account for the delay between activation of 
p53 and its transcriptional effect on Mdm2. Upon activation, p53 stimulates the synthesis of some 
downstream factors, like p21, 14-3-3σ, Gadd45α (see Figure 3.3), which further arrest cell cycle 
progression (Cann & Hicks, 2007; Zhan, 2005) by different means. Protein p21 is a Cyclin-Dependent 
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kinase Inhibitor (CKI) which binds to different Cyclin_Cdk complexes to inactivate them (see Sections 
3.3.3 & 3.3.4. for details of the processes related to this binding). Another protein called 14-3-3σ is a 
phosphoserine binding protein that binds to Cdc25 phosphatases to further inhibit their activation of 
Cyc_Cdk complexes (see section 3.3.4 for details of this binding). 
Gadd45α is another essential factor produced following DNA damage that has more impact on B-
type Cyclin_Cdk complex (see Section 3.3.4 for more details). However, the way that 14-3-3σ and 
Gadd45α act upon CycB_Cdk1 inactivation is different. The first factor (14-3-3σ) inhibits Cdc25C 
(which is CycB_Cdk1 activator), while the second (Gadd45α) physically interacts with Cdk1 in order to 
stimulate CycB_Cdk1 unbinding (Jin et al., 2002; Zhan, 2005). Therefore, Gadd45α is an important 
player at G2-M checkpoint. The proper incorporation of Gadd45α into the p53-module and seamless 
integration of the rapid and delayed DNA damage responses are new additions in our model. The 
ODE highlighting the Gadd45α dynamics and its interactions with the rest of the system is presented 
below (the bold letters refer to new elements/parameters).    
𝑑[𝐆𝐚𝐝𝐝𝟒𝟓𝛂]
𝑑𝑡
= 𝒌𝟑𝟔 + 𝒌𝟑𝟕 ∙ [𝑝53] − 𝒌𝟑𝟖 ∙ [𝐆𝐚𝐝𝐝𝟒𝟓𝛂]                    (3-3) 
Figure 3.3 p53-Related DNA Damage Module. This module represents the delayed DNA damage 
signalling that centres on transcription factor p53, which stimulates the synthesis of 
p21, 14-3-3σ and Gadd45α. These products contribute to cell cycle arrest in different 
ways. Red solid round-ended arrows indicate inhibition; green solid arrows denote 
biochemical reactions (i.e., synthesis or degradation of a protein, etc.) and purple 
dashed arrows correspond to transcriptional regulation. 
 
3.3.3 G1-S Checkpoint Signalling Sub-System 
The G1-S checkpoint sub-system comprises the most important components and their interactions 
from initiation of Cyclin D synthesis until transition to S phase. In fact, this sub-system is made of four 
important modules (Cdk4-Related, E2F-pRb, Cdk2-Related, and Tyrosine Phosphatase) interacting 
with each other to induce cell cycle progression from G1 to S phase. An overview of interactions at 
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both sub-system and module levels is demonstrated in Figure 3.4. At the sub-system level, it is shown 
that Growth Factor and DNA damage signalling sub-systems affect G1-S checkpoint signalling, 
whereas G1-S influences G2-M checkpoint signalling (blue arrows in Figure 3.4). Indeed, all the 
aforementioned events take place through interactions among some modules inside the sub-
systems. Therefore, it is also necessary to describe the system from module point of view. At the 
module level, the modules tightly interact with each other (black arrows in Figure 3.4) to contribute 
to the overall function of their corresponding sub-system (G1-S checkpoint signalling). The details of 
these modules are described in following sub-sections.  
Figure 3.4 G1-S Checkpoint Signalling Sub-System in the context of the whole system and its four 
modules: Cdk4-Related, E2F-pRb, Cdk2-Related, Tyrosine Phosphatase modules. Black 
arrows indicate interactions between modules while blue arrows indicate interactions 
between G1-S checkpoint and other sub-systems. 
 
Cdk4-Related Module 
This module, basically, receives the growth signal from outside G1-S checkpoint signalling sub-system 
(through Growth Factor sub-system) and interacts with the next internal module (E2F-pRb module) 
to help release E2F that is necessary to induce the synthesis of a number of crucial cell cycle proteins, 
such as Cyclin E and A. The detailed diagram of the Cdk4-Related module is demonstrated in Figure 
3.5. In the early G1 phase, Cdk4 is the protein kinase that is necessary for cell cycle initiation. 
Although Cdk4 is abundant during cell cycle, it needs to bind to Cyclin D to become functional toward 
its targets (Musgrove et al., 2011). As mentioned in Section 3.3.1, following the appearance of 
Growth Factors, c-Myc becomes activated and allows transcription of Cyclin D. Cyclin D, in turn, binds 
to Cdk4, to produce CycD_Cdk4 complex. Cyclin D is degraded by ubiquitin ligases “Skp_Cullin_F-box 
containing complex” (SCF) and APC_Cdc20 (Alao, 2007; Peters, 2002).  
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Another important group of proteins that play an essential role in regulation of CycD_Cdk4 complex 
(through binding to it) are CKIs, such as p27 and p21 (Figure 3.5). However, these two CKIs have 
contradictory effects toward different Cdk types. For example, p27 and p21 bind and activate 
CycD_Cdk4, but they inhibit CycE_Cdk2, CycA_Cdk2, and CycB_Cdk1 complexes. The main function of 
p27 is to keep the cell in quiescent mode (G0), so it exists in high levels during early G1 phase and it 
suppresses any activity of CycE_Cdk2, CycA_Cdk2 complexes. But upon availability of Growth Factor 
and accumulation of CycD_Cdk4 (as well as p27_ CycD_Cdk4), next module (E2F-pRb) is activated to 
release E2F - transcription factor that initiates the synthesis of Cyclin E and Cyclin A. This leads to 
accumulation of CycE_Cdk2 and CycA_Cdk2 which then triggers phosphorylation and degradation of 
p27 (Chu et al., 2008) that allows these latter complexes to break free from p27.  Therefore, removal 
of p27 is one of the requirements for progression of cell cycle from G1 to S phase. In summary, the 
role of Cdk4-Related module is to prepare the conditions through CycD_Cdk4, p27_ CycD_Cdk4 and 
p21_ CycD_Cdk4 complexes to interact with the next module (E2F-pRb) to release E2F - transcription 
factor that initiates the synthesis of Cyclin E and Cyclin A. 
Figure 3.5 Cdk4-Related Module. The key elements of this module are Cyclin D, Cdk4, and p27. 
The effects of some other elements on production, degradation, and combination of 
these proteins have also been presented in this module. Transcription factor c-Myc 
triggers the synthesis of Cyclin D which in complex with Cdk4 forms the most crucial 
controller (CycD_Cdk4) of mammalian cell cycle during early to mid G1 phase. 
Elements in the rectangular boxes are the proteins in this module; whereas, the other 
elements belong to other modules (their dynamics are presented elsewhere in the 
corresponding modules). Green solid arrows denote the biochemical reactions (i.e., 
synthesis, degradation, association, dissociation, etc.) while purple dashed arrows 
correspond to regulatory effects (i.e., enzymatic effect, transcriptional regulation 
through transcription factor, etc.). Double-ended arrows represent reversible 
reactions. Elements in blue rectangular boxes are the proteins of this module whereas 
the other elements belong to other modules. 
 
 46 




= 𝑘= + 𝒌𝟒𝟎 ∙ [𝒂𝒄𝑴𝒚𝒄] + 𝑘<X ∙ [𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] − (	𝑘<< + 𝑘<8 ∙ [𝐶𝑑𝑘4] +
𝒌𝟒𝟑 ∙ [𝒂𝑺𝑪𝑭] + 𝒌𝟏𝟒𝟕 	 ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20]) ∙ [𝐶𝑦𝑐𝐷]	        	
E2F-pRb Module  
E2F-pRb module is important in that it produces proteins (Cyclin E and A, Cdc25A, etc.) that are 
essential for G1-S transition. This is done through interaction of this module with two other internal 
modules, Cdk2-Related, and Tyrosine Phosphatase (as shown in Figures 3.4 & 3.6). This module 
centres on transcription factor E2F and a tumour suppressor protein, called Retinoblastoma protein 
(pRb), which binds to E2F and inhibits its activation (Figure 3.6). To become active and affect the said 
protein production, E2F needs to be released from pRb and this happens through phosphorylation of 
E2F_pRb by Cyc_Cdk complexes (Sherr & McCormick, 2002; Trimarchi & Lees, 2002).  
Figure 3.6 E2F-pRb Module. The key factor in this module is transcription factor E2F. When 
active, this transcription factor stimulates the production of a number of crucial cell 
cycle proteins, such as Cyclin E, Cyclin A, Tyrosine phosphatase Cdc25A, another 
transcription factor called B-Myb and itself. E2F is initially inactivated by a tumour 
suppressor protein called pRb. The detail of the process which results in activation of 
E2F is well covered in this module. Green solid arrows denote biochemical reactions 
(i.e., synthesis, degradation, association, dissociation, phosphorylation, etc.) while 
purple dashed arrows correspond to regulatory effects (i.e., enzymatic effect, 
transcriptional regulation through transcription factor, etc.). Elements in blue 
rectangular boxes are the proteins of this module whereas the other elements belong 




According to wiring diagram of E2F-pRb module shown in Figure 3.6, following initial phosphorylation 
of E2F_pRb by CycD_Cdk4, p27_CycD_Ckd4, and p21_CycD_Ckd4, and then further phosphorylation 
of E2F_pRbPP by small amount of available CycE_Cdk2 and CycA_Cdk2, a number of E2F molecules 
are released. Then, these E2F proteins trigger the synthesis of Cyclin E and Cyclin A, which in complex 
with Cdk2, lead to more phosphorylation of pRb and thereby releasing more E2Fs (Deckbar et al., 
2011; Helin, 1998). This positive feedback loop, resulting in an increase in concentration of 
CycE_Cdk2 as well as further release of E2F, is crucial for G1-S transition. The process of E2F 
degradation is mediated by aCycA_Cdk2 (Figure 3.6) upon G1-S transition (Ji & Dyson, 2010). At the 
end of cell cycle, pRbPPP becomes dephosphorylated (to pRb) by a crucial phosphatase called Protein 
Phosphatase 1 (PP1) (Berndt, 2002; Ludlow et al., 1993; Nelson et al., 1997; Trinkle-Mulcahy et al., 
2003). We emphasise that Iwamoto et al. (2011) model was not cyclic because PP1 was missing in 
that model. Since PP1 is a newly added element in our model, the corresponding equations are 
presented below (the bold letters refer to new elements/parameters).                   
c[𝑷𝑷𝟏]
cf
= 	𝒌𝟔𝟐 ∙ [𝒂𝑷𝑷𝟏] − 	𝒌𝟔𝟑 ∙ [𝒊𝑷𝑷𝟏]. [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]                  (3-5) 
c[𝒂𝑷𝑷X]
cf
= 	𝒌𝟔𝟑 ∙ [𝒊𝑷𝑷𝟏]. [𝒂𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] − 	𝒌𝟔𝟐 ∙ [𝒂𝑷𝑷𝟏]                                               (3-6)	 
c[m]
cf
= 	𝑘; + 	𝒌𝟔𝟒 ∙ [𝒂𝑷𝑷𝟏]. [𝑝𝑅𝑏𝑃𝑃𝑃] − 	(𝑘; ∙ [𝐸2𝐹] + 	𝑘) ∙ [𝑝𝑅𝑏]                                         (3-7)  
In addition to the need to insert PP1, we further found that few original parameters related to E2F 
needed modification to make the model cyclic and they were updated accordingly. These changes 
were as follows: (i) Dephosphorylation of pRbPPP to pRb: The rate of dephosphorylation of pRbPPP 
to pRb has been updated from 5.0E-8 to 2.0E-3. In Iwamoto et al. (2011) model, there is no way that 
the model can be cyclic with such a small dephosphorylation rate as it leads to accumulation of 
pRbPPP and not produce enough pRb. There should be enough E2F_pRb for the new cell cycle to 
begin; (ii) Degradation of pRb: The degradation rate of pRb should be lowered (from 5.0E-3 to 5.0E-5) 
because for a new cell cycle to begin, enough E2F_pRb is needed and if the rate of pRb degradation is 
high, not enough E2F_pRb is produced; (iii) Synthesis of E2F: The basal synthesis rate of E2F should 
be higher for the cell cycle to be periodic (change from 5.0E-7 to 3.0E-4). This rate will guarantee that 
enough E2F is created and available to be bound to pRb to create E2F_pRb complex; (iv) Binding of 
pRb and E2F: To guarantee that enough E2F_pRb is available for a new cell cycle, the binding rate of 




Placed at the heart of G1-S checkpoint sub-system and known as its main driver, Cdk2-Related 
module has the most interactions with internal modules (E2F-pRb and Tyrosine Phosphatase) and 
external sub-systems (G2-M checkpoint & DNA damage). Cyclin E and Cyclin A are two important 
cyclins that bind to Cdk2 to activate it and the two resulting complexes (CycE_Cdk2 and CycA_Cdk2) 
help initiation of S phase (Murray, 2004). An overview of this module is given in Figure 3.7. After 
formation of CycE_Cdk2 and CycA_Cdk2, phosphatase Cdc25A activates them by removing the 
inhibitory phosphate added by Tyrosine kinases upon the complex formation. But these two 
complexes become inactive through binding to CKIs, p21 and p27, and stay inactive until CKIs are 
released. In fact, the concentration of p27 is high in early to mid G1 phase to prevent initiation of S 
phase (through inactivation of CycE_Cdk2 and CycA_Cdk2) until all conditions are appropriate. 
However, as stated before, accumulation of the two Cyc-Cdk complexes allows them to degrade p27 
and break free from it thereby triggering G1-S transition.   
Figure 3.7 Cdk2-Related Module. The key players of this module are Cyclin E and Cyclin A whose 
synthesis and degradation depends on a number of transcription factors (E2F, B-Myb 
and NFY) and ubiquitin ligases (SCF, APC_Cdh1, and apc_Cdc20), respectively. 
Furthermore, the activity of CycE_Cdk2 and CycA_Cdk2 are affected by CKIs (p21 & 
p27) and Tyrosine phosphatase Cdc25A. Green solid arrows denote the biochemical 
reactions (i.e., synthesis, degradation, association, dissociation, etc.) while purple 
dashed arrows correspond to regulatory effects (i.e., enzymatic effect, transcriptional 
regulation through transcription factor, etc.). Double-ended arrows represent 
reversible reactions. Elements in blue rectangular boxes are the proteins of this 
module whereas the other elements belong to other modules. 
 49 
As stated previously, the amount of p21 increases in the presence of DNA damage (through 
transcription factor p53) to arrest cell cycle at G1-S checkpoint by forming p21_CycE_Cdk2 to 
inactivate the complex (Novák et al., 2001). It is important to emphasize that Cyclin E and Cyclin A are 
degraded differently (Figure 3.7). While Cyclin A is degraded by APC_Cdc20 and APC_Cdh1, the main 
degraders of Cyclins A and B, (abundance of APC-cdh1 at the beginning of cell cycle keeps respective 
cyclins levels at bay to supress cell cycle), degradation of Cyclin E is SCF-mediated. SCF (newly added 
in our model) is a ubiquitin ligase that has three different subunits (Fbw7, Skp2, and Btrc) which bind 
to it in order to activate it toward different substrates (Ang & Harper, 2004; Cardozo & Pagano, 2004; 
Nakayama & Nakayama, 2005). In this model, we assume that SCF switches between active and 
inactive forms and also its activation and inactivation rates depend on active CycE_Cdk2 and active 
APC_Cdh1, respectively. Cyc_Cdk2 complexes are also assumed to be slightly ubiquitinated and 
degraded to Cdk2.  
Another important part of this module is a set of supplementary transcription factors (NFY and B-
Myb). B-Myb, which is produced by E2F and activated by aCycA_Cdk2, induces the synthesis of Cyclin 
A (Fung & Poon, 2005; Joaquin & Watson, 2003; Zhu et al., 2004). However, NFY, which also becomes 
activated by aCycA_Cdk2, stimulates the production of both Cyclin A and Cyclin B (Chae et al., 2004; 
Chae & Shin, 2011; Fung & Poon, 2005; Yun et al., 2003). Therefore, Cyclin A indirectly helps 
production of next cyclin (Cyclin B) in the cell cycle system.  The new and modified equations related 
to this module are presented below. 
c[ng]
cf
= 	𝑘A9 ∙ [𝐸2𝐹] + 	𝑘A8 ∙ [𝑖𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] − (𝑘A= + 	𝑘AX ∙ [𝐶𝑑𝑘2] + 	𝒌𝟕𝟒 ∙
[𝒂𝑺𝑪𝑭]) ∙ [𝐶𝑦𝑐𝐸]                                                                                                         
c[𝒊𝑺𝑪𝑭]
cf
= 	𝒌𝟗𝟏 ∙ [𝒂𝑺𝑪𝑭] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] − 	𝒌𝟗𝟐 ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] ∙ [𝒊𝑺𝑪𝑭]                                           (3-9)  
c[l𝑺𝑪𝑭]
cf
= 	𝒌𝟗𝟐 ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] ∙ [𝒊𝑺𝑪𝑭] − 𝒌𝟗𝟏 ∙ [𝒂𝑺𝑪𝑭] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]                            (3-10)  
Tyrosine Phosphatase Module 
The main function of Tyrosine Phosphatase module is to activate CycE_Cdk2 and CycA_Cdk2 (through 
connection to Cdk2-Related module) which is necessary for G1-S transition. The Tyrosine 
Phosphatase module is also influenced by another internal module, E2F-pRb (as E2F produces 
Cdc25A) and an external sub-system, DNA damage (DNA damage causes inactivation of Cdc25A).  As 
shown in Figure 3.8, the central protein in this module is the phosphatase Cdc25A that induces the 
activation of iCycE_Cdk2 and iCycA_Cdk2 by removing the inhibitory phosphate from them. In fact, 
positive feedback loops between aCdc25A and these two Cyc_Cdks set the stage for G1-S transition. 
(3-8) 
 50 
It is important to note that following DNA damage, active Chk2 (rapid DNA response) phosphorylates 
Cdc25A and accelerates its degradation which eventually assists G1-S arrest (Bollen & Beullens, 2002; 
Boutros et al., 2007; Donzelli & Draetta, 2003; Karlsson-Rosenthal & Millar, 2006; Kiyokawa & Ray, 
2008; Kristjansdottir & Rudolph, 2004). In Figure 3.8, Cdc25A is transformed between active and 
inactive forms and the processes of synthesis and degradation are also included. 
Figure 3.8 Tyrosine Phosphatase Module. The main player of this module is Tyrosine 
phosphatase Cdc25A. Its synthesis and degradation are mediated through E2F and 
Chk2, respectively. Cdc25A has an important role in activating CycE_Cdk2 and 
CycA_Cdk2. The positive feedback loop between these Cyc_Cdks and Cdc25A triggers 
activation of more Cdc25A. Green solid arrows denote biochemical reactions (i.e., 
synthesis, degradation, association, dissociation, etc.) while purple dashed arrows 
correspond to regulatory effects (i.e., enzymatic effect, transcriptional regulation 
through transcription factor, etc.). Elements in blue rectangular boxes are the proteins 
of this module whereas the other elements belong to other modules. 
 
3.3.4 G2-M Checkpoint Signalling Sub-System 
B-type Cyclin complexes with Cdk1 (as CycB_Cdk1) and acts as the main regulator of G2-M 
checkpoint sub-system. This sub-system is divided into five inter-connected modules (Cdk1-Related, 
Tyrosine Kinase, Tyrosine Phosphatase, APC-Related and Plk1-Related). The corresponding 
interactions between these modules (together with interconnections between different sub-systems) 
are illustrated in Figure 3.9. As shown in this figure, G1-S checkpoint sub-system sends a signal to 
Cdk1-Related module of G2-M checkpoint sub-system. This leads to upregulation of CycB_Cdk1 
complexes. But, the two modules, Tyrosine Phosphatase and Tyrosine Kinase, stimulate activation 
and inactivation of CycB_Cdk1s, respectively. Further, APC- and Plk1-Related modules are vital in M 
phase (the detailed description of each module is provided in following sub-sections). DNA damage 
signalling also interacts with G2-M checkpoint sub-system in a way that Chk-Related (rapid) and p53-
Related (delayed) DNA damage modules interact with Tyrosine Phosphatase and Cdk1-Related 
modules, respectively, to arrest cell cycle in the case of any DNA damage, similar to corresponding 
processes at G1-S checkpoint.   
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Figure 3.9 G2-M Signalling Sub-System including its five modules: Cdk1-Related, APC-Related, 
Tyrosine Phosphatase, Tyrosine Kinase, and Plk1-Related modules. Black arrows 
indicate interactions between modules while blue arrows show interactions between 
G2-M checkpoint and other sub-systems. 
 
Tyrosine Kinase Module 
Tyrosine Kinase module interacts with two internal modules, Cdk1-Related (to inactivate CycB_Cdk1 
complexes) and Plk1-Related (Wee1 becomes inactivated through Plk1) (Figure 3.9). Phosphorylation 
of Thr14 and Tyr15 residues in mammalian Cdks inhibits the activity of Cyc_Cdk complexes. In 
particular, the phosphorylation state of these sites is important in Cdk1 at the initiation of M phase. 
This phosphorylation is done by Tyrosine kinases. The most important Tyrosine kinase in mammalian 
cell cycle is Wee1 (Perry & Kornbluth, 2007). There is another kinase (Myt1) which phosphorylates 
both Tyr15 and Thr14 residues in vertebrates (in this module, Wee1 is used for both Myt1 and 
Wee1). Phosphorylation of Cdk1 on the above residues, which leads to CycB_Cdk1 inactivation, can 
be neutralized by de-phosphorylation via Cdc25C phosphatase. Balance of these activations is geared 
towards triggering a process that leads to activation of Cdk1 and onset of M phase. As demonstrated 
in Figure 3.10, Wee1 is phosphorylated and inactivated by Plk1, which itself becomes activated by 
CycB_Cdk1_Cyt (van Vugt & Medema, 2005). Inactivated Wee1 is ubiquitinated and then degraded 
by SCF (Nakayama & Nakayama, 2005; Smith et al., 2007; Watanabe et al., 2004).  
Therefore, the double negative feedback loop between Wee1 and CycB_Cdk1 acts as an important 
suppressor of G2-M transition (Hamer et al., 2011). In this model, it is also assumed that aWee1 has a 
basal synthesis rate. Since SCF and Plk1 are newly added elements in our model, the corresponding 
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equations are presented below where the bold letters refer to new elements/parameters (all the 
equations of this module are provided in Appendix A).  
c[ddX]
cf
= [𝑎𝑊𝑒𝑒1] ∙ (𝒌𝟏𝟎𝟓 ∙ [𝒂𝑷𝒍𝒌𝟏]	) − (𝑘X9 + 𝒌𝟏𝟎𝟕 ∙ [𝒂𝑺𝑪𝑭]) ∙ [𝑖𝑊𝑒𝑒1]                             (3-11)  
c[lddX]
cf
= 𝑘X9B + 𝑘X9 ∙ [𝑖𝑊𝑒𝑒1] − 𝒌𝟏𝟎𝟓 ∙ [𝒂𝑷𝒍𝒌𝟏] ∙ [𝑎𝑊𝑒𝑒1]                                      (3-12)  
Figure 3.10 Tyrosine Kinase Module. Tyrosine Kinase Wee1 plays the main role in this module 
where active Wee1 mediates inactivation of CycB_Cdk1 inside the nucleus. Wee1 
becomes inactivated by Plk1 and then degraded by active ubiquitin ligase SCF. Green 
solid arrows denote the biochemical reactions (i.e., degradation, changing in the state 
of a protein by phosphorylation or dephosphorylation, etc.) while purple dashed 
arrows correspond to regulatory effects (i.e., enzymatic effect, etc.). Elements in blue 
rectangular boxes are the proteins of this module whereas the other elements belong 
to other modules. 
 
Tyrosine Phosphatase Module 
This module, which centres on Cdc25C phosphatase, interacts with internal Cdk1-Related module (to 
activate CycB_Cdk1 complexes), and with external DNA damage sub-system (to become inactivated 
in the presence of DNA damage). Unlike Tyrosine kinase Wee1, Tyrosine phosphatase Cdc25C 
removes the inhibitory phosphate from Cdk1 leading to activation of CycB_Cdk1 and M phase onset 
(Bollen & Beullens, 2002; Boutros et al., 2007; Perry & Kornbluth, 2007). As illustrated in Figure 3.11, 
inactive Cdc25C becomes phosphorylated and activated by active Plk1 and CycB_Cdk1 at G2-M 
transition and this positive feedback loop between CycB_Cdk1 and Cdc25C is crucial for M phase 
entry (Goulev & Charvin, 2011; Lindqvist et al., 2009; Trunnell et al., 2011; van Vugt & Medema, 
2005). 
It has also been shown that after DNA damage, Cdc25C is phosphorylated on Serine216 by Chk2 
(rapid damage response) and then 14-3-3σ (in the p53-Related delayed damage response module) 
can bind to it in order to prevent M phase entry (Figure 3.11) (Chaturvedi et al., 1999; Hermeking & 
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Benzinger, 2006; Kumagai & Dunphy, 1999). These crucial elements were abstracted into a module in 
our model (see Appendix A for equations). 
Figure 3.11 Tyrosine Phosphatase Module. This module covers the process of activation of 
Tyrosine phosphatase Cdc25C and its phosphorylated version Cdc25CP_S216. This 
phosphatase helps activation of CycB_Cdk1 which is the main controller of mammalian 
cell cycle during M phase. The effect of other regulatory proteins on different versions 
of this phosphatase is shown in this figure and explained in the text. Green solid 
arrows denote biochemical reactions (i.e., degradation, changing in the state of a 
protein by phosphorylation or dephosphorylation, etc.) while purple dashed arrows 
correspond to regulatory effects (i.e., enzymatic effect, etc.). Elements in blue 
rectangular boxes are the proteins of this module whereas the other elements belong 
to other modules. 
  
Plk1-Related Module 
This module, which mainly corresponds to Polo-like kinase-1 (Plk1), interacts with three internal 
modules, Tyrosine kinase (to inactivate it), Tyrosine phosphatase (to activate it), and Cdk1-Related 
modules (to mediate nuclear translocation of CycB_Cdk1) (as shown in Figure 3.9). Plk1 is one of the 
most important proteins in M-phase entry. Figure 3.12 shows the multiple functions of Plk1 including 
activation of Cdc25C phosphatase and APC_Cdc20 (degrader of Cyclins A & B), inactivation of Wee1 
kinase, and translocation of CycB_Cdk1 from cytoplasm to nucleus (Golan et al., 2002; Lindqvist et 
al., 2009; Van De Weerdt & Medema, 2006; van Vugt & Medema, 2005; Zitouni et al., 2014). Plk1 is 
activated by cytoplasmic CycB_Cdk1 through induced phosphorylation and its degradation is 
mediated by ubiquitination through active APC_Cdh1 (Eckerdt & Strebhardt, 2006; Lindon & Pines, 
2004). In this model, it is assumed (for simplification) that Plk1 is transformed between active and 
inactive forms and its inactivation is mediated by active APC_Cdh1 (Figure 3.12). Since Plk1 is a newly 
added element in our model, the Plk1 module is totally new and the corresponding equations are 
formulated as follows: 
c[𝒊𝑷𝒍𝒌𝟏]
cf
= 	𝒌𝟏𝟐𝟏 ∙ [𝒂𝑷𝒍𝒌𝟏] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] − 	𝒌𝟏𝟐𝟐 ∙ [𝒊𝑷𝒍𝒌] ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜]              (3-13) 
c[𝒂𝑷𝒍𝒌𝟏]
cf
= 	𝒌𝟏𝟐𝟐 ∙ [𝒊𝑷𝒍𝒌] ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] − 	𝒌𝟏𝟐𝟏 ∙ [𝒂𝑷𝒍𝒌𝟏] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]             (3-14) 
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Figure 3.12 Plk1-Related Module. Plk1 is one of the key cell cycle elements prior to, and during, M 
phase where it activates Cdc25CP_S216 and mediates translocation of CycB_Cdk1 from 
cytoplasm to nucleus. It also helps activation and inactivation of APC_Cdc20 and 
Wee1, respectively. The effects of aPlk1 on elements from other modules are shown 
with outgoing dashed arrows from aPlk1. Green solid arrows denote biochemical 
reactions (i.e., degradation, changing in the state of a protein by phosphorylation or 
dephosphorylation, etc.) while purple dashed arrows correspond to regulatory effects 
(i.e., enzymatic effect, etc.). Elements in blue rectangular boxes are the proteins of this 
module whereas the other elements belong to other modules. 
 
Cdk1-Related Module 
The main driver of G2-M checkpoint sub-system is Cdk1-Related module which is majorly related to 
all the interactions that lead to CycB_Cdk1 production and activation. This module interacts with all 
internal modules as well as two external sub-systems (G1-S checkpoint and DNA damage sub-
systems). In fact, the function of other modules in G2-M checkpoint sub-system is to control 
CycB_Cdk1 regulation (as shown in Figure 3.9). For example, Tyrosine kinase module has negative 
regulatory impact on Cdk1-Related module (through aWee1), while Tyrosine Phosphatase module 
positively regulates the same module (through aCdc25C). There are two different versions of 
CycB_Cdk1 which are vital for mitotic events (Cytoplasmic and Nuclear versions, as shown in Figure 
3.13). CycB_Cdk1_Cyt, which is formed in the cytoplasm near the end of G2 phase, indirectly helps 
the initiation of mitosis. At the end of G2 phase, this complex is translocated into the nucleus (after 
phosphorylation by active Plk1) to form aCycB_Cdk1_Nuc marking G2-M transition. The 
aCycB_Cdk1_Nuc later (in Anaphase) helps Nuclear Envelope Breakdown (NEB) (Lindqvist et al., 
2009; Morgan, 2007; van Vugt & Medema, 2005). It is also important to remind that existence of NFY 
in this module indicates interconnection between G1-S and G2-M checkpoint sub-systems so that the 
first system triggers the activation of the second one (through transcription factor NFY). In this 
model, it is assumed that different forms of CycB_Cdk complexes are ubiquitinated and degraded 
into Cdk1 by aAPC_Cdc20 and aAPC_Cdh1 in a two-step process. Now, in the presence of DNA 
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damage, p21, which is synthesised by p53, binds to active CycB_Cdk1 in the nucleus to inhibit its 
activity that eventually leads to prolonged G2-M arrest (Abbas & Dutta, 2009). As mentioned in 
Section 3.3.2, following DNA damage, Gadd45α (synthesised by p53) stimulates further dissociation 
of CycB_Cdk1 and this effect has been included as new in our model (Figure 3.13).  
Figure 3.13 Cdk1-Related Module. CycB_Cdk1 is the main controller of cell cycle system during M 
phase. This module comprises Cyclin B, Cdk1, their complexes in cytoplasm and 
nucleus and the impact of other proteins on them. The detailed description of all the 
shown interactions is presented in the text. Green solid arrows denote biochemical 
reactions (i.e., degradation, changing in the state of a protein by phosphorylation or 
dephosphorylation, etc.) while purple dashed arrows correspond to regulatory effects 
(i.e., enzymatic effect, etc.). Double-ended arrows represent reversible reactions. 
Elements in blue rectangular boxes are the proteins of this module whereas the other 
elements belong to other modules. 
 
 
The newly added equations associated with this module are provided below where the new 
elements/parameters are shown in bold (Refer to Appendix A for all equations). 
c[n]
cf
= 	𝑘X8= ∙ [𝑁𝐹𝑌] + [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ (	𝑘X8< + 	𝒌𝟏𝟐𝟓 ∙ [𝑮𝒂𝒅𝒅𝟒𝟓]) −
(	𝑘X8 + 𝑘X8A ∙ [𝐶𝑑𝑘1] 	+ (	𝑘X8B ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + 	𝑘X8 ∙
[𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1])) ∙ [𝐶𝑦𝑐𝐵]                 
c[cYX]
cf
= 	𝑘X=9 ∙ [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ ([𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]) +
[𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ 			 (	𝑘X=X ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + 	 	𝑘X=8 ∙
[𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]) + [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ (	𝑘X8< + 	𝒌𝟏𝟐𝟓 ∙ 			 [𝑮𝒂𝒅𝒅𝟒𝟓]) −






= 	𝑘X8A ∙ [𝐶𝑦𝑐𝐵] ∙ [𝐶𝑑𝑘1] + 	𝑘X== ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] −
(	𝑘X8< + 	𝒌𝟏𝟐𝟓 ∙ [𝑮𝒂𝒅𝒅𝟒𝟓] + 	𝑘X=< ∙ ([𝑎𝐶𝑑𝑐25𝐶] +
[𝑎𝐶𝑑𝑐25𝐶𝑃_𝑆216]) + 	𝑘X=9 ∙ ([𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] +
[𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1])) ∙ [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜]                           
c[ln_cYX_ft]
cf
= 	𝑘X=; ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] + 	𝑘X=< ∙ [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙
([𝑎𝐶𝑑𝑐25𝐶] + [𝑎𝐶𝑑𝑐25𝐶𝑃_𝑆216]) − (	𝑘X== + 	𝑘X=X ∙
[𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + 	 	𝑘X=8 ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] − 	𝒌𝟏𝟑𝟔 ∙ [𝒂𝑷𝒍𝒌𝟏]) ∙
[𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]               
c[ln_cYX_¡¢n]
cf
= 	𝒌𝟏𝟑𝟔 ∙ [𝒂𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ [𝒂𝑷𝒍𝒌𝟏] + 	𝑘X=B ∙
[𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] ∙ [𝑎𝐶𝑑𝑐25𝐶] + 	𝑘8 ∙
[𝑝21_𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] − 	(𝑘X=; + 	𝑘X=A ∙ [𝑎𝑊𝑒𝑒1] +
	𝑘X<9 ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + 	𝑘X<X ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] + 	𝑘=9 ∙ 𝑝21) ∙
[𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]      
             
APC-Related Module   
This module is particularly important during mid to late M phase. In late Prometaphase, APC_Cdc20 
(first degrader of Cyclins A & B) is phosphorylated and activated by CycB_Cdk1 complexes. Upon the 
deactivation of spindle assembly checkpoint (a control system that monitors the assembly of sister 
chromatids’ kinetochores to the microtubules on the mitotic plate) in Metaphase, Mad2/BubR1 
complex (not included in this model) is dissociated from APC_Cdc20 allowing APC_Cdc20 to attain its 
full activity and trigger the destruction of Cyclin B. Hence, Cyclin B is degraded in Anaphase and this 
leads to dephosphorylation of Cdh1 which results in formation of APC_Cdh1 (second degrader of 
Cyclins A & B). Active APC_Cdh1, in turn, stimulates the degradation of APC_Cdc20 and drives the 
final steps of M phase that lead to exit from cell cycle (Morgan, 2007). For the sake of simplicity, 
APC_Cdc20 and APC_Cdh1 were modelled as just active and inactive forms and their synthesis and 
degradation processes were excluded.  
As shown in Figure 3.14, inactive APC_Cdc20 becomes active by aPlk1 and aCycB_Cdk1_Nuc, while its 
inactivation is mediated by aAPC_Cdh1. An important point about active APC_Cdh1 is that it is not 
only crucial in late M phase, but also in early G1 phase. During G1 phase, the function of aAPC_Cdh1 
is to make sure that no new cell cycle starts unless environmental conditions favour proliferation and 
this is done through degradation of different entities, such as Cyclins A and B. However, following the 
appropriate conditions, activated CycE_Cdk2 complex promotes the deactivation of APC_Cdh1 (in 
late G1 phase) and it eventually results in higher expression of proteins needed for DNA synthesis, 





aCycB_Cdk1_Nuc (see Figure 3.14) (Berridge, 2014; Li & Zhang, 2009; Qiao et al., 2010; Yuan et al., 
2014).   
 
Figure 3.14 APC-Related Module. This module presents the process of activation/inactivation of 
ubiquitin ligases APC_Cdc20 and APC_Cdh1. These ligases are crucial ubiquitinators 
and their impact on CycB_Cdk1 is particularly important during M phase. Green solid 
arrows denote biochemical reactions (i.e., degradation, changing in the state of a 
protein by phosphorylation or dephosphorylation, etc.) while purple dashed arrows 
correspond to regulatory effects (i.e., enzymatic effect, etc.). Elements in blue 
rectangular boxes are the proteins of this module whereas the other elements belong 
to other modules. 
 
The newly added element Plk1 affects this module through the equations provided below (Refer to 
Appendix A for all equations). 
c[£h_cn89]
cf
= 	𝑘X<8 ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] − (	𝑘X<= ∙
[𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] + 	𝒌𝟏𝟒𝟖 ∙ [𝒂𝑷𝒍𝒌𝟏]) ∙ [𝑖𝐴𝑃𝐶_𝐶𝑑𝑐20]  
c[l£h_cn89]
cf
= 	(𝑘X<= ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] + 	𝒌𝟏𝟒𝟖 ∙ [𝒂𝑷𝒍𝒌𝟏]) ∙
[𝑖𝐴𝑃𝐶_𝐶𝑑𝑐20] − 	𝑘X<8 ∙ 	 [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20]                
             
 Results and Discussion 
In this section, we simulate the dynamic behaviour of the proposed model with and without DNA 
damage and demonstrate the effect of some newly added elements as well. The model is first 
simulated under no DNA damage condition (we call the cells under this condition healthy cells). In 
this condition, the parameter DDS (DNA Damage Signal) equals zero. Here, the temporal dynamics of 
newly added elements (c-Myc, PP1, SCF, and Plk1), indicators of G1-S and G2-M checkpoints 
(CycE_Cdk2, aCycB_Cdk1_Nuc) and some other significant proteins (p27, E2F, CycD_Cdk4, 
CycA_Cdk2, APC_Cdc20, APC_Cdh1) are discussed. As shown in Figure 3.15, p27 and aAPC_Cdh1 are 
predominant factors that suppress the initiation of cell cycle and this is in good agreement with 




we have highlighted the importance of p27 and APC_Cdh1 and represented them in sub-systems G1-
S and G2-M checkpoints, respectively). Following the presence of Growth Factor, c-Myc becomes 
activated (through our added Growth Factor signalling sub-system) and then it induces the 
production of Cyclin D which is consistent with biological findings (Adhikary & Eilers, 2005; de 
Alboran et al., 2001; Schmidt, 1999). Thus, as shown in Figure 3.15, CycD_Cdk4 starts to increase and 
this, in turn, causes a drop in concentration of p27 throughout the mid G1 phase (because some 
CycD_Cdk4 complexes bind to p27). However, CycD_Cdk4 level has a slight decrease in the middle of 
cell cycle, which is mediated by SCF, and a dramatic drop at the end of cell cycle through 
ubiquitination by aAPC_Cdc20 (Alao, 2007) (this and the processes below highlight the well 
represented role of the APC module).  
The model simulation properly shows that aAPC_Cdh1 remains at high level till late G1 phase where 
it is phosphorylated and deactivated by aCycE_Cdk2. The processes leading to this are as follows: At 
the beginning of cell cycle, the level of E2F_pRb is high for the reason that phosphatase PP1 mediates 
dephosphorylation of pRb leading to formation of complex E2F_pRb which has been well proven 
through experiments (Berndt, 2002; Ludlow et al., 1993; Nelson et al., 1997; Trinkle-Mulcahy et al., 
2003). In fact, activation of CycE_Cdk2 happens following the release of transcription factor E2F from 
pRb through multiple phosphorylation of E2F_pRb complex by different Cyc_Cdks (see Section 3.3.3 
for details). As shown in Figure 3.15, upon activation, CycE_Cdk2 stimulates further degradation of its 
inhibitor p27 (p27 concentration increases again at the end of cell cycle where the level of Cyc_Cdks 
is low) as well as phosphorylation and deactivation aAPC_Cdh1 (degrader of Cyclin A & B). In this 
way, aCycE_Cdk2 controls cell cycle transition from G1 to S phase and its peak time can be 
considered as an indicator of G1-S transition (Ohtsubo et al., 1995). Therefore, in the case of no DNA 
damage, the G1-S transition occurs at time-point 1095.  
The ubiquitin ligase SCF (solid brown line), which becomes activated after activation of CycE_Cdk2 
and inactivation of aAPC_Cdh1, functions as the main ubiquitinator of cell cycle until mid M phase 
where it is deactivated by aAPC_Cdh1 (dashed red line) which itself is activated around the same 
time (Figure 3.15). As shown in the simulated results, after G1-S transition, aCycE_Cdk2 starts to 
decrease and the reason is SCF-mediated degradation of Cyclin E. This behaviour is also in good 
agreement with biological findings  (Nakayama & Nakayama, 2005).  We compared Cyclin E 
behaviour in our model with SCF and without it (as in Iwamoto et al. (2011) model that does not 
incorporate the corresponding biological details of Cyclin E degradation). Results showed that with 
SCF, aCycE_Cdk2 peaks sooner and gets degraded more quickly than without it (Peak time of 
aCycE_Cdk2 (which indicates G1-S transition) with SCF is 1095 and without SCF is 1133, indicating a 
time difference of 38). These differences are shown in Figure 3.16. Therefore, we can assume that 
Cyclin E degrades more realistically in our model. 
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Figure 3.15 Temporal dynamics of the key players of mammalian cell cycle control system 
including newly added elements (c-Myc, PP1, SCF, and Plk1), indicators of G1-S and 
G2-M checkpoints (CycE_Cdk2, aCycB_Cdk1_Nuc) and some other significant proteins 
(p27, E2F, CycD_Cdk4, CycA_Cdk2, APC_Cdc20, APC_Cdh1). Cyc_Cdks are at the centre 
of this control system and the other elements regulate their concentration. G1-S and 
G2-M transitions under no DNA damage are denoted on the horizontal axis. The peak 
time (PT) of active CycE_Cdk2 and CycB_Cdk1_Nuc correspond to G1-S and G2-M 
transition, respectively [x-axis indicates time (simulation time units as well as hours); 
y-axis indicates protein concentration (mg/ml)]. 
 
Now, the concentration of aCycA_Cdk2 increases from S phase and keeps increasing throughout G2 
phase before decreasing at late G2 phase. For G2-M transition, active version of nuclear CycB_Cdk1, 
which is translocated from cytoplasm into nucleus by aPlk1, is selected as the indicator of this 
transition. As can be seen in Figure 3.15, Plk1 becomes activated preceding CycB_Cdk1_Nuc and 
these dynamics are in agreement with the corresponding biological findings (Lindqvist et al., 2009; 
van Vugt & Medema, 2005) (which highlights the value of incorporation of Plk1 in our model). 
Therefore, the peak time of aCycB_Cdk1_Nuc as the indicator of G2-M transition is justified. This 
peak time occurs at time-point 3208 in our model. Further, a deeper investigation into the behaviour 
of the two versions of CycB_Cdk1 in the presence of aPlk1 as in our model and without it as in 
Iwamoto et al. (2011) model showed that Plk1 modified the concentrations and temporal dynamics 
of the two CycB_Cdk1 versions. In particular, the peak time of CycB_Cdk1_Nuc (indicator of G2-M 























transition) with Plk1 and without it was 3208 and 3238, respectively, indicating that Plk1 accelerates 
the peak time by 30 time points. These results are shown in Figure 3.17.   
 
Figure 3.16 Impact of newly added Cyclin E degrader SCF on Cyclin E dynamics (solid line – with 
SCF and dashed line – without SCF). Figure shows that in the presence of SCF, Cyclin E 
peaks slightly sooner and degrades quicker than without SCF. Peak time (PT) of 
aCycE_Cdk2 indicates G1-S transition (with SCF: PT =1095, without SCF: PT= 1133; PT 
difference is 38) [x-axis indicates time (simulation time units as well as hours); y-axis 
indicates protein concentration (mg/ml)]. 
 
It is also important to note that at the end of cell cycle, first APC_Cdc20 and then APC_Cdh1 become 
activated as shown in Figure 3.15 to degrade all cyclins and help cell cycle exit (for detailed 
information, see Section 3.3.4). We also assessed the cyclic behaviour of the model over more than 
one cell proliferation cycles and the model produces cyclic behaviour reasonably well (see Appendix 
D for more details). In the case of DNA damage, the parameter DDS (DNA Damage Signal), is changed 
from zero (no DNA damage) to 0.012 (corresponds to 400-800 (𝐽/𝑚8) dose of UV) to assess the 















Figure 3.17 Impact of newly added Plk1 on Cyclin B dynamics (solid line – with Plk1; and dashed 
line – without Plk1).  Figure shows that Plk1 alters the concentration and Peak time 
(PT) of CycB_Cdk1_Cyt and CycB_Cdk1_Nuc complexes. PT of CycB_Cdk1_Nuc indicates 
G2-M transition (PT with Plk1 is 3208 and without Plk1 is 3238; PT difference is 30) [x-
axis indicates time (simulation time units as well as hours); y-axis indicates protein 
concentration (mg/ml)]. 
 
Figure 3.18 shows the dynamics of some important, including the newly added, elements of the rapid 
and delayed DNA response modules. In particular, Chk-Related (rapid) module is activated 
immediately and then p53 (delayed response) reaches peak activating other elements in the delayed 
module, in particular p21 and Gadd45α (newly added). The p53 shows oscillatory behaviour which 
agrees with findings in the literature (Batchelor et al., 2008) and Gadd45α increases while p53 is 
active. These results point to the integrated response of the two DNA damage modules and the value 
of Gadd45α in the expansion of the delayed DNA damage response in the model. Further, both G1-S 
and G2-M transitions take place with a delay indicating the occurrence of cell cycle arrest at these 
checkpoints. In this condition, G1-S and G2-M transitions happen at time-points 1125 and 3330, 
respectively, and the corresponding arrest durations are 30 and 122 time-points, respectively. This 
finding that G2-M arrest is longer than that of G1-S is consistent with experiments done on mouse 
Swiss3T3 cells revealing prolonged G2-M cell cycle arrest compared to G1-S after DNA damage (Siu et 
al., 1999). More analysis will be done on the proposed model in the next two chapters. 
 











Figure 3.18 Temporal dynamics of important elements in the rapid and delayed DNA damage 
response in cell cycle arrest. Chk2 is the key player in rapid DNA damage signalling 
(explained in Section 3.3.2) which becomes activated after the presence of DNA 
damage and inhibits the progression of cell cycle. This is followed by the delayed 
response centred on transcription factor p53. Since transcription is slower than 
activation (of Chk2), this module is called delayed DNA damage response. These 
results show the integrated response of the rapid and delayed pathways as proposed 
in this study. Transcription factor p53 induced the synthesis of Cyclin-dependent 
Kinase Inhibitor p21 and the newly added Gadd45α showing latter’s close 
correspondence to p53 and the joint activity of the delayed module (the significance of 
these elements is described in Section 3.3.2) [x-axis indicates time (simulation time 
units as well as hours); y-axis indicates protein concentration (mg/ml)]. 
 
 Summary 
In this chapter, a comprehensive system based mathematical model of mammalian cell cycle with 
new additions and extensions was proposed based on Iwamoto et al. (2011) ODE cell cycle model 
and analysed for determining the most influential sub-systems and parameters and for comparing 
the relative efficiency of G1-S and G2-M checkpoints.  We developed our model based on four 
abstracted functional sub-systems: Growth Factor (newly added), G1-S, G2-M, and DNA damage 
signalling sub-systems. The four sub-systems, abstracted from the existing cell cycle knowledge, were 
further enriched with some important new modules and elements: G1-S was abstracted into four 
interconnected modules (Cdk4-Related, E2F-pRb, Cdk2-Related and Tyrosine phosphatase where the 
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the model cyclic); G2-M was abstracted into five modules (Cdk1-Related, Tyrosine phosphatase, 
Tyrosine kinase, Plk1-Related and APC-Related where the latter four are novel additions and 
contained new elements); and DNA damage was abstracted into two modules including Chk-Related 
(rapid) and newly added elements in p53-Related (delayed) modules.   
This model enabled us to seamlessly and realistically study the function of sub-systems as well as the 
influence of sub-systems on each other where the Growth Factor sub-system senses the Growth 
Factor signals and triggers the activation of subsequent sub-systems. Past models have considered 
Growth Factor to be a binary signal - on or off. We represented it as a continuous signal and now the 
relationship (continuous dynamic) between c-Myc and Cyclin D is realistically represented. The 
function of Growth Factor signal is to activate c-Myc that in essence initiates the cell cycle by 
triggering the synthesis of Cyclin D. We added the Growth Factor signalling and especially c-Myc due 
to its biological significance to the cell cycle system and our numerical analysis in fact showed that c-
Myc is the most significant element in the whole system. Thus, the Growth Factor sub-system is a 
crucial part from a systems perspective and adding it is beneficial. Further, as an extension to the cell 
cycle model, Growth Factor signalling system gives a more complete description of cell cycle. Also, 
with c-Myc in the system, we now have the Transcription factors of all Cyclins in one model. 
Therefore, we have presented a more realistic description of cell cycle initiation through Growth 
Factor signalling sub-system that can also be used in future studies to investigate the impact of 
perturbation to growth signal on system behaviour.  
Our intuitive approach to breaking down the sub-systems into their constituent modules enabled us 
to determine the function of each module and correctly formulate their effects on each other using 
ODEs. For example, in the G1-S checkpoint signalling sub-system: (1) Cdk4-Related module (receives 
the signal from Growth Factor sub-system to initiate the cell cycle); (2) E2F-pRb module (receives the 
signal from Cdk4-Related module and induces the production of some critical cell cycle proteins 
through transcription factor, E2F); (3) Cdk2-Related module (talks to other internal and external 
modules and sub-systems to prepare the cell for entering into S phase); and (4) Tyrosine Phosphatase 
module (stimulates the activation of Cyc_Cdk2 complexes which are crucial for G1-S transition).  
The dynamic simulation of the model under no DNA damage conditions reveals the role and value of 
the newly added elements in filling the gaps and giving a fuller description of cell cycle. One of the 
newly added elements is phosphatase PP1 that dephosphorylates Retinoblastoma protein (pRb) at 
the end of cell cycle and helps a new cell cycle to begin which has been biologically proven (Berndt, 
2002; Ludlow et al., 1993; Nelson et al., 1997; Trinkle-Mulcahy et al., 2003). It should be noted that 
Iwamoto et al. model was not cyclic because PP1 was missing in that model. Plk1 is another newly 
added element which is one of the most important proteins in m-phase entry. In Iwamoto et al. 
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model, there were two types of CycB-Cdk1: nucleus and cytoplasmic versions; but there was no 
explanation for the translocation of the cytoplasmic version into nucleus version (Iwamoto et al., 
2011). Our model provides this explanation through Plk1. Plk1 has multiple functions including 
activation of Cdc25C phosphatase and APC_Cdc20 (degrader of Cyclin A and Cyclin B), inactivation of 
Wee1 kinase, and translocation of CycB_Cdk1 from cytoplasm to nucleus (Golan et al., 2002; 
Lindqvist et al., 2009; Van De Weerdt & Medema, 2006; van Vugt & Medema, 2005; Zitouni et al., 
2014). Plk1 is activated by cytoplasmic CycB_Cdk1 through induced phosphorylation and its 
degradation is mediated by ubiquitination through active APC_Cdh1 (Eckerdt & Strebhardt, 2006; 
Lindon & Pines, 2004). With Plk1 added, the model now incorporates correctly a process that 
explains an important cell cycle stage transition.  
SCF is another newly added element that is a ubiquitin ligase whose function in cell cycle system is to 
degrade a number of key elements in the cell cycle control system. The reason for adding SCF to our 
model is that there is biological evidence that Cyclin E, which is the key player of cell cycle during G1 
phase, is degraded by SCF (Ang & Harper, 2004; Cardozo & Pagano, 2004; Nakayama & Nakayama, 
2005). In Iwamoto et al. model, the process of Cyclin E degradation is not complete and we believe 
that adding SCF to the model makes it more accurate. In Iwamoto et al. model, biologically relevant 
CycE degradation details are not incorporated as in our model and therefore, CycE-Cdk2 degradation 
happens over a longer time. Therefore, we can assume that Cyclin E degrades more realistically in 
our model.     
Furthermore, the dynamic behaviour of the system was investigated where the cell cycle arrest 
occurred in the presence of DNA damage. Under this condition, both the Chk-Related (rapid) and 
p53-Related (delayed) modules were activated with p53 showing the expected oscillatory behaviour 
and the contributory role of new element being shown in perspective. The DNA damage part in 
Iwamoto et al. model had p53 as a transcription factor that induces synthesis of a number of 
proteins. One of them was 14-3-3σ that affects (inactivates) B-type Cyclin_Cdk complex to arrest cell 
cycle in the case of DNA damage. However, that does not represent the complete picture of impact 
of p53 on CycB_Cdk1. To make that picture more complete, we found another product of p53, 
Gadd45α, that also inactivates CycB_Cdk1 (as the main controller of cell cycle during M-phase) (Jin et 
al., 2002; Zhan, 2005). Furthermore, biological evidence shows that the way that 14-3-3σ and 
Gadd45α act upon CycB_Cdk1 inactivation is different. The first factor (14-3-3σ) inhibits Cdc25C 
(which is the CycB_Cdk1 activator), while the second (Gadd45α) physically interacts with Cdk1 in 
order to stimulate CyclinB_Cdk1 unbinding (Jin et al., 2002; Zhan, 2005). Therefore, Gadd45α is 
added to the model to present a more complete picture of G2-M checkpoint. As shown in Figure 
3.18, Gadd45α is produced throughout the period of activity of p53. We also noticed from the 
dynamic simulation results that G1-S and G2-M transitions occurred with a delay of 30 and 122 time-
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points, respectively, in comparison to no DNA damage condition thus revealing that the arrest 
duration at G2-M is longer than that of G1-S that has biological support (Siu et al., 1999). 
Therefore, this chapter provides an approach to represent and analyse a complex system, in 
particular, mammalian cell cycle, from a holistic systems perspective incorporating sub-systems and 
modules along with a number of new additions. Newly added elements provide an opportunity for 
biologists to set up new hypothesis to experiment in their lab for targeted cancer therapies. For 
example, PP1 can be used for cancer therapy as its knocking out can halt the cell proliferation by 
stopping the system from cycling. This chapter also gives a clearer view of cell cycle and provides new 
insights into systems dynamics, influential sub-systems/modules/parameters (will be presented in 
Chapter 4), and checkpoint efficiency (will be presented in Chapter 5).  
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Chapter 4 
Investigation of the Effect of Sub-Systems, Modules, and 
Parameters on Cell Cycle Control System Response 
In this chapter, the most effective sub-systems, modules, and parameters on cell cycle control system 
response associated with the comprehensive mathematical model presented in the last chapter are 
identified through Global Sensitivity Analysis (GSA), which focuses on global impact of parameters. A 
model called Self-Organizing Map with Correlation Coefficient Analysis (SOMCCA) is developed to 
perform GSA which shows that Growth Factor and G1-S checkpoint sub-systems and seven 
parameters in the modules within them are crucial for G1-S and G2-M transitions. An overview of the 
chapter is presented in the first section. In the second section, the GSA formulation through the 
SOMCCA model is presented. The third section of this chapter is devoted to identification of the most 
influential parameters, sub-systems, and modules of the comprehensive model on system response. 
Finally, a summary of the chapter is presented in Section 4.4. 
 Overview 
An effective way to investigate the system behaviour is to analyse the system parameters. The 
behaviour that we are investigating here is G1-S and G2-M transitions. Therefore, in this chapter, we 
describe a numerical analysis that is applied to the proposed model in Chapter 3 to identify the parts 
of the system that have the highest impact on G1-S and G2-M transitions. Thanks to our systems 
modelling scheme, it is possible to find these parts as sub-systems and modules in order to 
investigate the system response from a functional perspective. The Global Sensitivity Analysis (GSA) 
is performed to explore the changes in system behaviour with respect to variation of all parameters 
and to find a region of parameter space where the system response is highly disrupted. The rationale 
for using GSA instead of Local Sensitivity Analysis (LSA), which is based on perturbation of just one 
individual parameter at a time, is that GSA is closer to reality where all the system parameters are 
affected by environmental or other perturbations. A hybrid model is developed to perform GSA that 
has two main phases. In the first phase, an Artificial Neural Network (ANN) approach called Self-
Organizing Map (SOM) (Samarasinghe, 2006) is implemented to explore the space of parameter 
vectors and their relations. Then, the output of SOM goes through the second phase called 
Correlation Coefficient Analysis (CCA) to reveal the correlation between parameters and system 
response. The proposed hybrid model is called SOMCCA. It should be noted that the Peak Times (PTs) 
of aCycE_Cdk2 and aCycB_Cdk1_Nuc are considered as in silico indicators of G1-S and G2-M 
transitions, respectively. 
 67 
  GSA Formulation through SOMCCA Model  
GSA determines the collective impact of parameters on system response and reveals the effective 
parameters from a global perspective. It is based on perturbation of all parameters around their fixed 
values and then checking the impact of this change on system response. The fixed value for each 
parameter is its value in unperturbed condition and the output is the PT of the interested biological 
indicator, such as aCycE_Cdk2. We develop a model based on Self-Organizing Map and Correlation 
Coefficient Analysis called SOMCCA to perform GSA. Some of the benefits of using Self-Organizing 
Map are dimensionality reduction, visualisation, handling nonlinear relationships in data and showing 
similar entities closer to each other (topology preservation) (Samarasinghe, 2006). Using the 
SOMCCA model, we can demonstrate the global spectrum of parameters (in the form of 2D maps) 
and find the correlation between these parameters and system response. A flowchart of the 
proposed model is illustrated in Figure 4.1. 
 
Figure 4.1 A flowchart of the SOMCCA model. This model comprises two main phases, SOM and 
CCA. During the SOM phase, the SOM network is constructed and then trained using 
cell samples. The parameters are first qualitatively assessed through SOM input planes 
and then the input weight matrix (W) is extracted. The W matrix is used as input to 
CCA phase in order to calculate the Covariance (Cov) matrix. Using the Cov matrix, 
Pearson Correlation Coefficient (PCC) can be calculated and used to assess the 
parameters quantitatively. Finally, by sorting the effective parameters, we identify the 
most effective parameters from a global perspective. 
 
According to the SOMCCA model (Figure 4.1), all parameters are perturbed simultaneously and 
sampled 2000 times to produce 2000 cells (the assumed perturbation range is ±10%). The 
parameter vectors of these cells are inputs to SOM phase. SOM is an unsupervised ANN in which the 
topology of the data is exactly preserved and presented in a rectangular or hexagonal (depending on 
selected topology) 2D map of neurons (Samarasinghe, 2006). This allows visualisation of high 
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dimensional data (i.e., parameters and PT) and their relations on a 2D plane. A schematic diagram of 
an SOM model is shown in Figure 4.2. 
As demonstrated in Figure 4.2, 𝑚 input variables, 𝑦X, 𝑦8, … , 𝑦V, which are the parameters and PT of 
the cell cycle system, are connected to a feature map by a set of weighted arrows. In fact, each 
neuron 𝑗 in feature map corresponds to a vector of 𝑚 weights 𝑤𝑡© = (𝑤𝑡X© , 𝑤𝑡8©, … ,𝑤𝑡V©) coming 
from 𝑚 inputs. Each weight vector after training represents a cluster of input vectors. Training an 
SOM is a repetitive process. For each input vector, neurons compete with each other to represent 
the input vector and be the winner that allows them to modify their weights. The winner of the 
competition is the neuron that has the closest distance (there are different distance functions, such 
as Euclidian, Manhattan, etc.) to the input vector.  
Figure 4.2 A schematic diagram of SOM. It includes a set of input variables, 𝒚𝟏, 𝒚𝟐, … , 𝒚𝒎, 
(parameters and PT) and a set of neurons arranged in a 2D Feature Map.  Each neuron 
is represented by a weight vector linking it to input vectors. Input vectors are 
presented to the SOM and the output (activation level) of each neuron is the weighted 
sum of the input vector. The neuron with the highest activation is declared the winner 
and its weight vector is adjusted along with that of the neurons in its neighbourhood.  
This learning process continues until there is no or minimal weight adjustment. 
 
The corresponding formula for Euclidian measure is expressed as follows: 
𝐷𝑖𝑠𝑡© = 𝑦 − 𝑤𝑡© = «∑ 	(𝑦V­X − 𝑤𝑡©)8                                                   (4-1)  
Then the winner weights are brought closer to the input vector. For topology preservation that 
preserves relations in input data, the neighbours of winner neuron are also moved toward the input 
(by a smaller amount than that of winner). This is expressed through a function called Neighbour 
Strength (𝑁𝑆). The function can take different forms, such as Gaussian, Exponential, etc. For 
example, the Exponential 𝑁𝑆 function is shown in Eq. (4-2): 
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𝑁𝑆do = 𝐸𝑥𝑝¯−𝐶 × 𝑑𝑖𝑠𝑡,©°		 	 	 	 	 	 																																												(4-2) 
where 𝑑𝑖𝑠𝑡,©  is the distance between winner neuron 𝑖 and any neighbour neuron 𝑗, and 𝐶 is a 
constant between 0 and 1. The weight update for both winner and neighbours is presented below: 
∆²f³= 𝑤𝑡©
¡d² − 𝑤𝑡©´uc = 𝛽𝑒𝑡𝑎 × 𝑁𝑆 × (𝑦 − 𝑤𝑡©´uc)                                               (4-3) 
where ∆²f³  is the weight update or difference between new and old weight values, 𝛽𝑒𝑡𝑎 is learning 
rate that can be defined as a constant or variable through different functions. The training process is  
halted when ∆²f³	becomes zero or below a user-defined threshold over iterations (Samarasinghe, 
2006). In a trained SOM, individual neuron weights represent the centre of gravity or centre of a 
cluster of parameter vectors. After training, the results of SOM are usually presented through a 
Unified Matrix (U-Matrix). The U-Matrix is a map of the distance between neighbour neurons. One of 
the results that is of interest in this study is the spread of individual parameters separately on the 
map (map planes). Through these maps, it is possible to qualitatively evaluate the effect of different 
parameters on system response (PT).  
The topology preservation characteristic of SOM enables us to conduct a quantitative evaluation of 
parameters as well. To do this, the weight matrix 𝑊 is extracted from the trained SOM and imported 
to the next phase, CCA phase, to perform a statistical analysis in order to find the correlation 
coefficient between parameters and system response (see Figure 4.1). For example, if SOM has 25 
neurons (5×5 map) and the number of input variables is 10, 𝑊 will be a 25×10 matrix. The first step 
in CCA phase is to calculate the covariance of 𝑊. Basically, covariance matrix shows how much two 
variables 𝑦V and	𝑦¶ change together or behave similarly (Wasserman, 2013) and it can be 
represented as: 
𝐶𝑜𝑣V,¶ = 𝐸 ¸¯𝑦V − 𝐸(𝑦V)° × ¯𝑦¶ − 𝐸(𝑦¶)°¹                                                  (4-4) 
where 𝐸 corresponds to the expected value of variables. Considering the aforementioned example 
where 𝑊 was a 25×10 matrix, the corresponding covariance matrix becomes a 10×10 symmetric 
matrix whose diagonal elements are the variance of variables. To find the correlation coefficient 
between parameters and system response (PT), Pearson Correlation Coefficient (PCC) is used 




																																																															                                                  (4-5)   
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For the above example, PCC is a 10×10 symmetric matrix whose diagonal elements are one and the 
other elements indicate the correlation between variables in the range of ±1 where −1 corresponds 
to complete negative correlation, whereas +1 signifies total positive correlation.  
 Most influential Parameters/Sub-Systems/Modules  
Using SOMCCA model, it is possible to perform a quantitative analysis and sort the effective 
parameters from a global point of view based on correlation coefficient values (parameters with 
correlation coefficient value greater than 0.05 are considered as significant; the corresponding 
correlation coefficient values of the most significant parameters with respect to PTs of G1-S and G2-
M indicators are shown in the last row of Table 4.1). The 2D maps of the most significant parameters 
of the system with respect to PTs of G1-S indicator (aCycE_Cdk2) under No DDS is shown in Figure 
4.3. Here, the location of a particular neuron in the planes corresponds to each other, so by following 
a neuron location in two map planes, the relation (negative or positive) between two inputs can be 
assessed using the colour code. In this case, PT of aCycE_Cdk2, is mainly influenced by (in order of 
significance – the corresponding correlation coefficient values are shown in Table 4.1):	𝒌𝟒𝟎 (synthesis 
rate of Cyclin D through transcription factor c-Myc), 𝒌𝟔𝟒 (rate of dephosphorylation of pRbPPP to 
pRb through PP1),	𝒌𝟒𝟗 (synthesis rate of p27),	𝒌𝟔𝟎 (dissociation rate of E2F_pRbPP complex through 
aCycE_Cdk2),	𝒌𝟓𝟎 (dissociation rate of p27_aCycE_Cdk2 complex),	𝒌𝟓𝟐 (association rate of p27 and 
aCycE_Cdk2), 𝒌𝟗𝟖 (synthesis rate of iCdc25A through E2F),	𝒌𝟖𝟖 (activation rate of iCycE_Cdk2 
through aCdc25A),	𝒌𝟏𝟎𝟏 (activation rate of iCdc25A through aCycE_Cdk2 and aCycA_Cdk2),	𝒌𝟒𝟖 
(association rate of p27 and CycD_Cdk4),	𝒌𝟕𝟎 (synthesis rate of Cyclin E through transcription factor 
E2F),	𝒌𝟐 (activation rate of ic-Myc through Growth Factor), 𝒌𝟖𝟑 (degradation rate of iCycE_Cdk2 to 
Cdk2), and 𝒌𝟏𝟎𝟎 (degradation rate of iCdc25A). As shown in Figure 4.3, the parameters 
𝒌𝟔𝟒, 	𝒌𝟒𝟗,	𝒌𝟓𝟐,	𝒌𝟖𝟑 and	𝒌𝟏𝟎𝟎 positively correlate with PT of G1-S indicator, while others have negative 
correlation. For instance, the higher the synthesis rate of p27 (	𝒌𝟒𝟗), the longer the G1 phase. 
Overall, the positive correlations are with parameters of processes that increase PT due to their 
negative effect on CycE_Cdk2 production, activation (in particular through promoting p27 binding 
and inhibiting activation by Cdc25A) and degradation; whereas, the negative correlations are with 
parameters of processes that have the opposite effect on CycE_Cdk2 and Cyclin D.  
Based on our systems modelling approach, after identification of the most effective parameters, it is 
possible to identify the most impactful sub-systems and modules too. The impact of the 
aforementioned parameters on G1-S Transition under No DDS in terms of sub-systems and modules 
is demonstrated in Figure 4.4. As shown in this figure, under No DDS, just two sub-systems have 
impact on G1-S transition, Growth Factor and G1-S checkpoint sub-systems. Growth Factor sub-
system regulates the G1-S transition through two c-Myc-related Parameters,	𝒌𝟒𝟎  and	𝒌𝟐 and our 
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model has correctly identified them. This is in agreement with experiments that have shown that c-
Myc has an important role in S phase induction (Baluchamy et al., 2003; Berns et al., 2000). 
Furthermore, biological findings have suggested that c-Myc has an essential impact on cell growth 
and its down-regulation leads to prolonged G1 and G2 phases (Dang, 1999; Iritani & Eisenman, 1999).  
Figure 4.3 SOM planes showing the spread of the most significant parameters sorted through 
SOMCCA (in order of significance - parameters with correlation coefficient value 
greater than 0.05 are considered as significant) with respect to PT of G1-S indicator 
(the last figure). It shows the relationship of variables/parameters to the output PT 
and relationship of parameters to each other. Darker colours indicate lower values of 
a parameter and lighter ones indicate higher values. By comparing the colour pattern 
in the output plane with those in the input plane it is easy to see which parameter 
have similar patterns to the output (positive relationship = positive correlation) and 
which ones have opposite colour pattern (negative correlation) and which ones have 
weak or no correlation to the output. This is considered as qualitative evaluation.  
Also, comparing the parameter planes to each other, it can be determined which 
variables are positively, negatively, weakly, or not correlated. Parameters	𝒌𝟔𝟒	(rate of 
dephosphorylation of pRbPPP to pRb through PP1),	𝒌𝟒𝟗 (synthesis rate of p27),	𝒌𝟓𝟐 
(association rate of p27 and aCycE_Cdk2),	𝒌𝟖𝟑 (degradation rate of iCycE_Cdk2 to 
Cdk2) and	𝒌𝟏𝟎𝟎 (degradation rate of iCdc25A) have positive correlation with PT of G1-S 
indicator, while others (	𝒌𝟒𝟎 (synthesis rate of Cyclin D through transcription factor c-
𝑘X9X	 𝑘<B	𝑘;8	 𝑘B	 𝑘BB	
𝑘<	 𝑘<	 𝑘9	 𝑘;9	𝑘<9	
𝑘A9	 𝑘8	 𝑘B=	 𝑘X99	
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Myc),	𝒌𝟔𝟎 (dissociation rate of E2F_pRbPP complex through aCycE_Cdk2),	𝒌𝟓𝟎 
(dissociation rate of p27_aCycE_Cdk2 complex),	𝒌𝟗𝟖 (synthesis rate of iCdc25A through 
E2F),	𝒌𝟖𝟖 (activation rate of iCycE_Cdk2 through aCdc25A),	𝒌𝟏𝟎𝟏	(activation rate of 
iCdc25A through aCycE_Cdk2 and aCycA_Cdk2),	𝒌𝟒𝟖 (association rate of p27 and 
CycD_Cdk4),	𝒌𝟕𝟎 (synthesis rate of Cyclin E through transcription factor E2F) and	𝒌𝟐 
(activation rate of ic-Myc through Growth Factor)) have negative correlation. 
The G1-S checkpoint sub-system has also a crucial effect on G1-S transition through its four modules 
(Figure 4.4). As the first module that becomes functional following the presence of Growth Factor, 
Cdk4-Related module controls G1-S transition through its two p27-related parameters, 𝒌𝟒𝟖 and 𝒌𝟒𝟗. 
These two parameters (together with two other p27-related significant parameters,	𝒌𝟓𝟎 and 𝒌𝟓𝟐, 
which are associated with Cdk2-Related module) are correctly identified as effective in our model, 
confirming the findings that showed the importance of p27 repressor in G1-S transition (Chu et al., 
2008). E2F-pRb module, which comes to the picture after activations of Cdk4-Related module, affects 
G1-S transition through E2F-related parameters, 𝒌𝟔𝟎 and 𝒌𝟔𝟒 (Figure 4.4). Parameter 𝒌𝟔𝟒, which 
corresponds to a newly added protein PP1, is identified as one of the most significant parameters in 
our model. PP1 was biologically proven to be a crucial element in the cell cycle system as it 
dephosphorylates Retinoblastoma Protein (pRb) during late Mitosis and early G1 phase (Berndt, 
2002; Nelson et al., 1997; Trinkle-Mulcahy et al., 2003).  
Figure 4.4 Influential parameters, sub-systems and modules on G1-S transition under No DDS. 
Growth Factor sub-system and all the modules of G1-S checkpoint have impact on G1-
S transition. The significant parameters are shown on the corresponding arrows. 
 
During G1 phase, E2F acts as the main transcription factor and directs the cell toward G1-S transition 
by synthesis of some important target proteins including Cyclin E, which in turn stimulates the 
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release of more E2F (E2F is initially in locked mode by association with pRb). The release of E2F is an 
important process as correctly identified by the significant role of 	𝒌𝟔𝟎 (dissociation rate of 
E2F_pRbPP complex through aCycE_Cdk2). Experiments have demonstrated the key role of Tyrosine 
phosphatase Cdc25A as one of the most essential regulators of G1-S checkpoint (through its positive 
feedback loop with aCycE_Cdk2 as activator of iCycE_cdk2) (Blomberg & Hoffmann, 1999; Sexl et al., 
1999). That is why our simulation results show the vital effect of Tyrosine Phosphatase module on 
G1-S transition through three Cdc25A-related parameters, 𝒌𝟗𝟖, 𝒌𝟏𝟎𝟎	and	𝒌𝟏𝟎𝟏 (Figure 4.4). It is 
important to note that other experiments have also suggested that this phosphatase may mediate 
G2-M transition as well (Chen et al., 2003; Mailand et al., 2002; Timofeev et al., 2010). Cdk2-Related 
module, which comprises the reactions that regulate Cyclin E and CycE_Cdk2 complex through 
parameters,	𝒌𝟓𝟎, 𝒌𝟓𝟐, 𝒌𝟕𝟎, 𝒌𝟖𝟑 and 𝒌𝟖𝟖, also shows significant effect on G1-S transition (Figure 4.4).  
The SOMCCA analysis was also conducted for G2-M transition under no DNA damage with PT of 
CycB_Cdk1_Nuc as the indicator of transition. Under this condition, most of the aforementioned 
parameters remain significant and some new parameters are also recognized as significant (the 
corresponding correlation coefficient values of the most significant parameters with respect to PTs of 
G1-S and G2-M indicators are shown in the last row of Table 4.1). The reason is that the cell cycle 
system consists of a sequence of events which are tightly connected to each other and when 
something is wrong in one part (sub-system/module), it directly or indirectly affects the subsequent 
parts as well. In fact, from a high-level point of view, three different sub-systems have impact on G2-
M transition: Growth Factor, G1-S, and G2-M checkpoint sub-systems (Figure 4.5). The newly 
added/identified significant parameters are shown in bold in Figure 4.5.  As shown in Figures 4.4 & 
4.5, the first two sub-systems (Growth Factor and G1-S checkpoint) have more or less the same 
effect on G1-S and G2-M transitions. In fact, parameters	𝒌𝟕𝟔	(synthesis rate of Cyclin A through 
BMyb), 𝒌𝟖𝟎 (association rate of Cyclin A and Cdk2),	𝒌𝟗𝟑	(synthesis rate of iBMyb through E2F) 
and	𝒌𝟗𝟔	(activation rate of NFY through aCycA_Cdk2), which correspond to Cdk2-realated module of 
G1-S checkpoint sub-system, are also found significant for G2-M transition. The reason for this is that 
during S and G2 phases, Cyclin A, which is synthesised through BMyb and NFY, sets the stage for G2-
M transition through its indirect effect on CycB_Cdk1 complex (Chae & Shin, 2011; Joaquin & 
Watson, 2003). Therefore, our simulation results are consistent with experimental findings reported 
on the role Cdk2 function in activating Cdk1 and M phase entry (Hu et al., 2001).  
Cyclin B (which in complex with Cdk1 makes CycB_Cdk1) and Cdc25C are also found to be significant 
through G2-M checkpoint sub-system (through Cdk1-Related and Tyrosine phosphatase modules, 
respectively) which is consistent with biological findings (Boutros et al., 2007; De Souza et al., 2000; 
Lindqvist et al., 2009; Su et al., 2006; Trunnell et al., 2011). Tyrosine phosphatase module stimulates 
the G2-M transition through two parameters, 𝒌𝟏𝟎𝟗	and 𝒌𝟏𝟏𝟐, which correspond to synthesis rate of 
 74 
Cdc25C and activation rate of iCdc25C through aCycB_Cdk1_Cyto and aCycB_Cdk1_Nuc, respectively 
(Figure 4.5). As for the effect of Cdk1 related module, it controls G2-M transition through three Cyclin 
B-related parameters,	𝒌𝟏𝟐𝟑 (synthesis rate of Cyclin B through NFY),	𝒌𝟏𝟐𝟕 (association rate of Cyclin B 
and Cdk1) and	𝒌𝟏𝟑𝟒 (activation rate of iCycB_Cdk1_Cyto through aCdc25C and aCdc25CP_S216). 
Figure 4.5 The most Influential parameters, sub-systems and modules in G2-M transition under 
No DDS. The parameters are shown on the corresponding arrows. The newly found 
significant parameters (in comparison to those found significant for G1-S) are bolded. 
 
The SOMCCA analysis was also conducted on DNA damage condition. In the presence of DNA damage 
(in comparison with No DDS), some other new parameters related to DNA damage sub-system are 
identified and added to the list of significant parameters (see Table 4.1). The newly identified 
significant parameters on both G1-S and G2-M transitions are as follows:	𝒌𝟔 (rate of DNA damage 
repair),	𝒌𝟑𝟏	(degradation rate of p21),	𝒌𝟐𝟐	(synthesis rate of p21 through p53),	𝒌𝟐𝟔 (association rate 
of aCycE_Cdk2 and p21),	𝒌𝟓 (rate of DNA damage signal production),	𝒌𝟗 (activation rate of p53 
through ATM),	𝒌𝟏𝟏	(p53 degradation rate through Mdm2),	𝒌𝟏𝟒 (synthesis rate of Mdm2), and 𝒌𝟏𝟕 
(degradation rate of Mdm2). These simulation results are consistent with experimental findings 
which suggest that following the presence of DNA damage, p53, p21 and Mdm2 (through negative 
feedback with p53) are the key players of cell cycle arrest and DNA damage response (Agarwal et al., 
1995; Carvajal et al., 2005; Vassilev et al., 2004). A summary of significant parameters, sub-systems, 
and modules in different conditions (No DDS, with DDS) for both G1-S and G2-M transitions is 
demonstrated in Table 4.1. Parameters with correlation coefficient value greater than 0.05 are 
considered as significant. As shown in this table, G1-S checkpoint and Growth Factor sub-systems are 
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identified as significant in all conditions. Furthermore, G2-M checkpoint sub-system does not impact 
G1-S transition.  
Table 4.1 List of effective parameters as well as sub-systems and modules for G1-S & G2-M 
transitions with and without DNA damage (italicised modules in columns 3 and 5, 
respectively, indicate the additional modules for DDS compared to No DDS condition 
for G1-S and G2-M shown in columns 2 and 4; and underlined modules in columns 4 
and 5 are additional modules for G2-M compared to G1-S shown in columns 2 and 3). 
The value of the correlation coefficient of parameters with respect to PTs of G1-S and 
G2-M indicators are shown in brackets in the last row next to the corresponding 
parameter. Parameters with correlation coefficient value greater than 0.05 are 

















































































































































































For comparison, we also conducted the same GSA analysis on Iwamoto et al. (2011) model and found 
that the significant parameters in that model are mostly the same as ours, with the exception that in 
our model the parameters related to the two newly added elements c-Myc and PP1 -	𝒌𝟒𝟎 (synthesis 
rate of Cyclin D through transcription factor c-Myc) and 𝒌𝟔𝟒 (rate of dephosphorylation of pRbPPP to 
pRb through PP1) - have become the most significant. These parameters are missing in Iwamoto et 
al. (2011) model. The list of significant parameters from their model is provided in Appendix E. 
 Summary 
In this chapter, we performed Global Sensitivity Analysis (GSA) as a numerical analysis on the 
comprehensive mathematical model (proposed in the previous chapter) to find the most influential 
parameters and functional sub-systems on G1-S and G2-M transitions. To do this, we chose the 
biological indicators for checkpoints (G1-S and G2-M sub-systems) and then developed a Global 
Sensitivity Analysis model called SOMCCA to identify the kinetic parameters with the largest effect on 
the indicators. The analysis results showed that Growth Factor and G1-S signalling sub-systems have 
impact on G1-S and G2-M transitions in all (with or without DNA damage) conditions. In fact, the two 
most significant parameters of the system correspond to two newly added elements in our model 
that shows the importance of newly added proteins for cell cycle modelling. The first element is 
transcription factor c-Myc and its corresponding parameter is 	𝒌𝟒𝟎 (a parameter in the Growth Factor 
signalling sub-system) which is related to synthesis rate of Cyclin D through c-Myc. The second 
significant element is phosphatase PP1 whose related parameter is 𝒌𝟔𝟒 (a parameter in the G1-S 
checkpoint sub-system) which corresponds to the effect of PP1 on pRb (i.e., dephosphorylation rate 
of pRbPPP into Rb by PP1). The other significant parameters in the G1-S checkpoint sub-system are: 
𝒌𝟒𝟗 (a parameter in Cdk4-Related module) which is related to synthesis rate of p27 that inhibits Cyc-
Cdk cell cycle controllers),	𝒌𝟔𝟎 (a parameter in E2F-pRb module) which is related to dissociation rate 
of E2F_pRbPP complex through aCycE_Cdk2 to release E2F),	𝒌𝟓𝟎 (a parameter in Cdk2-Related 
module) which is related to dissociation rate of p27_aCycE_Cdk2 complex to release the cell cycle 
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controller),	𝒌𝟓𝟐 (a parameter in Cdk4-Related module) which is related to association rate of p27 and 
aCycE_Cdk2), 𝒌𝟗𝟖 (a parameter in Tyrosine Phosphatase module) which is related to activation rate 
of iCdc25A through E2F to activate cell cycle controllers. Accordingly, half of these parameters are 
related to p27 (the main Cdk inhibitor) indicating the crucial role it plays in cell cycle. This is in 
agreement with the current hypothesis that the release of p27 from Cyc-Cdk complexes triggers cell 
cycle phase transition (Chu et al., 2008). Results also indicate the importance of initial triggering of 
cell cycle (through Growth Factor signalling), production of two main cell cycle controllers (through 


















Efficiency of Cell Cycle Checkpoints in Detecting Damaged Cells 
In this chapter, we probe deeply into the relationship between DNA damage and cell cycle 
progression and test the biological evidence that G1-S checkpoint is relatively inefficient in arresting 
damaged cells compared to G2-M checkpoint using the comprehensive mathematical model 
presented in Chapter 3. To study the relative efficiency of DNA damage checkpoints, a Checkpoint 
Efficiency Evaluation (CEE) model is developed based on perturbation studies and statistical Type II 
error. In the first section of this chapter, an overview of the chapter is presented. The CEE model is 
presented in the second section of the chapter. Section 5.3 is devoted to the checkpoint efficiency 
based on the number of damaged cells passing G1-S and G2-M checkpoints as normal cells. Section 
5.4 presents the checkpoint efficiency based on the number of healthy cells getting sacrificed as 
damaged cells at G1-S and G2-M checkpoints. Finally, a summary of the chapter is presented in 
Section 5.5. 
 Overview 
Since it has been reported that G1-S checkpoint does not always perform efficiently in detecting 
damaged cells under DNA damage conditions (Beishline & Azizkhan-Clifford, 2014; Di Leonardo et al., 
1994), we conduct a comparative study of the efficiency of G1-S and G2-M checkpoints in their 
response to DNA damage through a proposed Checkpoint Efficiency Evaluation (CEE) model. The CEE 
model is applied to the comprehensive mathematical model presented in Chapter 3 under two 
different scenarios. The first one is regarding the number of damaged cells that pass each of the G1-S 
and G2-M checkpoints as normal cells under DNA damage and different perturbation levels. The 
second scenario is related to the number of healthy cells that get sacrificed as damaged cells at G1-S 
and G2-M checkpoints for different perturbation levels. The results demonstrate that G2-M 
checkpoint is more efficient than G1-S in correctly identifying damaged cells. Moreover, both 
checkpoints are near perfect in passing healthy cells. Biological findings have shown that cancer cells 
relay more on G2-M checkpoint in order to repair their excess DNA damage and avoid Apoptosis as 
their G1-S checkpoint is usually deficient which causes accumulation of mutations (Bucher & Britten, 
2008; Chen et al., 2012). Therefore, having a model that can represent the behaviour of checkpoints 
is beneficial for targeted cancer therapies. New hypotheses can be formulated by scientists to test in 
their lab, such as knocking out G2-M proteins in order to push cancer cells into unscheduled M-phase 
which leads to Apoptosis through mitotic catastrophe.  
 79 
 Checkpoint Efficiency Evaluation Model 
As the scientific aim of systems biology is not only to develop precise and detailed models but also to 
understand the underlying structural and fundamental principles of biological systems, it is important 
to gain deep insights into principles that govern the behaviour of complex systems (Kitano, 2007). 
One of the less investigated aspects of cell cycle checkpoints is the comparison of the efficiency of 
checkpoints in the presence of DNA damage. It has been reported that G1-S checkpoint is relatively 
inefficient compared to G2-M checkpoint in detecting damaged cells  (Beishline & Azizkhan-Clifford, 
2014; Di Leonardo et al., 1994) and therefore, for the first time in cell cycle modelling (to the best of 
our knowledge), we develop a model to investigate the efficiency of checkpoints in capturing 
damaged cells under DNA damage condition. We also test the efficiency of checkpoints in correctly 
identifying healthy cells. We call the model Checkpoint Efficiency Evaluation (CEE) model 
(demonstrated in Figure 5.1).  
As shown in Figure 5.1, the most significant parameters extracted through SOMCCA are identified 
(Step 1) and then perturbed simultaneously in order to simulate real situations that cells may 
confront (within five ranges of ±5%,±10%,	±15%,	±20% and ±30%) and sampled 2000 times for 
each level of perturbation (Step 2). Then, 2000 PTs are calculated for each indicator (Step 3) and the 
Probability Density Function (PDF) of PTs is estimated by normal distribution (Step 4). The procedure 
is repeated for DNA damage condition and the PDF of PTs of the indicators in the presence of DNA 
damage is obtained. Then, using Type II Error with significance level of 10% (Type II Error is the 
probability of accepting a null hypothesis while it is not true (Weiers, 2010)), the damaged cells 
passing each checkpoint as healthy/normal cells are labelled to calculate the efficiency of 
checkpoints in detecting damaged cells passing each checkpoint as healthy cells (Step 5). The 
efficiency of checkpoints in correctly detecting damaged cells is calculated using the number of 
correctly identified damaged cells and the total number of damaged cells (the formula is shown in 
the last step in Figure 5.1). This idea of identifying damaged cells from normal cells is depicted in 
Figure 5.2 for a hypothetical case where five damaged cells pass G1-S checkpoint as normal cells, 
while four out five cells are captured correctly at G2-M checkpoint. Using the CEE model, it is also 
possible to calculate the efficiency of each checkpoint in not arresting healthy cells. To do that, in 
step 5 of the CEE model, the healthy cells arrested at each checkpoint as damaged cells are labelled. 
Then, in step 6, the efficiency of checkpoints in correctly letting the healthy cells pass each 
checkpoint is calculated using the number of identified healthy cells (those healthy cells correctly 




Figure 5.1 Diagram of the Checkpoint Efficiency Evaluation (CEE) Model. The CEE model evaluates 
the performance of checkpoints in correctly identifying cells. Using the significant 
parameters identified through SOMCCA model, the CEE generates a cell population (by 
perturbing the significant parameters within a particular range) for both normal 
(healthy) and damage conditions and then calculates PTs of G1-S and G2-M checkpoint 
indicators for all the cells in the population. Then it draws the probability Density 
Function (PDF) of PTs for normal and damaged conditions for each checkpoint and 
labels the damaged cells passing each checkpoint as healthy cells (to calculate the 
efficiency of checkpoints in correctly identifying/arresting the damaged cells) or 
alternatively labels the healthy cells arrested as damaged at checkpoints (to calculate 
the efficiency of checkpoints in correctly letting the healthy cells pass the checkpoints) 
based on Type II error. Finally, it calculates the efficiency of checkpoints in correctly 
arresting the damaged cells using the number of identified damaged cells (those 
damaged cells correctly classified as damaged by the checkpoint) and the total number 
of damaged cells. To calculate the efficiency of checkpoints in correctly letting the 
healthy cells pass checkpoints, the number of identified healthy cells (those healthy 
cells correctly classified as healthy by the checkpoint) and the total number of healthy 
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Figure 5.2 A hypothetical example of PDF of PT of Normal and Damaged cells for G1-S (left figure) 
and G2-M (right figure) checkpoints showing how Type II Error is used to estimate the 
checkpoint efficiency. The figure shows a hypothetical case of a number of damaged 
cells (red dots) that pass each checkpoint as normal cells (the vertical line shows the 
significance level, 10%). In this example, G1-S checkpoint could not identify five 
damaged cells while G2-M checkpoint identified all but 1 of those damaged cells that 
escape G1-S. In this hypothetical case, G2-M checkpoint performs better than G1-S in 
detecting damaged cells. The concept of healthy cells arrested at each checkpoint as 
damaged cells can be shown with a similar example but in the opposite direction. 
 
 Checkpoint Efficiency Based on the Number of Damaged Cells Passing 
Checkpoints as Healthy Cells 
The simulation results for the efficiency of G1-S and G2-M checkpoints under DNA damage and 
different perturbation ranges are presented in Table 5.1. For this analysis, PDFs of PTs for normal and 
damaged cells for both G1-S and G2-M checkpoints similar to those in Figure 5.2 were developed. 
From these two tests, we first assessed the number of damaged cells that escaped the two 
checkpoints. Then, the damaged cells (i.e., the corresponding parameter vectors) that escaped G2-M 
checkpoint were compared with those passing G1-S to determine the proportion of the latter that 
also escapes G2-M. For clarity, we only show the number of cells passing G1-S and the portion of 
these cells that also escapes G2-M.  
As demonstrated in Table 5.1, G2-M checkpoint is capable of identifying and arresting a greater 
percentage of damaged cells than G1-S. For example, under ±5% perturbation, 543 out of 2000 
damaged cells pass G1-S checkpoint as healthy cells and then only 78 out of these 543 damaged cells 
are not caught at G2-M checkpoint. Therefore, the efficiency of G1-S is 2000−543
2000
= 72.85%, while the 
efficiency of G2-M is 543−78
543
= 85.63% (the efficiency of G2-M is higher than that of G1-S). The rate at 
which damage cells pass the combined checkpoint system as healthy cells is 3.9% (78/2000) (False 
Negative rate) making the whole system efficiency 2000−78
2000
= 96.1% (True Positive rate). 
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Table 5.1 Efficiency of checkpoints based on the number of damaged cells that pass each of the 
G1-S and G2-M checkpoints as normal cells under DNA damage and different 
perturbation levels (the total number of damaged cells is 2000). [For example, for ±5% 
perturbation, the number of damaged cells passing G1-S as healthy is shown in the 
second column (i.e., 543 out of 2000); the number of these damaged cells that are not 
caught at G2-M is in the fourth column (i.e., 78 out of 543); therefore, the efficiency of 
G1-S and G2-M are 𝟐𝟎𝟎𝟎:𝟓𝟒𝟑
𝟐𝟎𝟎𝟎
= 𝟕𝟐.𝟖𝟓% and 𝟓𝟒𝟑:𝟕𝟖
𝟓𝟒𝟑
= 𝟖𝟓.𝟔𝟑%, respectively. The 












Portion of G1-S 
Escaped 
Damaged Cells 












±5% 543 72.85 78 85.63 96.1 
±10% 1270 36.5 741 41.65 62.95 
±15% 1478 26.1 1049 29.02 47.55 
±20% 1586 20.7 1208 23.83 39.6 
±30% 1694 15.3 1427 15.76 28.65 
 
 Checkpoint Efficiency Based on the Number of Healthy Cells Getting 
Sacrificed as Damaged Cells 
While it is more important for damaged cells to be stopped at checkpoints, it is not beneficial to 
sacrifice too many healthy cells. Therefore, we also conducted another analysis to study checkpoint 
efficiency in correctly recognising healthy cells. Here, we allowed 2000 healthy cells to go through 
the checkpoints and counted the number of healthy cells incorrectly identified as damaged and 
arrested at checkpoints. The results are provided in Table 5.2 which shows that both checkpoints are 
highly efficient and near perfect in recognising healthy cells at ±5% perturbation (99.15% for G1-S 
and 99.49% for G2-M). As the perturbation level increases, both checkpoints drop in efficiency in 
recognising healthy cells but G2-M not only remains more efficient but also is more robust against 




Table 5.2 Efficiency of checkpoint based on the number of healthy cells that get sacrificed as 
damaged cells at G1-S and G2-M checkpoints for different perturbation levels (the 
total number of healthy cells is 2000). [For example, for ± 5% perturbation, the 
number of healthy cells incorrectly identified and arrested at G1-S is shown in the 
second column (i.e., 17 out of 2000 are sacrificed); the number of incorrectly arrested 
cells at G2-M is shown in the 4th column (i.e., 2000-17=1983 healthy cells go to G2-M 
checkpoint and just 10 cells (10 out of 1983) get incorrectly arrested as damaged). 
Therefore, the efficiency of G1-S and G2-M is 𝟐𝟎𝟎𝟎:𝟏𝟕
𝟐𝟎𝟎𝟎
= 𝟗𝟗.𝟏𝟓% and 𝟏𝟗𝟖𝟑:𝟏𝟎
𝟏𝟗𝟖𝟑
=













Portion of G1-S 
Released Healthy 















±5% 17 99.15 10 99.49 98.65 
±10% 601 69.95 185 86.77 60.7 
±15% 1064 46.8 372 60.25 28.2 
±20% 1329 33.55 358 46.64 15.65 
±30% 1706 14.7 213 27.55 4.05 
 
 Summary  
we conducted numerical and statistical analyses to assess the relative efficiency of checkpoints in 
arresting damaged cells as some biological findings indicate that G1-S is less efficient than G2-M 
checkpoint. In this regard, the checkpoint efficiency analysis model called CEE model was developed 
to determine the efficiency of the two cell cycle checkpoints in arresting damaged cells. Using this 
model, we were able to quantify the number of damaged cells that passed each checkpoint as 
healthy. The simulation results showed that in the presence of DNA damage and under different 
parameter perturbations, the efficiency of G2-M checkpoint was always higher than that of G1-S. We 
also analysed the potential of the two checkpoints to sacrifice normal cells as damaged and the 
results revealed that they are highly efficient in correctly recognising normal cells. The simulation 
results under ±5% parameter perturbation showed that cell cycle is about 96% efficient in arresting 
damaged cells with G2-M checkpoint being more efficient than G1-S. Further, both checkpoint 
systems are near perfect (98.6%) in passing healthy cells (under ±5% parameter perturbation). 
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Therefore, this study has shown the efficacy of the proposed systems approach to gain a better 
understanding of different aspects of mammalian cell cycle system separately and as an integrated 
system that will open new doors for further experiments and also be useful in investigating targeted 





Towards Abstraction of Computational Modelling of Mammalian 
Cell Cycle: A Petri Net Approach 
In this chapter, an abstract Petri Net-based model of the mammalian cell cycle is developed which is 
extracted from the comprehensive mathematical model presented in Chapter 3. Therefore, a model 
with 61 ODEs and 148 parameters is downsized to just four equations and 31 parameters. An 
overview of the chapter is presented in Section 6.1. The details of the most significant components 
used in the abstract model are presented in Section 6.2. Section 6.3 is devoted to the abstract model 
development through Petri Nets (in this section, the key elements of the model are described in Sub-
section 6.3.1. The next three sub-sections are devoted to High-level, Stage-level, and Low-level views 
of Multi-Level Hybrid Petri Net (MLHPN) model, respectively). In Section 6.4, the kinetics of the 
model are presented. The model Results are presented in Section 6.5 and the analysis of Checkpoint 
Efficiency Evaluation (CEE) on the MLHPN model is given in Section 6.6. Finally, a summary of the 
chapter is presented in Section 6.7. 
 Overview 
In Chapter 3, we proposed a comprehensive mathematical model of mammalian cell cycle control 
system and showed that the dynamical behaviour of the model is consistent with biological findings. 
Now, it is of interest to develop an abstract/minimised model of mammalian cell cycle in a way that 
the main characteristics (dynamics of the previously identified key players) and system response (G1-
S and G2-M transitions as well as response to DNA damage) remain intact. To do this, in this chapter, 
we propose a novel abstract systems approach to modelling mammalian cell cycle to gain deep 
insights into how it coordinates such an intricate system of interactions in a robust and timely 
manner. It involves incorporation of the most essential controllers of mammalian cell cycle (as 
primary elements) and regulators of these controllers (as secondary elements) at different levels of 
abstraction. Furthermore, the concept of cell cycle sub-systems is incorporated in this model same as 
the one introduced in Chapter 3 for the comprehensive model where cell cycle system was presented 
through four inter-connecting sub-systems (Growth Factor signalling, G1-S and G2-M checkpoints, 
and DNA damage signalling).  
The MLHPN model, which is a graphical Petri Net-based model, is proposed to model the mammalian 
cell cycle regulation system. Intuitive nature of the MLHPN makes it possible to present biological 
properties and processes with different time scales through a combination of continuous and 
discrete paradigms at different levels of abstraction. The goal is to gain a deep understanding of the 
 86 
mechanism of mammalian cell cycle regulation in the presence of Growth Factor with and without 
DNA damage. The MLHPN model has just four equations and 31 parameters while the 
comprehensive mathematical model presented in Chapter 3 had 61 ODEs and 148 parameters. 
Further analysis is done on the MLHPN using Checkpoint Efficiency Evaluation (CEE) model to 
investigate the efficiency of checkpoints based on detecting either damaged cells incorrectly passing 
checkpoints as healthy cells or healthy cells incorrectly arrested at checkpoints as damaged cells. The 
results of the CEE analysis on the MLHPN model is consistent with those of the comprehensive 
mathematical model presented in Chapter 5.   
 Identification of the Most Significant Components 
The first step towards model abstraction is to identify the core components with the highest impact 
on system response (G1-S and G2-M transitions). In Chapter 4, we identified the most effective 
parameters using the “Self-Organizing Map with Correlation Coefficient Analysis” (SOMCCA) model. 
Therefore, it is possible to identify the most significant components in the cell cycle system. These 
components are presented in Table 6.1 categorised based on the component type and sub-system. 
Table 6.1 The most significant components of mammalian cell cycle based on component type 
and corresponding sub-system. 
Components Component Type Sub-System 
c-Myc 
Transcription Factor 
Growth Factor signalling 
E2F G1-S signalling 
NFY G1-S & G2-M signalling 




CycE_Cdk2 G1-S signalling 
CycA_Cdk2 G1-S signalling 














APC_Cdc20 G2-M signalling 
APC_Cdh1 G2-M signalling 
Chk2 Kinase DNA damage signalling 
 
The components in Table 6.1 mainly correspond to production and degradation of Cyc_Cdks which 
have been known as key players of mammalian cell cycle control system (Berridge, 2014; Malumbres 
& Barbacid, 2009; Morgan, 1997; Ruddon, 2007; Satyanarayana & Kaldis, 2009). In fact, it is periodic 
synthesis and degradation of cyclins that regulates activity of Cdks in a timely manner (Malumbres & 
Barbacid, 2009). Therefore, whenever we talk about the effect of cyclins on other species here in this 
chapter, we mean the effect of Cyc_Cdk complexes. It should be noted that although PP1 was 
identified as one of the significant components of the comprehensive model in Chapter 3, since it 
doesn’t have a direct effect on Cyc_Cdks and it mainly affects E2F through pRb (and we already have 
E2F in the abstract model which represents the transcription factor E2F together with the total effect 
of all the absent elements on E2F), it is not included in the abstract model. Having the most 
significant players of the system, we develop a schematic of the abstract model (Figure 6.1). As 
shown in Figure 6.1, at the beginning of cell cycle, transcription factor c-Myc becomes activated 
(within Growth Factor signalling sub-system following the presence of Growth Factor) which 
eventually stimulates the synthesis of Cyclin D (Adhikary & Eilers, 2005; Alberts et al., 2014; Morgan, 
2007). Initiation of CycD_Cdk4 production is an indication of G0-G1 transition (START) and cell cycle 
initiation (Adhikary & Eilers, 2005). CycD_Cdk4, in turn, stimulates production of Cyclin E (next cyclin 
in the series of cyclins) through activation of transcription factor E2F (Ji & Dyson, 2010). Tyrosine 
phosphatase Cdc25A is also necessary for activation of CycE_Cdk2 (and CycA_Cdk2) that eventually 
results in G1-S transition (Boutros et al., 2007; Donzelli & Draetta, 2003; Karlsson-Rosenthal & Millar, 
2006; Kristjansdottir & Rudolph, 2004). These active Cyc_Cdks lead to phosphorylation and SCF-
mediated degradation of p27 (Chu et al., 2008). 
Transcription factor E2F also induces synthesis of next Cyclin, Cyclin A. Another transcription factor 
NFY also triggers the synthesis of Cyclin A and Cyclin B (Chae & Shin, 2011). Cyclin B has a key role at 
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G2-M transition as well as during M phase where its degradation through two ubiquitin ligases 
(APC_Cdc20 and APC_Cdh1) triggers the M-G1 transition event (“END” of one cell cycle). It is 
important to note that SCF ubiquitin ligase degrades Cyclin D and Cyclin E, while APC ubiquitin ligases 
degrade all cyclins excluding Cyclin E (Nakayama & Nakayama, 2005; Peters, 2002). In the case of 
DNA damage (Double-Strand Breaks (DSBs)), the key controllers of DNA damage signalling (p53, p21, 
and Chk2) trigger cell cycle arrest through their interactions with different Cyc_Cdks (Beishline & 
Azizkhan-Clifford, 2014; Meek, 2004; Morgan, 2007; Nyberg et al., 2002; Sancar et al., 2004).  
 
Figure 6.1 A schematic of the most significant components of mammalian cell cycle categorized 
under different sub-systems, and corresponding effects on ordered sequence of cell 
cycle transitions. 
 
 Abstract Cell Cycle Model Development: A Petri Net Approach 
We develop an abstract model based on the most significant identified components under different 
cell cycle sub-systems (the Growth Factor, G1-S, G2-M checkpoints, and DNA damage sub-systems). 
Since synthesis and degradation of cyclins are slow reactions but activation and inactivation of 
regulators of cyclins (transcription factors, ubiquitin ligases and Tyrosine Phosphatases) are by far 
faster, a hybrid modelling approach will be implemented. In this hybrid paradigm, we incorporate 
deterministic continuous (for slow reactions, such as synthesis/degradation of Cyc_Cdks) and 
discrete (for fast biochemical reactions, such as activation/inactivation) modelling schemes. We 
adopt Petri Net (PN) modelling approach to present this hybrid modelling in the most intuitive way. 
Growth Factor Signalling Sub-System 
END Start G2-M Transition 
G1-S Signalling Sub-System 
 
CycD_Cdk4 p27 E2F Cdc25A 
SCF CycE_Cdk2 CycA_Cdk2 NFY 










Moreover, to further extend our hybrid PN in terms of granularity, a multi-level extension is 
implemented and added to hybrid PN scheme. Thus, this Multi-Level Hybrid Petri Net (MLHPN) 
model is able to describe the whole mammalian cell cycle control system in an abstract intuitive yet 
comprehensive manner at three different levels of abstraction (High, Low, and Stage-levels). At High-
level of abstraction, the focus is on Cyc_Cdks as main controllers of the system. At Low-level, the 
regulators of cyclins are investigated. And the focus of Stage-level is on transition between different 
cell cycle stages/phases and the corresponding impact of Cyc_Cdks on them. 
6.3.1 Key Elements of the MLHPN Model 
Over the recent years, PN-based modelling started to be implemented for modelling biological 
networks and cell cycle, in particular (Fujita et al., 2004; Gilbert & Heiner, 2006; Grunwald et al., 
2008; Hardy & Robillard, 2004; Herajy & Heiner, 2012; Herajy et al., 2013; Liu et al., 2012; Matsui et 
al., 2004; Matsuno et al., 2003; Mura & Csikász-Nagy, 2008; Windhager & Zimmer, 2008). Among all 
these models, Hybrid Petri Net has been more promising due to its ability to represent different 
time-scales which suits the nature of cell cycle system. As a Petri Net-based model, the MLHPN 
comprises four key elements: Places, Transitions, Arcs, and Marking (shown in Table 6.2). Places 
represent species (such as proteins), while transitions indicate biochemical reactions. Arcs, on the 
other hand, denote the type of interaction between species and carry numbers (thresholds) that 
correspond to stoichiometric coefficients. Marking is used to represent the value of places. If a place 
is discrete, the marking is in the form of tokens, whereas, the marking for a continuous place is 
expressed as a real number. A list of elements utilized in the MLHPN model is shown in Table 6.2.  
Table 6.2 Elements used in the proposed model. 
Discrete Delayed transitions are fired after a pre-defined delay if the markings of their pre-places (the 
places that enter into a transition) are more than the corresponding arcs’ thresholds. However, 
continuous transitions are fired continuously as long as the marking of their pre-places is non-zero. 





















elements is that they appear at High-level of abstraction, while the elements inside them appear at 
Low-level. Generally, a macro place represents a place-bounded set of elements, whereas a macro 
transition signifies a set of transition-bounded elements. Logical elements are also utilised to 
represent a particular node (place or transition) in different reactions in a model and they are 
represented in grey colour (see Table 6.2). Standard arcs denote regular biochemical reactions with 
corresponding stoichiometric coefficients. Read arcs are used to represent reactions in which the 
marking is not consumed, such as enzymatic reactions, and a transition with an inhibitory arc can 
take place only if the marking of the corresponding pre-place is less than the arc’s threshold (Blätke 
et al., 2011). For a more detailed description of Petri Nets, the reader is referred to the book written 
by (Koch et al., 2010). It should be noted that the rules for firing transitions, thresholds of arcs and 
transition delays are intuitively perceived from the model figures throughout this chapter. 
Furthermore, the values of the model parameters, the initial values of places and the definition of 
transitions (together with firing rule for each transition) are provided in Appendices F, G, and H, 
respectively (in Tables F. 1, G. 1 and H.1, respectively). In the next three sub-sections, we explain the 
details of three different levels of abstraction. 
6.3.2 High-level of Abstraction  
The High-level view of the MLHPN presents a big picture of the model in which the control system is 
based on an ordered sequence of synthesis and degradation of Cyc_Cdks (Figure 6.2 - the details of 
the elements inside each macro elements are presented in Section 6.3.4). As shown in Figure 6.2, 
following the presence of Growth Factor, first, the Growth Factor sub-system comes to the picture 
where G0_G1_Activation macro transition (this macro transition centres around G0_G1_TF which 
refers to transcription factor c-Myc) triggers the production of CycD_Cdk4 through continuous 
transition T1 (see details in Figure 6.4). Then, as a part of G1-S sub-system, CycD_Cdk4 interacts with 
a macro transition called G1_S_TF_Activation (mainly associated with G1_S_TF, transcription factor 
E2F). This macro transition, in turn, stimulates the synthesis of CycE_Cdk2 and CycA_Cdk2. Then, G2-
M sub-system comes to the picture where CycA_Cdk2 interacts with the last macro transition, 
G2_M_TF_Activation (this macro transition centres around G2_M_TF which refers to transcription 
factors NFY and b-Myb), which encompasses a set of elements that results in synthesis of CycB_Cdk1 
& CycA_Cdk2 itself. The degradation of Cyc_Cdks, on the other hand, is mediated through macro 
places UBQ_D, UBQ_E, UBQ_A and UBQ_B where these macro places are associated with a set of 
elements mediating the degradation of CycD_Cdk4, CycE_Cdk2, CycA_Cdk2 and CycB_Cdk1, 
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As shown in Figure 6.2, The relationship between p27 and CycD_Cdk4, CycE_Cdk2 and CycA_Cdk2 
has been presented through p27 macro place where its effect on CycD_Cdk4 is activation (by an 
activating effect on G1_S_Activation macro transition) while the corresponding effect on CycE_Cdk2 
and CycA_Cdk2 is towards inhibiting their activation (through inhibiting G1_S_Activation macro 
transition). Furthermore, as shown in Figure 6.2, Cdc25A macro place represents the positive impact 
of Cdc25A on activation of CycE_Cdk2 and CycA_Cdk2 while Cdc25C macro place demonstrates the 
positive effect of Cdc25C on activation of CycB_Cdk1. Thus, these two macro places have crucial 
effect on G1-S and G2-M transitions that will be explained in detail in Section 6.3.4. Another crucial 
sub-system shown in Figure 6.2 is DNA damage which comprises a macro place called DNA_Damage. 
This macro place includes the key controllers of DNA damage signalling, such as p53, p21 and Chk2. 
The effect of this macro place on three other sub-systems is as follows: it has positive effect on 
Growth Factor sub-system because p21 can eventually activate CycD_Cdk4; on the other hand, the 
effect of this macro place on G1-S and G2-M sub-systems is inhibitory where the DNA damage 
controllers directly/indirectly suppress the activity of CycE_Cdk2, CycA_Cdk2, and CycB_Cdk1.  
6.3.3 Stage-level of Abstraction (Temporal Progression) 
At the stage-level, the different stages (and sub-stages) of mammalian cell cycle and the 
corresponding impact of different Cyc_Cdks on temporal progression of cell cycle are modelled. The 
important stages in mammalian cell cycle (Early_G1, Mid_G1, Late_G1, S, G2, Late_G2, Prophase, 
Metaphase, Anaphase, and Telophase) are modelled as discrete places (as shown in Figure 6.3). The 
transition between stages is either controlled by the level of Cyc_Cdks or takes place after a specific 
delay. Some details, such as duration of phases and sub-phases, are adopted from an article 
published by Singhania et al. (2011) in which flow cytometry data of cyclin levels have been utilised 
for model development. 
First, the system is assumed to be in stationary stage G0 which we call Early_G1. Then following the 
presence of Growth Factor (GF), Sensing_GF transition is fired and the state of the system is changed 
to Mid_G1 (Figure 6.3). In this stage, G0_G1_TF (mainly corresponds to transcription factor c-Myc) 
becomes activated and induces the synthesis of Cyclin D, which eventually leads to an increase in 
concentration of CycD_Cdk4. When the level of CycD_Cdk4 passes a threshold, G1_S_TF (mainly 
associated with transcription factor E2F) becomes activated and stimulates synthesis of some target 
proteins including Cyclin E & Cyclin A (this is represented by R_Point transition). The increase in the 
level of CycE_Cdk2 and CycA_Cdk2 sets the stage for beginning of DNA replication process. Hence, 
the level of CycE_Cdk2 is an indicator of transition from G1 to S which alters the system state from 
Late_G1 to S (Figure 6.3).  
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Figure 6.3 Stage-level view of the MLHPN model. It is assumed that at the beginning, the system 
is in G0 or Early_G1 state. The black squares demonstrate discrete transitions while 
the circles represent discrete/continuous places. For example, the cell cycle state 
switches from Late_G1 phase (modelled by a discrete place) to S phase (also modelled 
as a discrete place) through discrete transition G1_S when the level of continuous 
place CycE_Cdk2 is more than a threshold (8.5 simulation time units). The grey 
elements (places/transitions) are logical elements which may appear somewhere else 
in the model (it may be at the same level or at another level of abstraction). The 
weights for the arcs whose weight value is not equal to one are shown in the figure. 
For instance, the time it takes for the cell cycle to perform DNA replication (which 
happens during S phase) is assumed to be seven hours shown under S_G2 discrete 
transition in the figure. 
 
DNA replication happens during S phase and it is assumed that this process takes around seven hours 
Singhania et al. (2011). Afterwards, S_G2 transition is fired and system state changes from S to G2. 
CycA_Cdk2 triggers the activation of G2_M_TF (transcription factors NFY and b-Myb) whose 
activation stimulates further synthesis of CycA_Cdk2 as well as synthesis of CycB_Cdk1. The next 
transition is G2_M transition whose firing is controlled by CycB_Cdk1. It is important to emphasize 
that the transitions between M phase events (Prophase, Metaphase, Anaphase, and Telophase) 
occur according to some pre-defined delays adopted from Singhania et al. (2011). As seen in Figure 
6.3, The effect of CycB_Cdk1 on G2_M transition is mediated through a read arc because this 
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transition is fired if the level of CycB_Cdk1 becomes higher than a threshold (5.6 simulation time 
units). On the other hand, CycB_Cdk1 impacts the last cell cycle transition (M_G1) through an 
inhibitory arc as this transition takes place if the concentration of CycB_Cdk1 falls down below 
another threshold (0.15 simulation time units). 
6.3.4 Low-level of Abstraction  
At low-level of abstraction, the elements inside all macro places and transitions will be described in 
detail and categorised based on the sub-system they belong to. The first sub-system is Growth Factor 
sub-system which includes G0_G1_Activation macro transition (will be explained in Growth Factor 
Sub-System section). The second sub-system (G1-S checkpoint) comprises G1_S_Activation macro 
transition as well as p27, Cdc25A, UBQ_D, UBQ_E, and UBQ_A macro places (will be described in G1-
S Sub-System section). The third sub-system is G2-M checkpoint which includes G2_M_Activation 
macro transition as well as Cdc25C, and UBQ_B macro places (will be presented in G2-M Sub-System 
section). The last sub-system is DNA damage which includes DNA damage macro place (will be 
described in DNA Damage Sub-System section). It should be noted that in the next sub-sections, 
continuous transitions are presented with capital letter (i.e. T1) while discrete transitions are shown 
with lower-case letters (i.e. t1_1).   
Growth Factor Sub-System 
As shown in Figure 6.4, the Growth Factor sub-system comprises one macro transition 
(G0_G1_Activation) whose constituting elements will be explained in this section.  
Figure 6.4 Growth Factor Sub-System (inside dashed green rectangle) which includes GF as a 
discrete place and G0_G1_Activation macro transition. The connections between this 
sub-system and other cell cycle sub-systems have already been demonstrated in 
Figure 6.2.   
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G0_G1_Activation Macro Transition 
As described in Chapter 3, the Growth Factor signalling pathway comprises MAPK signalling cascade 
that eventually results in activation of G0_G1_TF, which in turn induces the synthesis of Cyclin D and 
starts the cell cycle engine (Blain, 2008; Pardee, 1989). The first state of the system is that Growth 
Factor is available and G0_G1_TF is inactive (shown as iG0_G1_TF in Figure 6.5). G0_G1_Activation 
Macro Transition is the main part of Growth Factor signalling sub-system in the MLHPN model in 
which the existence of Growth Factor (GF), which is modelled as a discrete place, triggers the firing of 
discrete transition t1_1 (through a read arc) that leads to activation of G0_G1_TF. In other words, 
Growth Factor signal stimulates the activation of transcription factor required for cell cycle start. 
Then active G0_G1_TF (shown as aG0_G1_TF in Figure 6.5) induces the synthesis of Cyclin D through 
continuous transition T1. In the absence of GF, discrete transition t1_2 is fired (through an inhibitory 
arc) and G0_G1_TF becomes inactive again (Figure 6.5). 
Figure 6.5 Elements of G0_G1_Activation macro transition as the main part of Growth Factor 
signalling sub-system. Active and inactive forms of transcription factor c-Myc are 
presented as aG0_G1_TF and iG0_G1_TF, respectively. At the beginning (initial state), 
Growth Factor (GF) is present and G0_G1_TF is inactive. Following the presence of GF, 
G0_G1_TF becomes active through discrete transition t1_1 and aG0_G1_TF, in turn, 
triggers the synthesis of CycD_Cdk4 through continuous transition T1. The absence of 
GF results in inactivation of G0_G1_TF through discrete transition t1_2. 
 
G1_S Sub-System 
As shown in Figure 6.6, the G1-S sub-system comprises one macro transition (G1_S_Activation), five 
macro places (UBQ_D, UBQ_E, UBQ_A, p27 and Cdc25A), three continuous places (CycD_Cdk4, 
CycE_Cdk2 and CycA_Cdk2) and three continuous transitions (T2, T3 and T4). The constituting 
elements of macro places/transitions will be explained in this section. 
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Figure 6.6 G1-S Sub-System (inside dashed brown enclosure) which includes G1_S_Activation 
macro transition, five macro places (UBQ_D, UBQ_E, UBQ_A, p27 and Cdc25A), three 
continuous places (for CycD_Cdk4, CycE_Cdk2 and CycA_Cdk2) and three continues 
transitions associated with degradation of Cyc_Cdks. The connections between this 
sub-system and other cell cycle sub-systems have already been demonstrated in 
Figure 6.2. 
 
UBQ_D Macro Place 
As a part of G1-S sub-system, UBQ_D macro place corresponds to the ubiquitination process of Cyclin 
D (CycD_Cdk4) through continuous transition T2 (as shown in Figure 6.7). As described in Chapter 3, 
Figure 6.7 Elements of UBQ_D macro place which is a part of G1-S sub-system. This macro place 




SCF and APC_Cdc20 are ubiquitin ligases that induce degradation of Cyclin D. Similar to the 
assumption made by Singhania et al. (2011), we distinguish between the activity of APC_Cdc20 
towards Cyclin A (called APC_Cdc20A - active from late G2 until the end of cell cycle) and Cyclin B 
(called APC_Cdc20B – active throughout M phase). It is also assumed that both APC_Cdc20 types 
affect Cyclin D degradation. 
G1_S_Activation Macro Transition 
G1_S_Activation macro transition is one of the major parts of G1-S sub-system that centres around 
transcription factor E2F (here called G1_S_TF). At the beginning of cell cycle, G1_S_TF is inactive 
because a tumour suppressor protein, called Retinoblastoma protein (pRb – not shown in the 
abstract model) binds to it and inhibits its activation. At late G1, G1_S_TF is released from pRb and 
becomes activated through phosphorylation by CycD_Cdk4 and CycE_Cdk2 (Sherr & McCormick, 
2002; Trimarchi & Lees, 2002). This process is presented through discrete transition t6_1 (Figure 6.8) 
where the weight values of CycD_Cdk4 and CycE_Cdk2 are 4.25 and 0.4, respectively (the weights are 
estimated so that the model dynamics are qualitatively similar to biological findings). Then active 
G1_S_TF (aG1_S_TF) triggers the production of CycE_Cdk2 and CycA_Cdk2 (Deckbar et al., 2011; 
Helin, 1998). This is modelled as continuous transitions T6 and T7, respectively. Finally, G1_S_TF 
becomes inactivated by CycA_Cdk2 (through discrete transition t6_2) when the level of CycA_Cdk2 
passes a particular threshold (2.3 simulation time units) (Ji & Dyson, 2010). It should be noted that in 
all figures throughout this chapter, the weight values equal to one are not shown. 
 
Figure 6.8 Elements of G1_S_Activation macro transition as a part of G1-S sub-system. Active and 
inactive G1_S_TF are demonstrated as aG1_S_TF and iG1_S_TF, respectively. The 




p27 Macro Place 
One of the parts of G1-S sub-system that has impact on the activity of Cyc_Cdks is p27 macro place 
which is mainly associated with Cyclin-Dependent Kinase Inhibitor p27. From the beginning of cell 
cycle, p27 is active (modelled through discrete transition t3_1 in Figure 6.9) and affects the activity of 
CycD_Cdk4, CycE_Cdk2, CycA_Cdk2 (Chu et al., 2008). Since in the abstract model Cyc_Cdks are 
presented as active components, the effect of p27 is modelled on production of these components. 
CycD_Cdk4 is further activated by p27 while CycE_Cdk2 and CycA_Cdk2 are inhibited following 
binding to p27 (the full description was presented in Chapter 3). The effect of p27 on CycD_Cdk4, 
CycE_Cdk2, and CycA_Cdk2 is modelled through continuous transitions T1, T6 and T7, respectively. 
When cell cycle enters Late_G1 phase, p27 becomes inactivated again (this is modelled through 
discrete transition t3_2) (Chu et al., 2008).  
Figure 6.9 Elements of p27 macro place as a part of G1-S sub-system. Active and inactive p27 are 
shown as ap27 and ip27, respectively. 
 
Cdc25A  Macro Place 
Cdc25A is a Tyrosine phosphatase which has a key role in activating CycE_Cdk2 and CycA_Cdk2 
(Boutros et al., 2007; Kiyokawa & Ray, 2008; Kristjansdottir & Rudolph, 2004). The activation of these 
two Cyc_Cdks is modelled through continuous transitions T6 and T7 (as shown in Figure 6.10). 
Through positive feedback loops, CycE_Cdk2 and CycA_Cdk2 stimulate activation of Cdc25A at late 
G1 which is modelled through discrete transition t6_3 (Bollen & Beullens, 2002; Donzelli & Draetta, 




Figure 6.10 Elements of Cdc25A macro place as a part of G1-S sub-system. Active and inactive 
Cdc25A are presented as aCdc25A and iCdc25A, respectively. The weights for the arcs 
whose weight value is other than one are shown in the figure. 
 
UBQ_E Macro Place 
UBQ_E macro place models the process of activation/inactivation of SCF, which has the primary role 
in degradation of CycE_Cdk2 (Cardozo & Pagano, 2004; Nakayama & Nakayama, 2005). The ubiquitin 
ligase SCF becomes activated upon S phase entry (modelled through discrete transition t3_3) and 
then active SCF (aSCF) induces the degradation of CycE_Cdk2 through continuous transition T3 
(Figure 6.11). At the next cell cycle, SCF becomes inactive again from Mid G1 (through discrete 
transition t3_4). 
Figure 6.11 Elements of UBQ_E macro place as a part of G1-S sub-system. Active and inactive SCF 
are demonstrated as aSCF and iSCF, respectively. 
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UBQ_A Macro Place 
As demonstrated in Figure 6.12, UBQ_A macro place models degradation of CycA_Cdk2 through two 
ubiquitin ligases APC_Cdc20A and APC_Cdh1 (Mateo et al., 2009). APC_Cdc20A becomes activated 
when the level of CycB_Cdk1 passes a threshold (3.9 simulation time units) which is modelled 
through discrete transition t4_3. Later in M phase (at Telophase), APC_Cdh1 also becomes activated 
(through discrete transition t4_1) and induces the full degradation of CycA_Cdk2 (via continuous 
transition T4). 
Figure 6.12 Elements of UBQ_A macro place as a part of G1-S sub-system. Active and inactive 
APC_Cdc20A are shown as aAPC_Cdc20A and iAPC_Cdc20A, respectively. The same 
prefixes are used for APC_Cdh1. The weights for the arcs whose weight value is other 
than one are shown in the figure. 
 
G2-M Sub-System 
As shown in Figure 6.13, the G2-M sub-system comprises G2_M_Activation macro transition, UBQ_B 
and Cdc25C macro places, CycB_Cdk1 continuous place and a continues transition associated with 
degradation of CycB_Cdk1. The constituting elements of macro places/transitions will be explained in 
this section. 
G2_M _Activation Macro Transition 
G2_M_Activation macro transition is one of the main players of G2-M sub-system. As illustrated in 
Figure 6.14, when the level of CycA_Cdk2 increased sufficiently (at the end of S phase), G2_M_TF 
becomes activated (shown as discrete transition t7_1) and triggers production of more CycA_Cdk2 
and CycB_Cdk1 (Transition T7 and T8, respectively) (Chae et al., 2011; Chae et al., 2004; Fung & 
Poon, 2005; Joaquin & Watson, 2003; Zhu et al., 2004). Therefore, the increased level of CycB_Cdk1 
results in G2-M transition (Fung & Poon, 2005). At the end of cell cycle (Telophase), G2_M_TF 
becomes inactivated again through discrete transitions t7_2 (Figure 6.14). 
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Figure 6.13 G2-M Sub-System (inside dashed purple enclosure) which includes G2_M_Activation 
macro transition, two macro places (UBQ_B and Cdc25C), one continuous place (for 
CycB_Cdk1) and one continues transition associated with degradation of CycB_Cdk1. 
The connections between this sub-system and other cell cycle sub-systems have 
already been demonstrated in Figure 6.2. 
 
Figure 6.14 Elements of G2_M_Activation macro transition as a part of G2-M sub-system. Active 
and inactive G2_M_TF are demonstrated as aG2_M_TF and iG2_M_TF, respectively. 




Cdc25C Macro Place 
As described in Chapter 3, at the beginning of M phase (prophase), CycB_Cdk1 stimulates the 
activation of Cdc25C and then Cdc25C leads to formation of more CycB_Cdk1 through a positive 
feedback loop (Bollen & Beullens, 2002; Boutros et al., 2007; Goulev & Charvin, 2011; Perry & 
Kornbluth, 2007). In the abstract model and as demonstrated in Figure 6.15, Cdc25C becomes 
activated through discrete transition t8_1 when the cell cycle enters Prophase modelled as a logical 
place. The active Cdc25C then stimulates production of more CycB_Cdk1 presented as continuous 
transition T8 in the model (Figure 6.15). On the other hand, Cdc25C becomes deactivated when cell 
cycle enters Mid_G1 (through t8_2 in Figure 6.15).  
UBQ_B Macro Place 
UBQ_B macro place models the degradation of CycB_Cdk1 through two ubiquitin ligases 
APC_Cdc20B and APC_Cdh1 (Mateo et al., 2009). As shown in Figure 6.16, the effect of these 
ubiquitin ligases on CycB_Cdk1 is modelled through continuous transition T5. APC_Cdc20B is inactive 
from Mid G1 (modelled through discrete transition t5_2) but it becomes activated at the beginning of 
M phase (through discrete transition t5_1). Later in M phase (at Telophase), the second ubiquitin 
ligase, APC_Cdh1, also becomes activated (modelled through discrete transition t4_1) and induces 
the full degradation of CycB_Cdk1 (through continuous transition T5).  
 
Figure 6.15 Elements of Cdc25C macro place as a part of G2-M sub-system. Active and inactive 






DNA Damage Sub-System 
As shown in Figure 6.17, the DNA damage sub-system comprises one macro place (DNA_Damage) 
whose constituting elements will be explained in this section. 
Figure 6.17 DNA Damage Sub-System (inside dashed blue rectangle) which includes DNA_Damage 
macro place. The connections between this sub-system and other cell cycle sub-
systems has already been demonstrated in Figure 6.2. 
 
Figure 6.16 Elements of UBQ_B macro place as a part of G2-M sub-system. Active and inactive 
APC_Cdc20B are demonstrated as aAPC_Cdc20B and iAPC_Cdc20B, respectively. The 




DNA_Damage Macro Place 
The DNA damage sub-system centres around DNA_Damage Macro place where the total effect of 
rapid and delayed DNA damage pathways on Cyc_Cdks is presented in a simplified version because 
the main purpose of developing the MLHPN model is to present an abstract minimised model of cell 
cycle. As demonstrated in Figure 6.18, DNA Damage Signal is presented as a discrete place (DDS). 
Furthermore, the key controllers of DNA damage signalling, p53, p21 and Chk2 (Beishline & Azizkhan-
Clifford, 2014; Meek, 2004; Morgan, 2007; Nyberg et al., 2002; Sancar et al., 2004), are modelled as 
one discrete place called DDS_Ctrls (DNA Damage Signalling Controllers) whose state switches 
between active and inactive depending on existence of DDS (Figure 6.18).  
As illustrated in Figure 6.18, following the presence of DNA Damage Signal, DDS_Ctrls place becomes 
activated through discrete transition t9_1 and then aDDS_Ctrls place affects different Cyc_Cdks. 
Since p21_CycD_Cdk4 helps the process of E2F activation (described in Chapter 3), the effect of 
aDDS_Ctrls on CycD_Cdk4 is positive (modelled through transition T1) while the corresponding effect 
on other Cyc_Cdks is negative and it is towards their inactivation (modelled through transition T6, T7, 
and T8). The absence of DNA damage triggers discrete transition t9_2 which makes aDDS_Ctrls 
inactive again (iDDS_Ctrls).  
Figure 6.18 Elements of DNA_Damage macro place which presents the DNA damage sub-system in 
the MLHPN model. 
 
 Kinetics of the Abstract Model  
In the previous section, the MLHPN model was described from three different levels of abstraction. 
The High-level of abstraction presented a big picture of the abstract model where the level of 
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Cyc_Cdks (as the main controllers of cell cycle system) is regulated through a number of macro places 
and transitions located within four different sub-systems, namely, Growth Factor, G1-S, G2-M, and 
DNA damage sub-systems. The details of the constituent macro places and transitions of the cell 
cycle sub-systems were presented in the section devoted to Low-level of abstraction. At the Stage-
level, the effect of different Cyc_Cdks on transition between different cell cycle stages was modelled. 
Now, the continuous transitions associated with Cyc_Cdks (as key controllers of cell cycle system) are 
presented below where the value of model parameters (together with corresponding parameter 
definition) and initial values of model elements (places) are provided in Tables F. 1 (in Appendix F) 
and G. 1 (in Appendix G), respectively. The value/state of the elements on the right side of equations 
is determined through interaction of the corresponding element with different elements in the 
system at different levels of abstraction. For example, elements that have positive effect on 
increasing the level of CycE_Cdk2 are aG1_S_TF and aCdc25A, where the first element is G1_S 
transcription factor whose state is determined through G1_S_Activation Macro Transition (shown in 
Figure 6.8) and the state of aCdc25A is determined through interactions shown in Figure 6.10. 
Parameters 𝑘X to  𝑘=X	are parameters that are used to calibrate the output of the abstract model 
according to the corresponding dynamics from the comprehensive model and Multilayer Neural 
Network (MLP) algorithm is used to perform parameter estimation (with two hidden layers each of 




= (𝑘X + 𝑘8 ∗ 𝑎𝐺0_𝐺1_𝑇𝐹 + 𝑘= ∗ 𝑎𝐷𝐷𝑆_𝐶𝑡𝑟𝑙𝑠 + 𝑘< ∗ 𝑎𝑝27) − 𝑎𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4 ∗ (𝑘; +




= (𝑘 + 𝑘X9 ∗ 𝑎𝐺1_𝑆_𝑇𝐹 + 𝑘XX ∗ 𝑎𝐶𝑑𝑐25𝐴) − 𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2 ∗ (𝑘X8 + 𝑘X= ∗ 𝑎𝑆𝐶𝐹 +




= (𝑘X + 𝑘XA ∗ 𝑎𝐺1_𝑆_𝑇𝐹 + 𝑘XB ∗ 𝑎𝐺2_𝑀_𝑇𝐹 + 𝑘X ∗ 𝑎𝐶𝑑𝑐25𝐴) − 𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2 ∗
(𝑘89 + 𝑘8X ∗ 𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20𝐴 + 𝑘88 ∗ 𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1 + 𝑘8= ∗ 𝑎𝑝27 + 𝑘8< ∗




= (𝑘8; + 𝑘8 ∗ 𝑎𝐺2_𝑀_𝑇𝐹 + 𝑘8A ∗ 𝑎𝐶𝑑𝑐25𝐶) − 𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1 ∗ (𝑘8B + 𝑘8 ∗
𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20𝐵 + 𝑘=9 ∗ 𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1 + 𝑘=X ∗ 𝑎𝐷𝐷𝑆_𝐶𝑡𝑟𝑙𝑠)	   (6-4) 
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 MLHPN Simulation Results  
With the system equations provided in the last section, it is possible to present the dynamics of 
Cyc_Cdks as the main controllers of cell cycle system. These dynamics are demonstrated in Figure 
6.19(A). As shown in this figure, first, CycD_Cdk4 level increases and in late_G1 phase, the 
concentrations of CycE_Cdk2 and CycA_Cdk2 start increasing (because of activation of G1_S_TF) and 
when the level of CycE_Cdk2 reaches a threshold, G1-S transition occurs at 6.0756 simulation time 
units  (shown with a vertical dashed pink line in Figure 6.19(A)). Then the levels of CycA_Cdk2 and 
CycB_Cdk1 increase and when the concentration of CycB_Cdk1 crosses a threshold, G2-M transition 
occurs at 17.2901 (shown with a vertical dashed pink line in Figure 6.19(A)). At the end of cell cycle, 
the level of CycB_Cdk1 decreases through degradation by aAPC_Cdc20B and aAPC_Cdh1 and cell 
cycle ends at simulation time point 20.57. 
When comparing the simulation results of the abstract MLHPN model (Figure 6.19(A)) with that of 
the comprehensive mathematical model presented in Chapter 3 (Figure 6.19(B)), we should not 
expect that the MLHPN model to be exactly the same as the comprehensive model and qualitative 
similarities in Cyc_Cdk dynamics would suffice as the MLHPN is an abstract model with just four 
equations in comparison to the comprehensive model with 61 ODEs. As shown in Figures 6.19(A) and 
6.19(B), the trends of Cyc_Cdks are qualitatively similar. In order to compare the MLHPN results with 
the corresponding results of the comprehensive model, we need to convert the figures to the scale 
of the comprehensive model (or vice versa) as each cell cycle of the MLHPN model is 20.57 
simulation time units while that of the comprehensive model is approximately 3700 units (they can 
also be converted to hours as shown in the simulation figures). Therefore, the G1-S transition 
happens at 6.0756 for the MLHPN model and the corresponding converted time point for the 
comprehensive model is (1095) × 89.;A
=A99
= 6.0876 which shows the closeness of the results. The 
corresponding values for the G2-M transition are 17.2901 and (3208) × 89.;A
=A99
= 17.8347 for the 
MLHPN and the comprehensive model, respectively, which also shows that the results of the two 





Figure 6.19 Temporal dynamics of Cyc_Cdks as key controllers of mammalian cell cycle system 
under no DNA damage for (A) the MLHPN model and (B) the comprehensive 
mathematical model. The vertical dashed pink lines show the G1-S and G2-M 
transitions in both top and bottom figures [x-axis indicates time (both simulation time 
units and hour); y-axis indicates protein concentration]. 
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The simulation results also show that following the DNA damage (100 units of damage), the G1-S 
transition time shifts from 6.0756 (no damage) to 6.2232. Furthermore, the G2-M transition shifts 
from 17.2901 (no damage) to 17.9438 (damage condition). After converting the results of the MLHPN 
model, the G1-S and G2-M arrest durations are (6.2232 − 6.0756) × =A99
89.;A
= 26.54 and (17.9438 −
17.2901) × =A99
89.;A
= 117.58 units, respectively, which are close to the corresponding arrest durations 
for the comprehensive model (30 and 122, respectively). Therefore, similar to the comprehensive 
model presented in Chapter 3, the proposed MLHPN model can qualitatively present the cell cycle 
arrest under DNA damage condition. There are also some differences between the two models which 
is not surprising as the abstract model has not been designed to be the exact same as the 
comprehensive model and rather, it is an abstract/minimised version of the comprehensive model 
and qualitatively presents the behaviour of cell cycle controllers, so the values and concentrations 
are not the main concern. For example, the dynamic behaviour of CycA_Cdk2 is a little bit different 
between the two models where the corresponding dynamics in the comprehensive model is 
smoother which may be due to the existence of all the elements contributing to the formation of 
CycA_Cdk2, such as Cyclin A, Cdk2, and all the other components associated with CycA_Cdk2 
presented in the comprehensive mathematical model but not in the MLHPN model (the same 
condition applies to other Cyc_Cdks as well). 
 Checkpoint Efficiency Evaluation on the MLHPN Model 
As there is biological evidence that G1-S checkpoint is not as efficient as G2-M checkpoint in 
detecting damaged cells (Beishline & Azizkhan-Clifford, 2014; Di Leonardo et al., 1994), in Chapter 5, 
we developed Checkpoint Efficiency Evaluation (CEE) model and applied it on the comprehensive 
mathematical model presented in Chapter 3 and showed that the comprehensive model results are 
in good agreement with biological findings. Now, having developed the abstract MLHPN model for 
mammalian cell cycle based on the most significant parameters of the comprehensive model, we aim 
to conduct a checkpoint efficiency evaluation analysis on the abstract model to evaluate the 
performance of G1-S and G2-M checkpoints in detecting damaged cells. Therefore, according to the 
CEE model, the MLHPN model parameters are perturbed simultaneously in order to simulate real 
situations that cells may confront (within five ranges of ±5%,±10%,	±15%,	±20% and ±30%) and 
sampled 2000 times for each level of perturbation. Then, 2000 Peak Time (PT) values are calculated 
for each checkpoint indicator (aCycE_Cdk2 and aCycB_Cdk1) and the Probability Density Function 
(PDF) of PTs is estimated by normal distribution. The procedure is repeated for DNA damage 
condition and the PDF of PTs of the indicators in the presence of DNA damage is obtained. Then, 
using Type II Error with significance level of 10% (Type II Error is the probability of accepting a null 
hypothesis while it is not true (Weiers, 2010)), the damaged cells passing each checkpoint as healthy 
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cells are labelled. The efficiency of checkpoints is calculated as the number of correctly identified 
damaged cells to the total number of damaged cells. Therefore, it is possible to check how many 
damaged cells are identified and captured at each checkpoint.  
6.6.1 Checkpoint Efficiency Based on the Number of Damaged Cells Passing 
Checkpoints as Healthy Cells 
The checkpoint efficiency is evaluated based on the number of damaged cells that pass checkpoints 
as healthy cells and the results are demonstrated in Table 6.3. As shown in this table, G2-M 
checkpoint captures more damaged cells than G1-S under all different perturbation levels and DNA 
damage condition. As a case in point, under perturbation level of ±5%, 614 out of 2000 damaged cells 
pass G1-S checkpoint as healthy cells and then only 118 out of these 614 damaged cells are not 
caught at G2-M checkpoint. Therefore, the efficiency of G1-S is 8999:X<
8999
= 69.3%, whereas the 
efficiency of G2-M is X<:XXB
X<
= 80.78%. The rate at which damage cells pass the combined 
checkpoint system as healthy cells is 5.9% (118/2000) (False Negative rate) making the whole system 
efficiency 8999:XXB
8999
= 94.1% (True Positive rate). Although the difference between the efficiency of 
G2-M and G1-S decreases when the level of perturbation increases, the efficiency of G2-M 
checkpoint in capturing damaged cells is higher than that of G1-S. This is in good agreement with 
experiments showing relative inefficiency of G1-S checkpoint in arresting damaged cells (Beishline & 
Azizkhan-Clifford, 2014; Di Leonardo et al., 1994). Another important point to mention is that the 
trend of efficiency percentages for the comprehensive model (presented in Table 5.1 in Chapter 5; 
for example, the G1-S efficiencies for ±5%, ±10%, ±15%, ±20% and ±30% perturbations are 72.85%, 
36.5%, 26.1%, 20.7% and 15.3%, respectively) and the MLHPN model (Table 6.3) is similar. In other 
words, the efficiencies of both checkpoints as well as combined efficiency decrease when the 
perturbation level increases. However, Increasing the perturbation level results in lower efficiency in 
the MLHPN model. This is due to the lower number of parameters in the MLHPN model that makes 
the model more sensitive to parameter perturbations. 
Table 6.3 Efficiency and the number of damaged cells that pass each of the G1-S and G2-M 
checkpoints as normal cells under DNA damage and different perturbation levels (the 










Portion of G1-S 
Escaped 
Damaged Cells 










Efficiency     
(%) 
±5% 614 69.3 118 80.78 94.1 
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±10% 1408 29.6 917 34.87 54.15 
±15% 1616 19.2 1266 21.65 36.7 
±20% 1766 11.7 1521 13.87 23.95 
±30% 1832 8.4 1645 10.2 17.75 
 
6.6.2 Checkpoint Efficiency Based on the Number of Healthy Cells Getting 
Sacrificed as Damaged Cells 
Although it is crucial to investigate the number of damaged cells passing cell cycle checkpoints as 
healthy cells, it is also important to check the number of healthy cells arrested at checkpoints 
incorrectly. Thus, we conduct another analysis on the MLHPN model to study the checkpoint 
efficiency in correctly recognising healthy cells. Here, we allow 2000 healthy cells to go through the 
checkpoints and count the number of healthy cells incorrectly identified as damaged and arrested at 
checkpoints. The results of this analysis are shown in Table 6.4. For example, at ±5% perturbation 
level, the number of healthy cells incorrectly identified and arrested at G1-S is shown in the second 
column (i.e., 55 out of 2000 are sacrificed); the number of incorrectly arrested cells at G2-M is shown 
in the fourth column (i.e., 2000-55=1945 healthy cells go to G2-M checkpoint and just 37 cells (37 out 
of 1945) get incorrectly arrested as damaged). Therefore, the efficiency of G1-S and G2-M is 
8999:;;
8999
= 97.25% and X<;:=A
X<;
= 98.09%, respectively. The combined checkpoint efficiency in 
releasing healthy cells is  8999:(;;s=A)
8999
= 95.4%.  
The results shown in table 6.4 indicate that both checkpoints are highly efficient and near perfect in 
recognising healthy cells at ±5% perturbation. As the perturbation level increases, both checkpoints 
drop in efficiency in recognising healthy cells but G2-M not only remains more efficient but also is 
more robust against sacrificing healthy cells. If we compare the results in Table 6.4 with the same 
results from the comprehensive model (presented in Table 5.2 in Chapter 5; for example, the G1-S 
efficiencies for ±5%, ±10%, ±15%, ±20% and ±30% perturbations are 99.15%, 69.95%, 46.8%, 33.55% 
and 14.7%, respectively), we notice that the trend of efficiencies is similar for both the MLHPN and 
the comprehensive models. However, the corresponding figures for the MLHPN are less than those 
of the comprehensive model which indicates that the abstract the MLHPN model is more sensitive to 
parameter perturbation which is normal because in the MLHPN, cell cycle is modelled with lower 
number of elements and parameters. 
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Table 6.4 Checkpoint efficiency and the number of healthy cells that get sacrificed as damaged 
cells at G1-S and G2-M checkpoints for different perturbation levels (the total number 
of healthy cells is 2000) for the MLHPN model. 
 
 Summary  
In this chapter, we developed an abstract model of mammalian cell cycle (the MLHPN model) based 
on the most significant parameters (of the comprehensive model presented in Chapter 3) identified 
through GSA and SOMCCA model. Using Petri Nets (PNs), we introduced a novel intuitive approach to 
modelling the mammalian cell cycle by presenting the system in three levels of abstraction: High-
level, Stage-level, and Low-level. The High-level of abstraction rendered a big picture of the model. At 
the Stage-level, the function of Cyc_Cdks in controlling transitions between different cell cycle stages 
was described. Finally, the details of regulators of Cyc_Cdks were presented at Low-level of 
abstraction. Furthermore, all the cell cycle sub-systems introduced in Chapter 3 for the 
comprehensive model (Growth Factor signalling, G1-S and G2-M checkpoints, and DNA damage 
signalling) also existed in the MLHPN model where the number of the corresponding elements inside 
each sub-system was less due to model abstraction. The proposed abstract model comprised just 
four equations and 31 parameters while the comprehensive mathematical model presented in 
chapter 3 had 61 ODEs and 148 parameters. Therefore, the MLHPL model provided ease of 
understanding of a process that has temporal and organizational complexity in a simpler and intuitive 
way while making it possible to easily access and assess either temporal or higher or lower (detail) 










Portion of G1-S 
Released Healthy 















±5% 55 97.25 37 98.09 95.4 
±10% 907 54.65 323 70.44 38.5 
±15% 1356 32.20 366 43.16 13.9 
±20% 1561 21.95 305 30.52 6.7 
±30% 1762 11.9 191 19.74 2.35 
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The simulation results based on simple mass action kinetic equations in the MLHPN were 
qualitatively in agreement with simulations of the comprehensive mathematical model. The 
significance of this study is mainly related to developing a minimal model that can represent the 
behaviour of Cyc_Cdks as key controllers of mammalian cell cycle. It was shown that the temporal 
development of all Cyc-Cdk complexes were qualitatively in agreement with the ODE counterpart. In 
conclusion, the proposed model in this chapter provided an intuitive approach to represent the 
complex system of mammalian cell cycle from different levels of abstraction where the sub-systems 
and their constituent elements (different places and transitions) interact with each other. More 
importantly, using the MLHPN, we were able to conduct the Checkpoint Efficiency Evaluation (CEE) 
analysis and the results were consistent with those of the comprehensive model showing that the 
MLHPN model can be used to gain similar insights into mammalian cell cycle control system as the 










In this thesis, we used Ordinary Differential Equations (ODEs) and Petri Nets (PNs) modelling 
approaches to achieve a better understanding of underlying mechanisms in cell cycle control system 
in the presence of DNA damage from a systems point of view. The major focus of the current study 
was to explore the current knowledge of mammalian cell cycle through developing a comprehensive 
mathematical model incorporating all cell cycle sub-systems introduced in this study (Growth Factor 
signalling, G1-S checkpoint signalling, G2-M checkpoint signalling, and DNA damage pathway) as well 
as performing a model abstraction through a PN-based approach. Numerical analyses were 
conducted to identify the most significant parameters, modules, and sub-systems of the cell cycle 
system on system responses (G1-S and G2-M transitions). Moreover, the efficiency of cell cycle 
checkpoints was investigated to gain more insights into performance of both G1-S and G2-M 
checkpoints in arresting damaged cells and not sacrificing healthy cells. Simulations have shown that 
our models are beneficial in attaining new insights into the behaviour of mammalian cell cycle 
system. This chapter is organized as follows: An overall overview of our achievements is given in 
Section 7.1. The research highlights are provided in Section 7.2. Section 7.3 is devoted to 
recommendations for future research. And section 7.4 provides a conclusion of our research. 
 Research Overview 
The first goal of this research was to gather the most recent knowledge of mammalian cell cycle 
control system in order to identify missing essential elements and pathways. Therefore, we did a 
thorough research on current understanding of mammalian cell cycle system and its computational 
modelling (presented in Chapter 2) which was published in an International Conference paper titled 
“A Review of Computational Models of Mammalian Cell Cycle” (Abroudi et al., 2015). Based on 
information gathered on the current cell cycle knowledge, we developed a comprehensive systemic 
mathematical model that enabled us to perform further analyses to gain more insights into 
mammalian cell cycle system behaviour. The associated study presented in Chapter 3 has been 
published in Journal of Theoretical Biology (JTB) with the title “A comprehensive complex systems 
approach to the study and analysis of mammalian cell cycle control system in the presence of DNA 
damage stress” (Abroudi et al., 2017). In order to develop our comprehensive model, we updated the 
most complete model of mammalian cell cycle at the time which was a model developed by Iwamoto 
et al. (2011). We identified the missing elements in that model according to the latest knowledge of 
mammalian cell cycle system. We added some crucial elements, such as c-Myc (a transcription factor 
which is vital for cell cycle initiation by inducing the synthesis of Cyclin D), PP1 (a vital phosphatase 
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whose addition made the Iwamoto et al. (2011) model cyclic. This phosphatase mainly functions 
through dephosphorylation of Retinoblastoma protein pRb), Plk1 (one of the essential proteins in 
mitotic entry which activates Cdc25C phosphatase and APC_Cdc20, inactivates Wee1 kinase, and 
helps translocation of CycB_Cdk1 from cytoplasm to nucleus), SCF (a crucial ubiquitin ligase which 
has impact on G1-S transition through degradation of Cyclin E), and Gadd45α (this protein is one of 
the bi-products of transcription factor p53, and it physically interacts with Cdk1 in order to stimulate 
CycB_Cdk1 unbinding). The simulation results of the model showed the effect of newly added 
elements on system response (G1-S and G2-M transitions). 
We also introduced the concept of functional sub-systems where the whole system was divided into 
four inter-connected sub-systems (Growth Factor signalling, G1-S & G2-M checkpoints, and DNA 
damage signalling). Unlike previous models that presented Growth Factor as a constant signal, we 
presented a more realistic Growth Factor signalling by introducing Growth Factor signalling sub-
system centring around transcription factor c-Myc. G1-S and G2-M checkpoints were two other 
essential sub-systems presented along with their functional modules in our model. G1-S checkpoint 
sub-system consisted Cdk4-Related, E2F-pRb, Cdk2-Related, and Tyrosine phosphatase modules 
where the latter is a novel addition to this sub-system and E2F-pRb module is expanded and 
modified to make the model cyclic. G2-M checkpoint sub-system was presented as five inter-
connected modules: Cdk1-Related, Tyrosine phosphatase, Tyrosine kinase, Plk1-Related, and APC- 
related where the latter four are novel additions and contained new elements. We also expand the 
DNA damage sub-system into two modules including Chk-Related (rapid) and newly added elements 
in p53-Related (delayed) modules. The detailed description of the abovementioned elements, sub-
systems, and modules as well as the corresponding equations of our comprehensive mathematical 
model were presented in Chapter 3.  
The second goal of this study was to investigate the behaviour of cell cycle system under different 
circumstances including different perturbation levels and DNA damage in order to identify the most 
significant parameters, sub-systems and modules of the system. To accomplish this objective, we first 
determined the indicators of G1-S and G2-M transitions (PT of CycE_Cdk2 and CycB_Cdk1_Nuc, 
respectively). Then, we introduced an analytical method involving Global Sensitivity Analysis (GSA) 
based on Self-Organizing Map with Correlation Coefficient Analysis (SOMCCA) to find the most 
significant parameters, modules and sub-systems which showed that Growth Factor and G1-S 
checkpoint sub-systems and seven parameters in the modules within them were crucial for G1-S and 
G2-M transitions (Chapter 4). Having identified the most influential parameters and their 
corresponding proteins, we were able to take a step forward to develop an abstract minimal model 
based on the identified significant components and see if this new abstract model behaves similar to 
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the comprehensive model presented in Chapter 3 (this investigation forms our fourth goal but before 
that we have the third goal which was devoted to checkpoints efficiency analysis). 
The third goal of this study was to investigate the relative efficiency of G1-S and G2-M checkpoints in 
detecting damaged cells as there is biological evidence that G2-M checkpoint is more efficient in 
detecting damaged cells in the presence of DNA damage. We developed a Checkpoint Efficiency 
Evaluation (CEE) model enabling us to count the number of damaged cells passing cell cycle 
checkpoints as healthy (normal) cells. We also performed further investigation on efficiency of 
checkpoints by calculating the number of healthy cells got arrested incorrectly as damaged cells at 
checkpoints. The simulation results of CEE applied to our comprehensive model showed that cell 
cycle is about 96% efficient in arresting damaged cells with G2-M checkpoint being more efficient 
than G1-S and both checkpoint systems are near perfect (98.6%) in passing healthy cells (under ±5% 
parameter perturbation). The results were in good agreement with biological findings showing the 
usefulness of our comprehensive model in gaining deeper insights into mammalian cell cycle control 
system. The work associated with this goal was presented in Chapter 5. 
The last goal of this thesis centred around the idea of model abstraction using the most significant 
parameters identified in Chapter 4. As mammalian cell cycle is a complex system with reactions with 
different time-scales, in order to develop an abstract model, we used a hybrid modelling approach 
that combined discrete and continuous interactions and elements (proteins). Therefore, we adopted 
an intuitive graphical modelling approach called Petri Nets (PNs) to present the most significant 
identified elements of mammalian cell cycle system. This modelling approach also enabled us to 
present the system in different levels of abstraction (High, Stage, and Low-levels). At high-level of 
abstraction, Cyc_Cdks, as the key players of cell cycle machinery, were modelled as continuous 
elements (places). At stage-level, the interactions between Cyc_Cdks and cell cycle stages (i.e., 
Late_G1, S, G2, etc.) were introduced. And finally, the interactions between Cyc_Cdks and their 
regulators (i.e., Ubiquitin ligases, phosphatases, CKIs, etc.) were provided at low-level of abstraction. 
We called our model Multi-Layer Hybrid Petri Net (MLHPN). The simulation results of MLHPN were 
qualitatively similar to its parent model (the comprehensive mathematical model presented in 
Chapter 3) with some minor differences that were expected when downsizing a model with 61 
equations to just 4. To investigate whether the MLHPN model can be used to validate some biological 
findings on mammalian cell cycle control systems, we conducted the CEE analysis on the MLHPN to 
evaluate and compare the efficiency of checkpoints in detecting damaged cells and found out that 
the MLHPN results are consistent with those of the comprehensive model. In other words, the 
MLHPN was able to correctly show that G2-M checkpoint is more efficient than G1-S in capturing 
damaged cells as well as not arresting healthy cells. 
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 Research Highlights 
The highlights of our research are briefly outlined as follows: 
• Developed the most comprehensive ODE-based mammalian cell cycle model  
• Presented a holistic complex systems modelling approach involving interacting sub-systems 
and modules 
• Abstracted known cell cycle pathways into sub-systems and added new essential modules 
and elements.    
• Demonstrated the value and role of the newly added components 
• Introduced a Global parameter sensitivity approach using Self-Organising Maps with 
Correlation Coefficient Analysis (SOMCCA model) 
• Identified the most significant sub-systems, modules and parameters in cell cycle 
• Introduced a statistical/simulation-based approach to assess efficiency of DNA damage 
checkpoints and quantified the efficiency of checkpoints in arresting damaged cells and not 
sacrificing healthy cells (CEE model) 
• Revealed a relatively higher G2-M checkpoint efficiency compared to G1-S checkpoint  
• Performed a model abstraction using a PN-based modelling approach (MLHPN model) 
• Showed that the MLHPN model is capable of mimicking the systems dynamics of the 
comprehensive mathematical model and validating biological findings regarding relative 
efficiency of G1-S and G2-M checkpoints in correctly detecting damaged/healthy cells  
 
 Recommendations for Future Research  
The current study recommends the following directions for future research: 
• One area that could be investigated more is exploring the impact of Growth Factor 
deprivation at different stages of cell cycle as biological findings show that Growth Factor 
deprivation can prevent cell division and promote cell Apoptosis (Kearney & Martin, 2013; 
Mason & Rathmell, 2011; Vander Heiden et al., 2001). Further investigation could involve the 
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relationship between the stage the Growth Factor deprivation occurs and the effect it may 
have on cell cycle progression. 
• Following the point noted in the previous bullet-point, the Apoptosis pathway can be added 
to the model to further explore the effect of Growth Factor on cell Apoptosis. 
• In Chapter 3, we mentioned that since Iwamoto et al. (2011) model is not cyclic, some 
updates need to be made to make the model cyclic. Therefore, we identified a missing 
protein called PP1 and added that to our model and also made changes to some existing 
parameters to make the model cyclic. Although our comprehensive model was cyclic, the 
cyclic behaviour was dampened. This could be due to the assumed values for the parameters 
and there might be a better set of parameters that need to be estimated to fix the 
dampening behaviour. Thus, future work could address this issue.   
• In our comprehensive mathematical model, DNA damage repair mechanism has been 
modelled with a constant rate. A future work could focus on adding DNA damage repair 
signalling to investigate the repair process more thoroughly as there are a lot of biological 




Mammalian cell cycle is one of the most complex biological systems; and because of its complexity, it 
is not only challenging but also expensive to explore the underlying mechanisms of this system just 
by in vitro technologies. Therefore, computational modelling approaches, such as mathematical 
models, Boolean networks, Petri Nets (PNs), etc., provide a good avenue to study and investigate the 
behaviour of biological systems. Furthermore, computational models are able to shed lights on 
biological processes and interactions through variety of predictions that can be verified by 
experiments later which shows the value of computational modelling in biological discovery.  In this 
research, we showed that our comprehensive mathematical model (comprising four essential sub-
systems: Growth Factor signalling, G1-S & G2-M checkpoints, and DNA damage pathway) can be used 
to explore underlying mechanisms of G1-S and G2-M checkpoints in the presence of DNA damage 
and Growth Factor signals. Using analysis of GSA through our developed model called SOMCCA, we 
characterised and identified the most significant parameters, sub-systems, and modules on system 
response (G1-S and G2-M transitions). Moreover, to validate our model regarding biological evidence 
on the relative efficiency of checkpoints (G2-M being more efficient in detecting damaged cell than 
G1-S), we developed a model called Checkpoint Efficiency Evaluation (CEE). The results showed that 
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our comprehensive model is in good agreement with biological findings. Lastly, we investigated the 
possibility of PN-based modelling approach for model abstraction from our comprehensive 
mathematical model to an abstract minimal model that can qualitatively present the behaviour of 
the parent model. We successfully performed the abstraction using the parameters identified as the 
most significant in the comprehensive model. The developed abstract model was called MLHPN. 
More importantly, we investigated the ability of the MLHPN model in revealing the efficiency of 
checkpoints using the CEE analysis. The CEE analysis results on the MLHPN were consistent with the 
corresponding biological evidence.  
While the current study tried to cover the most essential pathways of mammalian cell cycle including 
Growth Factor signalling, G1-S and G2-M checkpoints, and DNA damage signalling, there is still a 
variety of pathways, such as Apoptosis, TGF-Beta signalling pathway, etc., that can be incorporated 
into cell cycle system to shed more lights on behaviour of this complex system in response to 
different internal and external signals. We believe that the models developed in this research 
together with corresponding insightful analyses provide a good understanding of different aspects of 
mammalian cell cycle system separately and as an integrated system that will also be beneficial in 












Equations of the Comprehensive Mathematical Model 
This section contains Ordinary Differential Equation (ODEs) of different sub-systems/modules of the 
comprehensive mathematical model presented in Chapter 3. In the formulae, dot sign indicates 
multiplication; i and a prefixes denote inactive and active, respectively. We provide all equations 
here while Chapter 3 contains only equations that have the newly added proteins in them. Initial 
values and definition of all parameters are presented in Appendices B and C. The software used for 
simulation and analysis is Matlab.  




= 𝑘X ∙ [𝑎𝑐𝑀𝑦𝑐] − 𝑘8 ∙ 𝐺𝐹 ∙ [𝑖𝑐𝑀𝑦𝑐]                                                       (A-1)	 
c[lnwn]
cf
= 𝑘8 ∙ 𝐺𝐹 ∙ [𝑖𝑐𝑀𝑦𝑐] − 𝑘X ∙ [𝑎𝑐𝑀𝑦𝑐]		 	 	 	 	 																													(A-2) 
Within brackets is shown the concentration of respective proteins. Active and inactive c-Myc are 
shown as [acMyc] and [icMyc], respectively.  
 DNA Damage Signalling Sub-system 
A.2.1 Chk-Related Module 
The detailed dynamics of this module is formulated as follows (the formulae for Cdc25 phosphatases 
and Cyc_Cdks are presented in subsequent sections):		
c[£Çw]
cf
= 𝑘; ∙ 𝐷𝑆𝐵(𝑡) − 𝑘 ∙ [𝐴𝑇𝑀]                                   (A-3) 
c[ÈY8]
cf
= 𝑘= ∙ [𝑎𝐶ℎ𝑘2] − 𝑘< ∙ [𝑖𝐶ℎ𝑘2] ∙ [𝐴𝑇𝑀]                                                                                      (A-4) 
c[lÈY8]
cf
= 𝑘< ∙ [𝑖𝐶ℎ𝑘2] ∙ [𝐴𝑇𝑀] − 𝑘= ∙ [𝑎𝐶ℎ𝑘2]                                                      (A-5)  
where 𝐷𝑆𝐵(𝑡) = 𝐷𝐷𝑆 ∙ 𝑒𝑥𝑝(−𝑘A ∙ 𝑡), 𝑡		𝑖𝑠	𝑡𝑖𝑚𝑒, and 𝐷𝐷𝑆 is the DNA Damage Strength. 𝐷𝑆𝐵(𝑡) is 
Double-Strand Break signal that can trigger the DNA damage response in both Chk-Related and p53-
Related modules and it varies as repair progresses as shown by the formula. It is important to note 
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that the repair process is also embedded in the model by parameter 𝑘A (see Appendices B and C for 
initial values and definition of all parameters). 
A.2.2 p53-Related Module 
The temporal dynamics of this module can be expressed as follows (since p21, 14-3-3σ and Gadd45α 
have interactions with elements in G1-S and G2-M sub-systems, the corresponding dynamics may 
include some elements from those systems): 
c[;=]
cf











− 𝑘89 ∙ [𝐼𝐹]                      (A-8) 
c[8X]
cf
= 𝑘8X + 𝑘88 ∙ [𝑝53] + 𝑘8= ∙ [𝑝21_𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] + 𝑘8; ∙ [𝑝21_𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] +
𝑘8A ∙ [𝑝21_𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] + 𝑘8 ∙ [𝑝21_𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] − (𝑘8< ∙
[𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] + 𝑘8 ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] + 𝑘8B ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] +	𝑘=9 ∙
[𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] + 𝑘=X) ∙ [𝑝21]           
c[X<_=_=Ò]
cf
= 𝑘=8 + 𝑘== ∙ [𝑝53] − 𝑘=< ∙ [14_3_3𝜎] − 𝑘=; ∙ [14_3_3𝜎] ∙ [𝑖𝐶𝑑𝑐25𝐶_𝑃𝑠216]              (A-10)                                                                                                  	
c[ÔÕÖÖ<;×]
cf
= 𝑘= + 𝑘=A ∙ [𝑝53] − 𝑘=B ∙ [Gadd45α]                                            (A-11)
         
where 𝐷𝐸𝐺(𝑡) = 𝑘XX − 𝑘X8 ∙ (𝐷𝑆𝐵(𝑡) − 𝐷𝐷𝑆 ∙ exp(−𝑘X= ∙ 𝐷𝐷𝑆 ∙ 𝑡)).	𝐷𝐸𝐺(𝑡) is a time-dependent 
function that represents the degradation rate of p53 and it also depends on 𝐷𝑆𝐵(𝑡)	and the level of 
DNA damage (𝐷𝐷𝑆). 
 G1-S Checkpoint Signalling Sub-system 
A.3.1 Cdk4-Related Module 
The dynamics of Cdk4-Related module can be written as follows:  
c[ne]
cf
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= 𝑘<8 ∙ [𝐶𝑦𝑐𝐷] ∙ [𝐶𝑑𝑘4] + 𝑘8= ∙ [𝑝21_𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] + 𝑘<A ∙
[𝑝27_𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] −	 (𝑘<X + 𝑘<; + 𝑘8< ∙ [𝑝21] + 𝑘<B ∙ [𝑝27]) ∙
[𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4]                                          
c[8A]
cf
= 𝑘< + 𝑘<A ∙ [𝑝27_𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] + 𝑘;9 ∙ [𝑝27_𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] + 𝑘;X ∙
[𝑝27_𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] − (𝑘<B ∙ [𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] + 𝑘;8 ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] +
	𝑘;= ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] + 𝑘;< ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] + 𝑘;; ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2]) ∙
[𝑝27]																																																						       
c[8A_ne_cY<]
cf
= 𝑘<B ∙ [𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] ∙ [𝑝27] − (𝑘< + 𝑘<A) ∙ [𝑝27_𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4]                        (A-16)          
c[8X_ne_cY<]
cf
= 𝑘8< ∙ [𝑝21] ∙ [𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] − 𝑘8= ∙ [𝑝21_𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4]                            (A-17) 
A.3.2 E2F-pRb Module  
The equations of elements of this module are as follows: 
c[g8Ì_m]
cf
= 	𝑘; ∙ [𝐸2𝐹] ∙ [𝑝𝑅𝑏] − (	𝑘;A ∙ [𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] + 	𝑘;B ∙
[𝑝27_𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4] + 	𝑘; ∙ [𝑝21_𝐶𝑦𝑐𝐷_𝐶𝑑𝑘4]) ∙ [𝐸2𝐹_𝑝𝑅𝑏]           
                                                                 
c[hhX]
cf
= 	𝑘8 ∙ [𝑎𝑃𝑃1] − 	𝑘= ∙ [𝑖𝑃𝑃1]. [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]                             (A-19) 
c[lhhX]
cf
= 	𝑘= ∙ [𝑖𝑃𝑃1]. [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] − 	𝑘8 ∙ [𝑎𝑃𝑃1]                                            (A-20)
                   
c[mhhh]
cf
= (	𝑘9 ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] + 	𝑘X ∙ [𝑎𝐶𝑦𝑐𝐴cY8]) ∙ [𝐸2𝐹_𝑝𝑅𝑏𝑃𝑃] − 	𝑘< ∙
[𝑝𝑅𝑏𝑃𝑃𝑃]                                    
c[m]
cf
= 	𝑘; + 	𝑘< ∙ [𝑎𝑃𝑃1]. [𝑝𝑅𝑏𝑃𝑃𝑃] − 	(𝑘; ∙ [𝐸2𝐹] + 	𝑘) ∙ [𝑝𝑅𝑏]                                        (A-22)                                   
c[g8Ì]
cf
= 	𝑘A + 	𝑘B ∙ [E2F] + (	𝑘9 ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] + 	𝑘X ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2]) ∙
[𝐸2𝐹_𝑝𝑅𝑏𝑃𝑃] −	 	(𝑘; ∙ 	 [𝑝𝑅𝑏] + 	𝑘X< ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] + 	𝑘) ∙ [𝐸2𝐹]                                                          	
A.3.3 Cdk2-Related Module 
The mathematical equations of this module can be expressed as follows: 
c[ng]
cf
= 	𝑘A9 ∙ [𝐸2𝐹] + 	𝑘A8 ∙ [𝑖𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] − (𝑘A= + 	𝑘AX ∙ [𝐶𝑑𝑘2] + 	𝑘A< ∙










= 	𝑘A; ∙ [𝐸2𝐹] + 	𝑘A ∙ [𝑎𝐵𝑀𝑦𝑏] + 	𝑘AA ∙ [𝑁𝐹𝑌] + 	𝑘AB ∙ [𝑖𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] −
(	𝑘A + 𝑘B9 ∙ [𝐶𝑑𝑘2] + 	𝑘BX ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + 	𝑘B8 ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]) ∙
[𝐶𝑦𝑐𝐴]                     
c[cY8]
cf
= 	𝑘A8 ∙ [𝑖𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] + 	𝑘B= ∙ [𝑖𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] + 	𝑘B< ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] ∙
[𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] 	+ 𝑘AB ∙ [𝑖𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] + (	𝑘B; ∙ [𝑖𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] + 	𝑘B ∙
[𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2]) ∙ ([𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]) − (	𝑘AX ∙ [𝐶𝑦𝑐𝐸] +
	𝑘B9 ∙ [𝐶𝑦𝑐𝐴]) ∙ [𝐶𝑑𝑘2],           
c[ng_cY8]
cf
= 	𝑘AX ∙ [𝐶𝑦𝑐𝐸] ∙ [𝐶𝑑𝑘2] + 	𝑘BA ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] − (	𝑘A8 + 	𝑘B= +
	𝑘BB ∙ [𝑎𝐶𝑑𝑐25𝐴]) ∙ [𝑖𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2]          
c[lng_cY8]
cf
= 	𝑘BB ∙ [𝑖𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] ∙ [𝑎𝐶𝑑𝑐25𝐴] + 	𝑘;9 ∙ [𝑝27_𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] +
	𝑘8; ∙ 	 [𝑝21_𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] − (	𝑘BA + 	𝑘B< ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] +
	𝑘;8 ∙ [𝑝27] + 	𝑘8 ∙ [𝑝21]) ∙ 	 [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2]             
c[n£_cY8]
cf
= 	𝑘B9 ∙ [𝐶𝑑𝑘2] ∙ [𝐶𝑦𝑐𝐴] + 	𝑘B ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] − (	𝑘AB + 	𝑘B; ∙
([𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + 	[𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]) + 	𝑘9 ∙ [𝑎𝐶𝑑𝑐25𝐴]) ∙
[𝑖𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2]												 		   
c[ln£_cY8]
cf
= 	𝑘9 ∙ [𝑖𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] ∙ [𝑎𝐶𝑑𝑐25𝐴] + 	𝑘;X ∙ [𝑝27_𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] +
	𝑘8A ∙ [𝑝21_𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] − (	𝑘B + 	𝑘;; ∙ [𝑝27] + 	𝑘8B ∙ [𝑝21] +
	𝑘B ∙ 		 ([𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1])) ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2]    
c[8A_lng_cY8]
cf
= 	𝑘;8 ∙ [𝑝27] ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] − 	𝑘;9 ∙ [𝑝27_𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2]                            (A-31)																		           
c[8X_lng_cY8]
cf
= 	𝑘8 ∙ [𝑝21] ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] − 	𝑘8; ∙ [𝑝21_𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2]                          (A-32)  
c[8A_ln£_cY8]
cf
= 	𝑘;; ∙ [𝑝27] ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] − 	𝑘;X ∙ [𝑝27_𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2]                            (A-33)  
c[8X_ln£_cY8]
cf
= 	𝑘8B ∙ [𝑝21] ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] − 	𝑘8A ∙ [𝑝21_𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2]                            (A-34)           
c[pÌ]
cf
= 	𝑘X ∙ [𝑎𝑆𝐶𝐹] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] − 	𝑘8 ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] ∙ [𝑖𝑆𝐶𝐹]                                           (A-35)  
c[lpÌ]
cf
= 		𝑘8 ∙ [𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] ∙ [𝑖𝑆𝐶𝐹] − 𝑘X ∙ [𝑎𝑆𝐶𝐹] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]                                           (A-36)  
c[wm]
cf










= 	𝑘< ∙ [𝑖𝐵𝑀𝑦𝑏] ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] − 	𝑘; ∙ [𝑎𝐵𝑀𝑦𝑏]                                            (A-38)  
c[¡Ìà]
cf
= 	𝑘 ∙ [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] − 	𝑘A ∙ [𝑁𝐹𝑌]                         (A-39)  
A.3.4 Tyrosine Phosphatase Module 
The dynamics of this module can be formulated as follows: 
c[cn8;£]
cf
= 	𝑘B ∙ [𝐸2𝐹] + 	𝑘 ∙ [𝑎𝐶𝑑𝑐25𝐴] − (	𝑘X99 + 	𝑘X9X ∙
([𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] + [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2]) + 	𝑘X98 ∙ [𝑎𝐶ℎ𝑘1]) ∙
[𝑖𝐶𝑑𝑐25𝐴]        
                          
c[lcn8;£]
cf
= 	𝑘X9X ∙ ([𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2] + [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2]) ∙ [𝑖𝐶𝑑𝑐25𝐴] − (	𝑘X9= +
	𝑘 + 	𝑘X9< ∙ 		 [𝑎𝐶ℎ𝑘1]) ∙ [𝑎𝐶𝑑𝑐25𝐴]                                                                     
 G2-M Checkpoint Signalling Sub-system 
A.4.1 Tyrosine Kinase Module 
The temporal dynamics of this module can be written as follows:  
c[ddX]
cf
= [𝑎𝑊𝑒𝑒1] ∙ (𝑘X9; ∙ [𝑎𝑃𝑙𝑘1]	) − (𝑘X9 + 𝑘X9A ∙ [𝑎𝑆𝐶𝐹]) ∙ [𝑖𝑊𝑒𝑒1]                                (A-42)  
c[lddX]
cf
= 𝑘X9B + 𝑘X9 ∙ [𝑖𝑊𝑒𝑒1] − 𝑘X9; ∙ [𝑎𝑃𝑙𝑘1] ∙ [𝑎𝑊𝑒𝑒1]                    (A-43)  
A.4.2 Tyrosine Phosphatase Module 
The dynamics of Tyrosine Phosphatase module can be written as follows: 
c[cn8;]
cf
= 𝑘X9 + 𝑘XX9 ∙ [𝑎𝐶𝑑𝑐25𝐶] − (𝑘XXX ∙ [𝑎𝐶ℎ𝑘1] + 𝑘XX8 ∙
([𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] + [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]) + 𝑘XX= ∙ [𝑎𝑃𝑙𝑘1]) ∙
[𝑖𝐶𝑑𝑐25𝐶]                                       
c[lcn8;]
cf
= 𝑘XX8 ∙ [𝑖𝐶𝑑𝑐25𝐶] ∙ ([𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] + [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]) +
𝑘XX= ∙ [𝑖𝐶𝑑𝑐25𝐶] ∙ [𝑎𝑃𝑙𝑘1] + 𝑘XX< 		 ∙ 	 [𝑎𝐶𝑑𝑐25𝐶𝑃_𝑆216] −
(𝑘XX9 + 𝑘XX; + 𝑘XX ∙ 		 [𝑎𝐶ℎ𝑘1]) 	 ∙ [𝑎𝐶𝑑𝑐25𝐶]    
c[cn8;h_p8X]
cf
= 𝑘XXX ∙ [𝑖𝐶𝑑𝑐25𝐶] ∙ [𝑎𝐶ℎ𝑘1] + 𝑘XXA ∙ [𝑎𝐶𝑑𝑐25𝐶𝑃_𝑆216] −
(𝑘XXB ∙ ([𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] + [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]) + 𝑘XX ∙









= 𝑘XX ∙ [𝑎𝐶𝑑𝑐25𝐶] ∙ [𝑎𝐶ℎ𝑘1] + 𝑘XXB ∙ [𝑖𝐶𝑑𝑐25𝐶𝑃_𝑆216] ∙
([𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] + [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]) + 𝑘XX ∙
[𝑖𝐶𝑑𝑐25𝐶𝑃_𝑆216] ∙ [𝑎𝑃𝑙𝑘1] − (𝑘XX<	+	𝑘XXA) ∙
[𝑎𝐶𝑑𝑐25𝐶𝑃_𝑆216]                         
c[X<_=_=Ò_cn8;h_p8X]
cf
= 𝑘=; ∙ [𝑖𝐶𝑑𝑐25𝐶𝑃_𝑆216] ∙ [14_3_3𝜎] − 𝑘X89 ∙
																																																[14_3_3𝜎_𝑖𝐶𝑑𝑐25𝐶𝑃_𝑆216]             
A.4.3 Plk1-Related Module 
The dynamics of Plk1-Related module can be written as follows: 
c[huYX]
cf
= 	𝑘X8X ∙ [𝑎𝑃𝑙𝑘1] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] − 	𝑘X88 ∙ [𝑖𝑃𝑙𝑘] ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜]                           (A-49) 
c[lhuYX]
cf
= 	𝑘X88 ∙ [𝑖𝑃𝑙𝑘] ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] − 	𝑘X8X ∙ [𝑎𝑃𝑙𝑘1] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]             (A-50) 
A.4.4 Cdk1-Related Module 
The Cdk1-Related module has the following temporal dynamics: 
c[n]
cf
= 	𝑘X8= ∙ [𝑁𝐹𝑌] + [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ (	𝑘X8< + 	𝑘X8; ∙ [𝐺𝑎𝑑𝑑45]) −
(	𝑘X8 + 𝑘X8A ∙ [𝐶𝑑𝑘1] 	+ (	𝑘X8B ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + 	𝑘X8 ∙
[𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1])) ∙ [𝐶𝑦𝑐𝐵]                                    
c[cYX]
cf
= 	𝑘X=9 ∙ [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ ([𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]) +
[𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ 			 (	𝑘X=X ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + 	 	𝑘X=8 ∙
[𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1]) + [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ (	𝑘X8< + 	𝑘X8; ∙ 			 [𝐺𝑎𝑑𝑑45]) −
	𝑘X8A ∙ [𝐶𝑦𝑐𝐵 ∙ 𝐶𝑑𝑘1]                                        
c[n_cYX_ft]
cf
= 	𝑘X8A ∙ [𝐶𝑦𝑐𝐵] ∙ [𝐶𝑑𝑘1] + 	𝑘X== ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] −
(	𝑘X8< + 	𝑘X8; ∙ [𝐺𝑎𝑑𝑑45] + 	𝑘X=< ∙ ([𝑎𝐶𝑑𝑐25𝐶] +
[𝑎𝐶𝑑𝑐25𝐶𝑃_𝑆216]) + 	𝑘X=9 ∙ ([𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] +
[𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1])) ∙ [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜]                           
c[ln_cYX_ft]
cf
= 	𝑘X=; ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] + 	𝑘X=< ∙ [𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙
([𝑎𝐶𝑑𝑐25𝐶] + [𝑎𝐶𝑑𝑐25𝐶𝑃_𝑆216]) − (	𝑘X== + 	𝑘X=X ∙
[𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] + 	 	𝑘X=8 ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] − 	𝑘X= ∙ [𝑎𝑃𝑙𝑘1]) ∙
[𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]                         
c[n_cYX_¡¢n]
cf
= 	𝑘X=A ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] ∗ [𝑎𝑊𝑒𝑒1] − 	𝑘X=B ∙
[𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] ∙ [𝑎𝐶𝑑𝑐25𝐶] − 	𝑘X= 	 ∙











= 	𝑘X= ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝐶𝑦𝑡𝑜] ∙ [𝑎𝑃𝑙𝑘1] + 	𝑘X=B ∙
[𝑖𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] ∙ [𝑎𝐶𝑑𝑐25𝐶] + 	𝑘8 ∙
[𝑝21_𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] − 	(𝑘X=; + 	𝑘X=A ∙ [𝑎𝑊𝑒𝑒1] +




= 	𝑘=9 ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] ∙ [𝑝21] − 	𝑘8 ∙
[𝑝21_𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐]     
A.4.5 APC-Related Module 
The mathematical equations of this module are as follows: 
c[£h_cn89]
cf
= 	𝑘X<8 ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] − (	𝑘X<= ∙
[𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] + 	𝑘X<B ∙ [𝑎𝑃𝑙𝑘1]) ∙ [𝑖𝐴𝑃𝐶_𝐶𝑑𝑐20]                                                                         
c[l£h_cn89]
cf
= 	(𝑘X<= ∙ [𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] + 	𝑘X<B ∙ [𝑎𝑃𝑙𝑘1]) ∙ [𝑖𝐴𝑃𝐶_𝐶𝑑𝑐20] −
	𝑘X<8 ∙ 	 [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑𝑐20]    
c[£h_cÈX]
cf
= 	𝑘X<< ∙ [𝑎𝐴𝑃𝐶_𝐶𝑑ℎ1] ∙ ([𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] + [𝑎𝐶𝑦𝑐𝐴_𝐶𝑑𝑘2] +
[𝑎𝐶𝑦𝑐𝐸_𝐶𝑑𝑘2]) − 	𝑘X<; ∙ [𝑖𝐴𝑃𝐶_𝐶𝑑ℎ1]   
c[l£h_cÈX]
cf
= 	𝑘X<; ∙ [𝑖𝐴𝑃𝐶_𝐶𝑑ℎ1] − 	𝑘X<< ∙ ([𝑎𝐶𝑦𝑐𝐵_𝐶𝑑𝑘1_𝑁𝑢𝑐] +


















Initial Values of Concentration of Chemical Species of the 
Comprehensive Mathematical Model 
This section contains initial values of concentration of chemical species of the comprehensive 
mathematical model presented in Chapter 3. The initial values are presented in Table B. 1 (they have 
been mainly taken from the mathematical model of Iwamoto et al. (2011)).  
Table B. 1 Initial values of concentration (mg/ml) of chemical species used in the comprehensive 
mathematical model presented in Chapter 3.  
Chemical Specie Initial Value 





































14-3-3σ_iCdc25CP_S216  0.03 





































Parameters of the Comprehensive Mathematical Model 
This section contains parameters of the comprehensive mathematical model presented in Chapter 3. 
The kinetic parameters and the corresponding biochemical meaning are shown in Table C. 1. The 
parameters have been mainly taken from the mathematical model of Iwamoto et al. (2011). 
Table C. 1 Kinetic parameters and their biochemical meaning used in the comprehensive 




Biochemical meaning Value 
𝒌𝟏 rate of acMyc inactivation 0.001 
𝒌𝟐 rate of icMyc activation 0.01 
𝒌𝟑 rate of aChk2 inactivation 1 
𝒌𝟒 rate of iChk2 activation through ATM 1 
𝒌𝟓 rate of ATM activation 0.2 
𝒌𝟔 rate of ATM inactivation 0.01 
𝒌𝟕 rate of DNA damage repair 1e-08 
𝒌𝟖 rate of p53 basal synthesis 1e-04 
𝒌𝟗 rate of p53 synthesis through ATM 0.07 
𝒌𝟏𝟎 rate of p53 degradation 0.001 
𝒌𝟏𝟏 rate of p53 degradation through Mdm2 0.0556 
𝒌𝟏𝟐 rate of suppression of p53 degradation through DSB(t)  0.772 
𝒌𝟏𝟑 rate of suppression of Mdm2-mediated degradation of p53 0.02 
𝒌𝟏𝟒 rate of Mdm2 basal synthesis 9.4e-04 
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𝒌𝟏𝟓 synthesis rate of Mdm2 through IF  10 
𝒌𝟏𝟔 Hill function constant 9.5 
𝒌𝟏𝟕 rate of Mdm2 degradation 0.02 
𝒌𝟏𝟖 rate of p53 activity through binding to DNA after damage 6 
𝒌𝟏𝟗 rate of Mdm2 and p53 association 0.004 
𝒌𝟐𝟎 rate of IF degradation 0.005 
𝒌𝟐𝟏 rate of p21 basal synthesis 5e-05 
𝒌𝟐𝟐 rate of p21 synthesis through p53 0.001 
𝒌𝟐𝟑 rate of p21_CycD_Cdk4 dissociation  0.005 
𝒌𝟐𝟒 rate of p21 and CycD_Cdk4 association 5e-04 
𝒌𝟐𝟓 rate of p21_aCycE_Cdk2 dissociation 1.75e-04 
𝒌𝟐𝟔 rate of p21 and aCycE_Cdk2 association 0.0225 
𝒌𝟐𝟕 rate of p21_aCycA_Cdk2 dissociation 1.75e-04 
𝒌𝟐𝟖 rate of p21 and aCycA_Cdk2 association 0.0025 
𝒌𝟐𝟗 rate of p21_aCycB_Cdk1_Nuc dissociation 1.75e-04 
𝒌𝟑𝟎 rate of p21 and aCycB_Cdk1_Nuc association 0.0225 
𝒌𝟑𝟏 rate of p21 degradation 0.005 
𝒌𝟑𝟐 rate of 14-3-3σ basal synthesis 1 
𝒌𝟑𝟑 rate of 14-3-3σ synthesis through p53 0.01 
𝒌𝟑𝟒 rate of 14-3-3σ degradation 1 
𝒌𝟑𝟓 rate of 14-3-3σ and iCdc25CP_S216 association 100 
𝒌𝟑𝟔 rate of Gaddα45 basal synthesis  1e-05 
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𝒌𝟑𝟕 rate of Gaddα45 synthesis through p53 1e-04 
𝒌𝟑𝟖 rate of Gaddα45 degradation 1e-06 
𝒌𝟑𝟗 rate of Cyclin D basal synthesis 1e-05 
𝒌𝟒𝟎 rate of Cyclin D synthesis through acMyc 0.003 
𝒌𝟒𝟏 rate of CycD_Cdk4 dissociation  0.0025 
𝒌𝟒𝟐 rate of Cyclin D and Cdk4 association 0.08 
𝒌𝟒𝟑 rate of Cyclin D degradation through aSCF 0.2 
𝒌𝟒𝟒 rate of Cyclin D degradation 5e-05 
𝒌𝟒𝟓 rate of CycD_Cdk4 degradation to Cdk4 8e-05 
𝒌𝟒𝟔 rate of p27_CycD_Cdk4 degradation to Cdk4 0.001 
𝒌𝟒𝟕 rate of p27_CycD_Cdk4 dissociation 5e-04 
𝒌𝟒𝟖 rate of p27 and CycD_Cdk4 association 0.009 
𝒌𝟒𝟗 rate of p27 basal synthesis 0.0015 
𝒌𝟓𝟎 rate of p27_aCycE_Cdk2 dissociation 1.75e-04 
𝒌𝟓𝟏 rate of p27_aCycA_Cdk2 dissociation 1.75e-04 
𝒌𝟓𝟐 rate of p27 and aCycE_Cdk2 association 0.0225 
𝒌𝟓𝟑 degradation rate of p27 through aCycE_Cdk2 0.05 
𝒌𝟓𝟒 degradation rate of p27 through aCycA_Cdk2 0.0015 
𝒌𝟓𝟓 rate of p27 and aCycA_Cdk2 association 0.0025 
𝒌𝟓𝟔 rate of pRb and E2F association 5e-02 
𝒌𝟓𝟕 rate of E2F_pRb phosphorylation through CycD_Cdk4  0.0025 
𝒌𝟓𝟖 rate of E2F_pRb phosphorylation through p27_CycD_Cdk4 0.0025 
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𝒌𝟓𝟗 rate of E2F_pRb phosphorylation through p21_CycD_Cdk4 0.0025 
𝒌𝟔𝟎 rate of E2F_pRbPP dissociation to E2F & pRbPPP through aCycE_Cdk2 0.04 
𝒌𝟔𝟏 rate of E2F_pRbPP dissociation to E2F & pRbPPP through aCycA_Cdk2 0.0025 
𝒌𝟔𝟐 rate of inactivation of PP1 1e-03 
𝒌𝟔𝟑 rate of activation of PP1 through aCycB_Cdk1_Nuc 5e-02 
𝒌𝟔𝟒 rate of dephosphorylation of pRbPPP to pRb through PP1 5e-03 
𝒌𝟔𝟓 rate of pRb basal synthesis 5e-05 
𝒌𝟔𝟔 rate of pRb degradation 5e-05 
𝒌𝟔𝟕 rate of E2F basal synthesis 5e-04 
𝒌𝟔𝟖 rate of E2F synthesis through E2F 5e-08 
𝒌𝟔𝟗 rate of E2F degradation 5e-04 
𝒌𝟕𝟎 rate of Cyclin E synthesis through E2F 0.1 
𝒌𝟕𝟏 rate of Cyclin E and Cdk2 association 0.0025 
𝒌𝟕𝟐 rate of aCycE_Cdk2 dissociation 2.5e-05 
𝒌𝟕𝟑 rate of Cyclin E degradation 0.0025 
𝒌𝟕𝟒 rate of Cyclin E degradation through aSCF 0.01 
𝒌𝟕𝟓 rate of Cyclin A synthesis through E2F 8e-05 
𝒌𝟕𝟔 rate of Cyclin A synthesis through aBMyb 2e-04 
𝒌𝟕𝟕 rate of Cyclin A synthesis through NFY 1e-06 
𝒌𝟕𝟖 rate of iCycA_Cdk2 dissociation 2e-04 
𝒌𝟕𝟗 rate of Cyclin A degradation 5e-04 
𝒌𝟖𝟎 rate of Cyclin A  and Cdk2 association 5e-04 
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𝒌𝟖𝟏 rate of Cyclin A degradation through aAPC_Cdc20 0.005 
𝒌𝟖𝟐 rate of Cyclin A degradation through aAPC_Cdh1 0.005 
𝒌𝟖𝟑 rate of iCycE_Cdk2 degradation to Cdk2 0.005 
𝒌𝟖𝟒 rate of aCycE_Cdk2 degradation to Cdk2 0.05 
𝒌𝟖𝟓 




rate of aCycA_Cdk2 degradation to Cdk2 through aAPC_Cdc20 & 
aAPC_Cdh1  
0.0075 
𝒌𝟖𝟕 rate of aCycE_Cdk2 inactivation to form iCycE_Cdk2 0.00175 
𝒌𝟖𝟖 
rate of iCycE_Cdk2 dephosphorylation and activation through 
aCdc25A  
0.006 
𝒌𝟖𝟗 rate of aCycA_Cdk2 inactivation to form iCycA_Cdk2 5e-05 
𝒌𝟗𝟎 
rate of iCycA_Cdk2 dephosphorylation and activation through 
aCdc25A  
9e-04 
𝒌𝟗𝟏 rate of aSCF inactivation through aAPC_Cdh1 0.015 
𝒌𝟗𝟐 rate of iSCF activation through aCycE_Cdk2 0.01 
𝒌𝟗𝟑 rate of iBMyb production through E2F 0.05 
𝒌𝟗𝟒 rate of iBMyb activation through aCycA_Cdk2 0.05 
𝒌𝟗𝟓 rate of aBMyb degradation 0.002 
𝒌𝟗𝟔 rate of NFY production mediated by aCycA_Cdk2 0.001 
𝒌𝟗𝟕 rate of NFY degradation 0.005 
𝒌𝟗𝟖 rate of iCdc25A synthesis through E2F 0.04 
𝒌𝟗𝟗 rate of aCdc25A inactivation  0.005 
𝒌𝟏𝟎𝟎 rate of iCdc25A degradation 0.005 
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𝒌𝟏𝟎𝟏 rate of iCdc25A degradation through aCycE_Cdk2 & aCycA_Cdk2 0.05 
𝒌𝟏𝟎𝟐 rate of iCdc25A degradation through aChk1 0.001 
𝒌𝟏𝟎𝟑 rate of aCdc25A degradation 5e-04 
𝒌𝟏𝟎𝟒 rate of aCdc25A degradation through aChk1 0.001 
𝒌𝟏𝟎𝟓 rate of aWee1 phosphorylation and inactivation through aPlk1 0.1 
𝒌𝟏𝟎𝟔 rate of iWee1 activation 1 
𝒌𝟏𝟎𝟕 rate of iWee1 degradation through aSCF 1 
𝒌𝟏𝟎𝟖 rate of aWee1 basal synthesis  2e-04 
𝒌𝟏𝟎𝟗 rate of iCdc25C basal synthesis  1e-05 
𝒌𝟏𝟏𝟎 rate of aCdc25C inactivation  0.01 
𝒌𝟏𝟏𝟏 rate of iCdc25C phosphorylation on Serine216 through aChk1 0.001 
𝒌𝟏𝟏𝟐 
rate of iCdc25C activation through aCycB_Cdk1_Cyto & 
aCycB_Cdk1_Nuc 
1 
𝒌𝟏𝟏𝟑 rate of iCdc25C activation through aPlk1 0.1 
𝒌𝟏𝟏𝟒 rate of aCdc25CP_S216 dephosphorylation to form aCdc25C 0.01 
𝒌𝟏𝟏𝟓 rate of aCdc25C degradation 1e-04 
𝒌𝟏𝟏𝟔 rate of aCdc25C phosphorylation on Serine216 through aChk1 0.001 
𝒌𝟏𝟏𝟕 rate of aCdc25CP_S216 inactivation 0.01 
𝒌𝟏𝟏𝟖 
rate of iCdc25CP_S216 phosphorylation and activation through 
aCycB_Cdk1_Cyto & aCycB_Cdk1_Nuc 
1 
𝒌𝟏𝟏𝟗 rate of iCdc25CP_S216 phosphorylation and activation through aPlk1 0.1 
𝒌𝟏𝟐𝟎 rate of 14-3-3σ_iCdc25CP_S216 degradation 1 
𝒌𝟏𝟐𝟏 rate of aPlk1 inactivation through aAPC_Cdh1 0.1 
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𝒌𝟏𝟐𝟐 rate of iPlk1 activation through aCycB_Cdk1_Cyto 0.015 
𝒌𝟏𝟐𝟑 rate of Cyclin B synthesis through NFY 0.02 
𝒌𝟏𝟐𝟒 rate of iCycB_Cdk1_Cyto dissociation 1e-05 
𝒌𝟏𝟐𝟓 rate of iCycB_Cdk1_Cyto dissociation mediated by Gaddα45  2e-04 
𝒌𝟏𝟐𝟔 rate of Cyclin B degradation 0.005 
𝒌𝟏𝟐𝟕 rate of Cyclin B and Cdk1 association 0.00125 
𝒌𝟏𝟐𝟖 rate of Cyclin B degradation through aAPC_Cdc20  0.001 
𝒌𝟏𝟐𝟗 rate of Cyclin B degradation through aAPC_Cdh1 0.3 
𝒌𝟏𝟑𝟎 
rate of iCycB_Cdk1_Cyto degradation to form Cdk1 through 
aAPC_Cdc20 & aAPC_Cdh1  
0.005 
𝒌𝟏𝟑𝟏 




rate of aCycB_Cdk1_Cyto degradation to form Cdk1 through 
aAPC_Cdh1  
0.05 
𝒌𝟏𝟑𝟑 rate of aCycB_Cdk1_Cyto inactivation 1e-04 
𝒌𝟏𝟑𝟒 
rate of iCycB_Cdk1_Cyto activation through aCdc25C & 
aCdc25CP_S216  
0.05 
𝒌𝟏𝟑𝟓 rate of translocation of aCycB_Cdk1 from Nucleus to Cytoplasm 5e-05 
𝒌𝟏𝟑𝟔 
rate of translocation of aCycB_Cdk1 from Cytoplasm to Nucleus 
mediated by aPlk1 
0.01 
𝒌𝟏𝟑𝟕 




rate of iCycB_Cdk1_Nuc dephosphorylation and activation through 
aCdc25C 
0.01 
𝒌𝟏𝟑𝟗 rate of iCycB_Cdk1_Nuc degradation through aAPC_Cdc20 & 0.005 
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aAPC_Cdh1 
𝒌𝟏𝟒𝟎 rate of aCycB_Cdk1_Nuc degradation through aAPC_Cdc20  0.005 
𝒌𝟏𝟒𝟏 rate of aCycB_Cdk1_Nuc degradation through aAPC_Cdh1 0.03 
𝒌𝟏𝟒𝟐 rate of aAPC_Cdc20 inactivation through aAPC_Cdh1 0.05 
𝒌𝟏𝟒𝟑 rate of iAPC_Cdc20 activation through aCycB_Cdk1_Nuc 0.01 
𝒌𝟏𝟒𝟒 
rate of aAPC_Cdh1 inactivation through aCycE_Cdk2 & aCycA_Cdk2 & 
aCycB_Cdk1_Nuc  
0.1 
𝒌𝟏𝟒𝟓 rate of iAPC_Cdh1 activation  0.005 
𝒌𝟏𝟒𝟔 EF2 degradation rate through aCycA_Cdk2 0.01 
𝒌𝟏𝟒𝟕 rate of Cyclin D degradation through aAPC_Cdc20 10 
𝒌𝟏𝟒𝟖 rate of iAPC_Cdc20 activation through aPlk1 1e-04 
𝑮𝑭 Growth Factor 1 











Simulation of the Comprehensive Mathematical Model Over More 
Than One Cycle 
We assessed the dynamics of the comprehensive mathematical model presented in Chapter 
3 over more than one cell proliferation cycles and the results are shown in Figure D.1. The 
model produces cyclic behaviour reasonably well. There is still some dampening in the 
behaviour and indicates that further investigation is required in future to modify the model 





Figure D.1  Cyclic behaviour of the comprehensive mathematical model presented in Chapter 3; 
[x-axis indicates time (simulation time units as well as hours); y-axis indicates 
protein concentration (mg/ml)]. 












Results of GSA on Iwamoto et al. Model 
The most sensitive parameters from Global Sensitivity Analysis (GSA) on Iwamoto et al. (2011) model 
for G1-S under no DDS is presented below (sorted based on the level of significance).  
• 𝑘1: synthesis of Cyclin D (through GF) 
• 𝑘34: rate of synthesis of p27 
• 𝑘24: rate of association of p27 and CycE_Cdk2 
• 𝑘5: synthesis of Cyclin E by E2F 
• 𝑘80: synthesis of Cdc25A through E2F 
• 𝑘82: Activation of Cdc25A through CycE_Cdk2 and CycA_Cdk2 
• 𝑘20: association of p27 and Cyc_Cdk4 
• 𝑘22: Activation of CycE_Cdk2 through Cdc25A 
 
Results of GSA on Iwamoto et al. (2011) model for G2-M under no DDS show that all the above 
parameters as well as the parameters presented below are significant.  
• 𝑘9: synthesis of Cyclin A by B-Myb 
• 𝐾89: synthesis of NFY through CycA_Cdk2 
• 𝑘91: synthesis of Cyclin B by NFY 
• 𝑘93: association of Cyclin B and Cdk1 
• 𝑘105: synthesis of B-Myb by E2F 
• 𝑘110: activation of Cdc25C through CycB_Cdk1 (Nuc and Cyt) 
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Therefore, the results of GSA on Iwamoto et al. (2011) model show consistency between the 
significant parameters identified in our model (presented in Chapter 4) and theirs. The only 
difference is about c-Myc and PP1 which are absent in Iwamoto et al. model (in fact, these are the 























Kinetic Parameters of the MLHPN Model 
Kinetic parameters and corresponding biochemical meaning of the MLHPN model (presented in 
Chapter 6) are shown in Table F. 1. The software used for simulation and analysis is Matlab. 
Table F. 1     Kinetic parameters of the MLHPN model and their biochemical meaning. 
Kinetic 
Parameter 
Biochemical meaning Value 
𝒌𝟏 basal production rate of CycD_Cdk4  0.01 
𝒌𝟐 production rate of CycD_Cdk4 through aG0_G1_TF 1 
𝒌𝟑 The rate showing the effect of aDDS_Ctrls on activity of CycD_Cdk4 0.1 
𝒌𝟒 The rate showing the effect of ap27 on activity of CycD_Cdk4 0.001 
𝒌𝟓 basal degradation rate of CycD_Cdk4 0.065 
𝒌𝟔 degradation rate of CycD_Cdk4 through aSCF 0.05 
𝒌𝟕 degradation rate of CycD_Cdk4 through aAPC_Cdc20A 0.8 
𝒌𝟖 degradation rate of CycD_Cdk4 through aAPC_Cdc20B 0.8 
𝒌𝟗 basal production rate of CycE_Cdk2 0.1 
𝒌𝟏𝟎 production rate of CycE_Cdk2 through aG1_S_TF 5 
𝒌𝟏𝟏 production rate of CycE_Cdk2 through the effect of aCdc25A 0.001 
𝒌𝟏𝟐 basal degradation rate of CycE_Cdk2 0.05 
𝒌𝟏𝟑 degradation rate of CycE_Cdk2 through aSCF 0.6 
𝒌𝟏𝟒 The rate showing the effect of aDDS_Ctrls on activity of CycE_Cdk2 0.1 
𝒌𝟏𝟓 The rate showing the effect of ap27 on activity of CycE_Cdk2  0.01 
𝒌𝟏𝟔 basal production rate of CycA_Cdk2 0.2 
𝒌𝟏𝟕 production rate of CycA_Cdk2 through aG1_S_TF 0.2 
𝒌𝟏𝟖 production rate of CycA_Cdk2 through aG2_M_TF 7.5 
𝒌𝟏𝟗 production rate of CycA_Cdk2 through the effect of aCdc25A 0.001 
𝒌𝟐𝟎 basal degradation rate of CycA_Cdk2 0.1 
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𝒌𝟐𝟏 degradation rate of CycA_Cdk2 through aAPC_Cdc20A 2 
𝒌𝟐𝟐 degradation rate of CycA_Cdk2 through aAPC_Cdh1 0.8 
𝒌𝟐𝟑 The rate showing the effect of ap27 on activity of CycA_Cdk2  0.01 
𝒌𝟐𝟒 The rate showing the effect of aDDS_Ctrls on activity of CycA_Cdk2 0.1 
𝒌𝟐𝟓 basal production rate of CycB_Cdk1 0.1 
𝒌𝟐𝟔 production rate of CycB_Cdk1 through aG2_M_TF 1 
𝒌𝟐𝟕 production rate of CycB_Cdk1 through the effect of aCdc25C 0.001 
𝒌𝟐𝟖 basal degradation rate of CycB_Cdk1 0.05 
𝒌𝟐𝟗 degradation rate of CycB_Cdk1 through aAPC_Cdc20B 2 
𝒌𝟑𝟎 degradation rate of CycB_Cdk1 through aAPC_Cdh1 0.8 

















Initial Values of Places of the MLHPN Model 
Definition of places, place type and corresponding initial values for the MLHPN model (presented in 
Chapter 6) are given in Table G. 1. 
Table G. 1     Places of the MLHPN model and corresponding initial values. 
Place Type Definition 
Initial 
Value 
CycD_Cdk4 Continuous This place represents the CycD_Cdk4 complex 0 
CycE_Cdk2 Continuous This place represents the CycE_Cdk2 complex 0 
CycA_Cdk2 Continuous This place represents the CycA_Cdk2 complex 0 
CycB_Cdk1 Continuous This place represents the CycB_Cdk1 complex 0 
DNA_Damage Macro This Macro place comprises the components associated 
with DNA damage sub-system  
N/A 
p27 Macro This Macro place represents the elements related to Cyclin 
Dependent Kinase Inhibitor p27 
N/A 
UBQ_D Macro This macro place comprises the elements associated with 
degradation of CycD_Cdk4 
N/A 
UBQ_E Macro This macro place encompasses the elements related to 
degradation of CycE_Cdk2 
N/A 
UBQ_A Macro This macro place comprises the elements associated with 
degradation of CycA_Cdk2 
N/A 
UBQ_B Macro This macro place includes the elements related to 
degradation of CycB_Cdk1 
N/A 
Cdc25A Macro This Macro place represents the elements related to 
Tyrosine Phosphatase Cdc25A 
N/A 
Cdc25C Macro This Macro place comprises the elements associated with 
Tyrosine Phosphatase Cdc25C 
N/A 
GF Discrete Growth Factor  1 
iG0_G1_TF Discrete Inactive G0_G1 transcription factor (mainly corresponds to 
transcription factor c-Myc) 
1 
aG0_G1_TF Discrete Active G0_G1 transcription factor (mainly corresponds to 0 
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transcription factor c-Myc) 
iG1_S_TF Discrete Inactive G1_S transcription factor (mainly corresponds to 
transcription factor E2F) 
1 
aG1_S_TF Discrete Active G1_S transcription factor (mainly corresponds to 
transcription factor E2F) 
0 
aG2_M_TF Discrete Inactive G2_M transcription factor (mainly corresponds to 
transcription factor NFY) 
0 
iG2_M_TF Discrete Active G2_M transcription factor (mainly corresponds to 
transcription factor NFY) 
1 
ip27 Discrete Inactive p27 0 
ap27 Discrete Active p27 1 
iCdc25A Discrete Inactive Cdc25A 0 
aCdc25A Discrete Active Cdc25A 1 
iCdc25C Discrete Inactive Cdc25C 0 
aCdc25C Discrete Active Cdc25C 1 
iSCF Discrete Inactive SCF 0 
aSCF Discrete Active SCF 1 
iAPC_Cdh1 Discrete Inactive APC_Cdh1 0 
aAPC_Cdh1 Discrete Active APC_Cdh1 1 
iAPC_Cdc20A Discrete Inactive APC_Cdc20A 0 
aAPC_ Cdc20A Discrete Active APC_ Cdc20A 1 
iAPC_ Cdc20B Discrete Inactive APC_ Cdc20B 0 
aAPC_ Cdc20B Discrete Active APC_ Cdc20B 1 
Early_G1 Discrete The discrete place representing early G1 phase 1 
Mid_G1 Discrete The discrete place representing mid G1 phase 0 
Late_G1 Discrete The discrete place representing late G1 phase 0 
S Discrete The discrete place representing S phase 0 
G2 Discrete The discrete place representing G2 phase 0 
Prophase Discrete The discrete place representing Prophase phase 0 
Metaphase Discrete The discrete place representing Metaphase phase 0 
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Anaphase Discrete The discrete place representing Anaphase phase 0 
Telophase Discrete The discrete place representing Telophase phase 0 
DDS Discrete The discrete place representing DNA damage  0  
iDDS_Ctrls Discrete DNA damage signalling controllers in its inactive form 1 




















Transitions of the MLHPN Model 
Transitions of the MLHPN model (presented in Chapter 6) and type of transitions together with their 
definitions are presented in Tables H. 1. 




Definition Firing Rule 
T1 Continuous 
The transition associated with 
production of CycD_Cdk4 
(aG0_G1_TF) OR (ap27) OR 
(aDDS_Ctrls) 
T2 Continuous 
The transition associated with 
degradation of CycD_Cdk4 
(aSCF) OR (aAPC_Cdc20A) OR 
(aAPC_Cdc20B) 
T3 Continuous 
The transition associated with 
degradation of CycE_Cdk2 
(aSCF)  
T4 Continuous 
The transition associated with 




The transition associated with 




The transition associated with 
production of CycE_Cdk2 




The transition associated with 
production of CycA_Cdk2 
(aG1_S_TF) OR (aG2_M_TF) 
OR aCdc25A OR NOT(ap27) OR 
NOT(aDDS_Ctrls) 
T8 Continuous 
The transition associated with 
production of CycB_Cdk1 
 (aG2_M_TF) OR aCdc25C OR 
NOT(aDDS_Ctrls) 
t1_1 Discrete 
The transition presenting the 
activation of G0_G1_TF 
GF 
t1_2 Discrete 
The transition presenting the 
inactivation of G0_G1_TF 
NOT(GF) 
t3_1 Discrete 
The transition presenting the 
activation of p27 
Early_G1 
t3_2 Discrete 
The transition presenting the 




The transition presenting the 
activation of SCF 
S 
t3_4 Discrete 
The transition presenting the 
inactivation of SCF 
Mid_G1 
t4_1 Discrete 
The transition presenting the 
activation of APC_Cdh1 
Telophase 
t4_2 Discrete 
The transition presenting the 
inactivation of APC_Cdh1 
Late_G1 
t4_3 Discrete 
The transition presenting the 
activation of APC_Cdc20A 
CycB_Cdk1 > 3.9 
t4_4 Discrete 
The transition presenting the 
inactivation of APC_Cdc20A 
Mid_G1 
t5_1 Discrete 
The transition presenting the 
activation of APC_Cdc20B 
Prophase 
t5_2 Discrete 
The transition presenting the 
inactivation of APC_Cdc20B 
Mid_G1 
t6_1 Discrete 
The transition presenting the 
activation of G1_S_TF 
(Late_G1) AND (CycD_Cdk4 > 
4.25) AND (CycE_Cdk2 > 0.4) 
t6_2 Discrete 
The transition presenting the 
inactivation of G1_S _TF 
CycA_Cdk2 > 2.3 
t6_3 Discrete 
The transition presenting the 
activation of Cdc25A 
(Late_G1) AND (CycE_Cdk2 > 
0.4) AND (CycA_Cdk2 > 0.22) 
t6_4 Discrete 
The transition presenting the 
inactivation of Cdc25A 
Mid_G1 
t7_1 Discrete 
The transition presenting the 
activation of G2_M_TF 
CycA_Cdk2 > 2.1 
t7_2 Discrete 
The transition presenting the 
inactivation of G2_M_TF 
Telophase 
t8_1 Discrete 
The transition presenting the 
activation of Cdc25C 
Prophase 
t8_2 Discrete 
The transition presenting the 
inactivation of Cdc25C 
Mid_G1 
t9_1 Discrete 
The transition presenting the 
activation of DDS_Ctrls 
DDS 
t9_2 Discrete The transition presenting the NOT(DDS) 
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inactivation of DDS_Ctrls 
G0_G1_Activation Macro 
The transition that 
encompasses the elements 
associated with cell cycle start 
and Growth Factor sub-system 
Not Applicable 
G1_S_Activation Macro 
The transition that 
encompasses the elements 




The transition that 
encompasses the elements 




The transition associated with 
changing the cell cycle stage 
from Early_G1 to Mid_G1 
GF 
R_Point Discrete 
The transition associated with 
changing the cell cycle stage 
from Mid_G1 to Late_G1 
CycD_Cdk4 > 4.25 
G1_S Discrete 
The transition associated with 
changing the cell cycle stage 
from Late_G1 to S 
CycE_Cdk2 > 8.5 
S_G2 Discrete 
The discrete delayed transition 
associated with changing the 
cell cycle stage from S to G2 
Delay = 7 time units 
G2_M Discrete 
The transition associated with 
changing the cell cycle stage 
from G2 to M 
CycB_Cdk1 > 5.6 
Pro_Meta Discrete 
The discrete delayed transition 
associated with changing the 
cell cycle stage from Prophase 
to Metaphase 
Delay = 0.75 time units 
Meta_Ana Discrete 
The discrete delayed transition 
associated with changing the 
cell cycle stage from Metaphase 
to Anaphase 
Delay = 1.5 time units 
Ana_Telo Discrete 
The discrete delayed transition 
associated with changing the 
cell cycle stage from Anaphase 




The transition associated with 
changing the cell cycle stage 
from M to G1 
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